








SCUOLA DI DOTTORATO IN SCIENZE E TECNOLOGIE DELLA CHIMICA E DEI 
MATERIALI 
CORSO DI DOTTORATO IN SCIENZE FARMACEUTICHE, ALIMENTARI E 




Isolation, structural elucidation and evaluation of bioactivity of 




Tutor:       Dottorando: 
 









                                                                         List of contents 
Acknowledgments                                                                                                                                             3 
Aim of the thesis                                                                                                                                                4 
Summary                                                                                                                                                              6 
Chapter 1. Use of herb since antiquity to date                                                                                            8 
Chapter 2. Genus Salvia                                                                                                                                  11 
2.1 Taxonomy history 
2.2 Molecular phylogenetic studies 
2.3 Name of plant and their importance – Do they really matter? 
2.4 Geografical distribution 
Chapter 3. Phytochemistry of Salvia L.: secondary metabolites (SM)                                                  15 
Chapter 4. Biological activities considered in this thesis                                                                         15 
4.1 The impact of antimicrobial resistance 
4.2 Effect on ectopic oxidative phosphorylation in rod outer segments of bovine retina 
Chapter 5. Salvia species considered in this work                                                                                    19 
5.1 Salvia corrugata Vahl. 
5.2 Salvia tingitana Etl. 
5.2.1 History 
5.2.2 Taxonomy 
Chapter 6. Diterpenes                                                                                                                                    22 
6.1 Focus on Diterpenes Quinones isolated from Salvia species 
6.2 Chemical investigation of roots of S. corrugata 
6.2.1 Antimicrobial activity 
6.3 Chemical investigation of roots of S. tingitana 
6.3.1 Antimicrobial activity 
Chapter 7. Sesterterpenes                                                                                                                           28 
7.1 Sesterterpenes isolated from Lamiaceae family 
7.2 Sesterterpenes isolated from Salvia species 
7.3 Biological and pharmacological properties of sesterterpenes 




7.4.2 Spectroscopic data 
7.4.3 Antibacterial activity 
7.4.3.1 Microorganisms 
7.4.3.2 Active constituents and control antibiotics 
7.4.4 Time killing curves 
7.4.5 ATP production in purified mammalian ATP synthase 
7.4.6 Molecular modeling 
7.4.7 Evaluation of ATP production 
Chapter 8. General experimental procedures                                                                                       62 
8.1 Solvents for extraction and chromatographic purposes 
8.2 Extraction techniques 
8.3 Chromathographic techniques 
8.4 Spectroscopic tecniques and structural elucidation 
8.5 Spectrophotometric techniques used for biological analyses 
8.6 Microscopy technique 
8.7 Purified bovine rod OS preparations 
8.8 ATP synthesis assay in rod OS 
8.9 ATP hydrolysis assay in rod OS 
8.10 Determination of ATP concentration in bacterial culture in the presence of manool 
8.11 Computational method 
8.12 Statistical analysis 
8.13 Docking studies 
8.14 Molecular Dynamic simulations 
8.15 Binding Energy Evaluation 
8.16 Plant material 
Chapter 9. References                                                                                                                                68 
Chapter 10. Appendix                                                                                                                                 84 
Table 1 
Table 2 
Supporting informations of S. tingitana 




Il primo grazie va alla mia famiglia sempre pronta a sostenermi in ogni mia decisione e a 
incoraggiarmi ad andare avanti nonostante tutto e tutti. Grazie per esserci sempre stati 
soprattutto nei momenti di sconforto. 
Grazie a Simone per essermi accanto, per ascoltarmi, per gioire con me di ogni mio piccolo 
successo e per essere la spalla su cui posso contare. 
Grazie alle splendide persone che ho incontrato durante questo percorso: Giorgia, Silvia, 
Ylenia, Hanna, Martina, Valeria e tutti coloro che hanno vissuto con me le gioie e difficoltà 
del laboratorio. 
Grazie alla Prof.ssa Angela Bisio per questi 3 anni di dottorato e per le esperienze che mi ha 
permesso di svolgere e condividere. 
Infine, dedico questa tesi a me stessa, ai miei sacrifici e alla mia tenacia che mi hanno 





Aim of the thesis 
Objective of my research project is to identify and isolate new bioactive terpenoids from 
aromatic plants grown in Liguria (Italy). The main line of research in our laboratories is the 
study of the antimicrobial activity of extracts and compounds isolated from Salvia species. 
The aim is to isolate and identify possible promising compounds for future biological 
applications. The research activity was mainly carried out at the Department of Pharmacy, 
University of Genoa, Laboratory of Phytochemistry. 
 
This thesis reports the work during my three - years of doctorate. The surface extract of the 
aerial parts, the methanolic extract of the roots of S. tingitana and the methanolic extract of 
the roots of Salvia corrugata were investigated. Further purification of fractions will be 





Plants have always been in existence for thousands of years because they formed the basis 
of sophisticated traditional medicine systems and continue to provide mankind with new 
remedies [1]. Some, may not comprehend the scientific reason behind the medicines but 
personal experience has shown them the highly effective use of plant in therapeutic doses. 
Countries like China and India together with other traditional medicine systems have also 
been documented; and continued to do so as estimated by the World Health Organization 
[2]. In the past, natural products were used as therapeutic products and for long time were 
the main source of drugs. Infact there is a growing interesting in alternative therapies and 
the therapeutic use of the products. There are many examples of these natural plants and 
their therapeutic resources demonstrated by Rates in 2001, Rios in 2005 and others [3]; [4].  
In my thesis I have mainly dealt with plants coming from the genus Salvia. Sage ora Salvia is 
widely appreciated for its great beauty in horticultural trade; its 900 species of variations 
found in different parts of the world and the noitable translation from Latin which means 
“to save”, still confirms its essential use both in traditional medicine and in culinary purposes. 
While our laboratory was investigating the methanolic extract of roots of Salvia corrugata 
for the first time, we isolated some quinone diterpenes. In order to gather complete 
information about the distribution of these compounds within Salvia species, we performed 
a literature investigation. We also included a classification of how sage changed in time 
beginning with morphology parameters followed by geographic distribution as far as the 
most recent molecular phylogenetic studies.  
Regarding the phytochemistry of Salvia, plants produce an array of primary and secondary 
metabolites [5]. In the past the latter were seen as waste products as a results of “errous” 
of primary metabolism but it has became clear that many secondary products are the 
essential key components of active and potent defence mechanisms [6]. The three main 
categories of plants secondary metabolites are: terpenes/terpenoids, alkaloids and phenolic 
acids [7]. The most aboundant and structurally diverse groups of plants secondary 
metabolites are terpenoids [8]. Terpenoids contain an whole number of 5 carbon units 
(isoprene) forming the sequential combination of these basic 5C units, from which we can 
obtain the categories of: C10 (mono-), C15 (sesqui-), C20 (di-), C25 (sester-), C30 (tri-), C40 (tetra-
terpenoids). Throughout history the use of terpenoids as treatment for various kinds of 
diseases can be seen because different terpenoid molecules have various health benefitial 
properties [9]. Note that Salvia species produce terpenoids such as triterpenes, diterpenes 
and monoterpenes.  
The two species considered in my thesis are: Salvia tingitana Etl. and Salvia corrugata Vahl.  
Salvia tingitana Etl. is an aromatic multi-stemmed perennial shrub, till 100 cm, with 
eglandular and glandular indumentum, with white flowers showing a cream-yellow lower lip 
[10]; [11]. The species has a long and enigmatic history. The chemical separation of the 
extract of the aerial parts of S. tingitana afforded one nor-sesterterpene (1), eight new 
sesterterpenes (2-9) and five known sesterterpenes, together with other known compounds 
that include five labdane and one abietane diterpene, one sesquiterpene and four 
flavonoids. The new compounds were identified by NMR spectroscopy, including TOCSY, 
COSY, HSQC, HMBC and ROESY experiments, HRESIMS, and ECD and VCD analysis. The 
antimicrobial activity of compounds was evaluated against thirty human pathogens. The 
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compounds were also tested for the inhibition of the ATP production in the purified 
mammalian rod outer segments. Molecular docking was also performed. Finally, the ATP 
production in the presence and absence of manool (17) by Enterococcus faecalis MB1 (VRE) 
and E. faecium MB 152 (VRE) was assessed in whole-cell assay.  
The methanolic extract of the roots of S. tingitana, was also investigated. The methanolic 
extract was tested for the antimicrobial activity against different Gram positive clinical 
isolates which include multiresistant strains of Staphylococcus aureus, S. epidermidis, E. 
faecium, E. faecalis and Micrococcus luteus showed MIC values ranging from 8 to 32 μg/mL. 
The methanolic extract was subsequently purified by silica gel column chromatography, 
giving 11 semi purified fractions, that were tested against different other Gram positive 
multi-resistant clinical bacterial strains, also of marine origin. All fractions were active against 
the tested strains showing MIC values ranging from 2 to 64 μg/mL, with the exception of 
fraction 1 and fraction 11. Fraction IIIc was the most active, which displayed MIC values 
ranging from 2 to 8 μg/mL against both Staphylococci and Enterococci. Fraction IIIc was then 
purified, by semi-preparative RP-HPLC, giving compounds Hypargenin C, Royleanone and 7-
O-Methylhorminone, identified by IR, 1D and 2D NMR, ESI-MS and HR-MS analysis. 
Hypargenin C, which was isolated in suitable amounts, exhibited MIC values ranging from 2 
to 8 μg/mL against the same Gram positive isolates. 
Salvia corrugata Vahl. is an American species and it is grown near the Mediterranean coastal 
area as an ornamental plant. The methanolic extract of the roots and the twelve semi-
purified fractions purified by silica gel column chromatography were tested against different 
multidrug resistant clinical strains also of marine origin, showing MIC values which go from 
4 to >128 μg/mL. 7-O-methylhorminone, Horminone and 7-O-acetylhorminone were 
isolated. Horminone and 7-O-acetylhorminone, obtained in adaptable quantities, displayed 




1 Use of herb since antiquity to date 
Plants are an essential source of medicine which play a key role in our World Health. 
Medicinal herbs or plants have been known to be a very potential source of therapeutics or 
curative fields. The use of medicinal plants has attained a decisive role in the health system 
all over the world. [1]. Domestic medicine consisted largely in the use of vegetable products, 
or herbs which are still used today. Herbal remedies cured common colds and constipation. 
However, grave and disabling diseases, were put into different categories because they 
derived from supernatural origin. Magic and religion played an important role in the 
medicine of early human study. An example of such an irrational conception is the Doctrine 
of Signatures, elements of which are found in various healing cultures of the world. The 
Doctrine of Signatures is based on the assumption that the appearance of plants could give 
clues to their medicinal properties—it is seen as God’s signature on the plant. [1]. Some, may 
not comprehend the scientific reason behind the medicines but they know from personal 
experience that some medicinal plants can be highly effective, if used at therapeutic doses 
[1]. 
The first traces of the use of Medicinal plants date back to 4000 B.C. Since then Western 
civilisation already knew about the use of curative plants also known today as opium, thyme 
and liquorice, senna, coriander, saffron, cinnamon and garlic [12] have been documented as 
far back as Babylon in old engravings in rocks. The Egyptian culture has given us a great 
number of documents of their knowledge for medicinal purposes. The best known, dating 
back to 3000 B.C, Ebers Papyrus takes its name from the German Egyptologist Georg Ebers. 
The documents showed at least 800 recipes and approximately 700 medicinal plants, both 
local and foreign origin. Among the examples mentioned are also aloe, absinth, peppermint, 
colocynth, cannabis and others [12].  
Vegetable drugs from indigenous plants like cardamom, cinnamon that appeared in Western 
Pharmacopoeias come from India, while the Chinese Materia medica has always been 
extensive and also consists of famous herbs from ancient times. Among the drugs taken over 
by western medicine from the Chinese are Rhubarb, castor oil, kaolin, aconise and cannabis 
sativa. Ephedra Vulgaris has been utilized in China for at least 4000 years and the isolation 
of its alkaloid ephedrine has very much helped the Western cure of asma and other close 
states. Ginseng has shown its diuretic properties, while reserpine, which is the active 
principle of the Chinese plant Rauwolfia, has been used in the treatment of hypertension. 
There again, the Greek Roman period in Europe, has also left scripts dealing with medicinal 
plants used for treatment of illnesses. Hippocrates is often called “The Father of the 
medicinal art” [12] because of the many references which described the plants he used. His 
successors like Theophrastus wrote “Historia plantarum” again describing their use as 
medicinal plants, followed by Plinius the elder, who wrote “Historia naturalis”. This 
document was used as a reference source for several centuries dealing with medicine, plants 
and their products. The best known medical period from the Roman period was Pedanius 
Dioscorides who wrote “De Materia Medica” describing 600 medicinal plants. This document 
called Pharmacopeias was considered to be the precursor of later documents on medicinal 
plants (see Indian medicine). Dioscorides used extracts from mandragora to induce 
anesthesia [12] under surgery. Persons were not left unconscious but had a feeling of not 
being present. Claudius Aelius Galenus theories dominated Western medical science for well 
over a millenum. The Roman physician and philosopher was one of the early ones to prepare 
medicines in dosage forms and explained the process of coating on pills. Once again his 
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documentations on 130 medicinal plants and recipes led the way into Pharmaceutical 
sciences of today known as Galenical pharmacy.  
During the Middle Ages medicine passed from the Christian church and Arab Scholars. The 
most important contribution of Arabian medicine was in chemistry and in the acquisition of 
knowledge in the preparation of medicine. At that time the chemists were alchemists but 
during their experiments, various substances were named and identified and some were 
found to have great medicinal use. Arab pharmacies spread and were government 
supervised. They also developed a system of dosage for medications using mathematics. 
Avicenna, a famous philosopher and physician, is best known for his report “Canon 
Avicenna” (Canon of medicine) which carefully described the understanding of medicine and 
pharmacology of that time. Pharmacies were created where remedies like camphor, mastix, 
rhubarb, saffron and aloe were also sold. Description of the production of juices, tintures, 
extracts of herbs, pills with coatings and distillation of alcohol are also found in the Canon of 
medicine. Avecenna also recognized other factors like proper diet, climate changes and 
environment on our health.  
The Monastery period was very important for the health care system. The Salernoschool 
wrote about the importance of sanitary sanitation in documents like “Regime sanitates 
Salernitanum”. Most plants were used for health benefits and the Monastery gardens that 
spread all over Europe were introduced by Ansegis, requested by “Charles the great”. 
Ansegis was the origin of the text “Capitulare de villis” which included rules on how to live 
and grow medicinal plants in the monasteries. His work was such a great success that he was 
canonized as Saint Ansegisus. Later the great reformer Paracelsus Phillipus Aurelius 
Theophrastus Paracelsus Bombastus von Hohenheim, better known as Paracelsus [12] was 
the very first to carry out clinical trials in order to test the effect of the products, which he 
used as a doctor before actually applying them on his patients. He was the founder of clinical 
studies and his definition of what could be a poison is still valid: “Everything is poison; it is 
just the concentration that will decide if something is nontoxic.”  
The invention of the letter press by Johanes Gutenberg led to a resurrection of the Greek-
Roman knowledge in the 15th and 16th century, and also to the compilation of several herbal 
books that were distributed widely in Europe, thus contributing to a spread of knowledge. 
Two influential examples are the “Mainz Herbal” Herbarius Moguntius (1484) and the 
“Germen Herbal” (1485).  
The “Scientific period” started after Paracelsus. Modern science started around 1600 till 
present. One of the names to be remembered forever is Carl von Linnè who underlined the 
importance of giving a specific identification and systematization to all living species. He 
introduced plant systematics that contained rules on the determination of characteristics of 
the plant and later utilized these characteristics to categorized plants into a system which 
simplified their identification. “The system of Linnè” still carry his name. Today, gene 
classification is used.  
Another Swedish scientist and pharmacist, Carl Wilhelm Scheele is best known for the 
discovery of oxygen and nitrogen which became an important basis for modern chemistry. 
Two important German chemists are: Friedrich Wohler who is best known for being the first 
to synthetize urea and to isolate several chemical elements; Paul Ehrlich who worked on 
hermatology in autoimmunity that he called “horror autotoxicus”.  
In 1923 Sir Alexander Fleming, a Scottish biologist, first discovered the enzyme lysozyme, but 
he is best known for the re- discovery of penicillin from the fungus Penicillinum notatum in 
1928, for which he received the Nobel Price [12]. The result led to a radical change in the 
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treatment of diseases, caused by bacteria and has saved a large number of deaths 
worldwide.  
 





2 Genus Salvia 
 
For a long time Salvia, or Sage, has been used in traditional medicine as well as for culinary 
purposes. The ethymology of the word Sage derives from the Latin verb “salvare” (to heal/to 
save), and the Latin proverb “Cur moriatur homo, cui Salvia crescit in horto?” (Why should a 
man die who has sage in his garden?) has confirms its use for centuries [13]. In English there 
is a corresponding proverb: “He that would live for aye, Must eat Sage in May”. The word 
was popularly altered by the French to Sauja and Sauge coming from Old English, “Sawge”, 
which is used in the present day name of Sage [14]. In the middle of the 7th century, Linneo, 
a Swedish biologist and naturalist, gave the specific epithet officinalis to this plant. In the 
11th and 12th centuries, the Salerno Medical School, considered Sage as the best miraculous 
herb and therefore named it Salvia salvatrix.  
In traditional medicine, Salvia species have been adopted to treat colds, bronchitis, 
tuberculosis, haemorrhage and menstrual disorders [15]. The plants are typically 30-150 cm 
tall, herbaceous or suffruticose, and perennial, seldom biennial, or annual, with flowers in 
different shades of colors [16].  
 
2.1 Taxonomy history 
Various attempts to classify Salvia were carried out in the19th century introducing different 
subgenera and sections [17]. 
In 1777 Etlinger published the first botanical monograph of Salvia recognizing 48 species. 
Later, Bentham formed the first infrageneric grouping on Salvia in the Labiatarum (1832-
1836) [18], which was based on calyx, corolla and stamen morphology [19], and gave the last 
world-wide revision of the genus, and put the then known 266 species into [19] 14 sections. 
The genus is characterized by modified lever-like stamens which play the main role in the 
process of pollen transfer. Because of this unusual structure, the genus as a whole has long 
been thought as monophyletic. In the second study (De Candolle’s Prodromus 1848), 
Bentham [20] classified 406 Salvia species into 12 sections [19]. In a third study (1876), he 
added Salvia into the tribe Monardeae, along with Perovskia Karel, Dorystaechas Boiss et. 
Heldr., Meriandra Benth., Salviastrum Scheele, Audibertia, Rosmarinus L., Monarda L., 
Blephilia Raf., and Ziziphora L. In order to further classify the 12 sections, he established four 
subgenera, Salvia, Sclarea, Calosphace and Leonia, based on the geographical distribution 
and morphology of the calyx, corolla and stamens. This classification is still used today [17]. 
Modifications on Bentham’s 1876 subgeneric arrangement have been modified by Briquet, 
(1895-1897), Stibal (1934) and Pobedimova, (1954). The latter assigned Salvia spp. which 
was distributed in the former USSR to seven subgenera and eight sections [21]. In 1873 
Bunge revised the sections accepted by Bentham in 1848, in particular the Southwest Asian 
ones [17]. In the Flora Orientalis (Boissier, 1875), the Turkish Salvia species were placed into 
7 sections, all of which were previously recognized by Bentham (1833), that is the sections 
Salvia (syn. Eusphace), Hymenosphace, Horminum, Aethiopis, Drymosphace, Plethiosphace, 
and Hemisphace. In 1972 Hedge changed sect. Eusphace to sect. Salvia [22]. However in 1895 
Briquet in the Pflanzenfamilien did give a more recent review without a monographic 
treatment [11]. Approximately 500 Salvia species in 17 sections and eight subgenera were 
arranged by him and Salviastrum, Polakia Stapf and Ramona Greene (=Audibertia Benth. 
sensu Boissier, 1879) were considered as genera distinct from, but associated to Salvia. 
These genera were put into in the tribe Salvieae [17]. Epling (1938-1939) updated subgenus 
Calosphace and recognized about 470 species, all of which are found in the New World, 
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mainly in Central and South America. Stibal also updated the Chinese (1934) and Indian 
(1936) species. Hruby´ (1962) proposed the upgrading of some subsections to the genus level 
which was also proposed by Rafinesque (1837) more than one century earlier [17]. 
Hedge starts talking about “species-groups”, so he revised the Europan and African species 
and prepared the Turkish and Iranian Salvia accounts [23]. When treating SW Asian Salvia 
Hedge concentrated on N African/SW Asian disjunctions and talked about their relationships 
[17]. Hedge (1974) believed that previous classifications were insufficient and therefore he 
suggested a worldwide research to clarify the subgeneric and sectional delimitation in the 
genus. The first revision of Salvia L in Turkey was revised by Hedge in Flora of Turkey in 1982 
[24]. ‘Species groups’ were not explicitly named but rather indicated by horizontal dots [17]. 
The results of the studies carried out by Hedge’s view of ‘species groups’ gave a better 
understanding of relation in Old World Salvia, as well as providing a more up-to-date 
infrageneric classification for the corresponding local floras [17]. 
 
2.2 Molecular phylogenetic studies 
Recent phylogenetic studies confirm that Salvia is polyphyletic with four distinct clades 
(Clade I-IV), of which five added genera (Dorystaechas, Meriandra, Perovskia, Rosmarinus e 
Zhumeria). There are two phylogenetic and taxonomical valid proposals on how to treat the 
paraphyly: one is either by including the five above mention genera in the Salvia genera, in 
the broad sense and dealing with the five genera as subgenera itself; or by subdividing the 
species in six genera. Several coding and non-coding regions have been proposed for use as 
DNA barcodes in plants. These include rbcL, matK, psbA-trnH, and ribosomal intergenic 
spacer regions (ITS) [25]. According to the results of molecular studies presented by Walker 
et al. 2004, based on chloroplast rbcL and trnL‐F sequences, three clades were identified 
(Clade I-III): Salvia clade I— largely Old World but with one New World lineage; Salvia clade 
II—New World lineage comprising subg. Calosphace and sect. Audibertia; and Salvia clade 
III—an independent Asian lineage. Following up, Walker et al. 2007, thanks to a slight 
increase of samples, individualized the genera Zhumeria in a different position and so 
renamed Salvia “Clade III”. However, in 2014 according to Will and Claßen-Bockhoff Salvia 
“Clade III” was indicated as two independent clades: Clade III (specie Salvia asiatica SW e 
Zhumeria) and Clade IV (E Asian Salvia) [26]. 
Regarding relative studies on the Salvia origin from China: Takano and Okada in 2011 did 
phylogenical analysis on 11 species of Japanese Salvia stating that they are monophyletic 
and they discovered that the species were distributed into three subclasses: 1) S. plebeia 
(subg. Sclarea), (2) subg. Salvia and (3) subg. Allagospadonopsis [27]. In the phylogenetic 
analysis carried out by Li et al. 2013, the Chinese and Japanese species of Salvia (except S. 
deserta) clearly formed a separate clade. The classification suggested by Li et al. 2013 
foresaw three subclades in the Chinese clade: (i) subg. Allagospadonopsis and sect. 
Drymosphace; (ii) sect. Notiosphace and the sister species S. trijuga (sect. Drymosphace) and 
S. pauciflora (sect. Eurysphace); and (iii) sect. Eurysphace. The first subclade contained two 
principal groups: (i) sect. Drymosphace and (ii) subg. Allagospadonopsis plus several 
individuals from sect. Drymosphace, and S. yunnanensis (sect. Drymosphace) were its sister 
group. Moreover, all species introduced from America were in Clade II, and all species from 
Europe were in Clade I [28]. Samples of representative taxa of 73 sections of Calosphaceae 
were used to investigate and identify the phylogenetic relationships and principal lineages 
using chloroplast (intergenic spacer psbA-trnH) and nuclear ribosomal DNA (internal 
transcribed spacer). Phylogenetic analysis of the combined data sets determined monophyly 
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of seven sections (Blakea, Corrugatae, Erythrostachys, Hastatae, Incarnatae, Microsphace, 
and Sigmoideae) and four principal lineages (S. axillaris, ‘‘Hastatae clade’’, ‘‘Uliginosae 
clade’’, and ‘‘core Calosphace’’) [29]. Moreover, Jenks and collegues claimed that Epling’s 
infra-subgeneric sections were not supported as monophyletic in their results because many 
of Epling’s sections were distinct being made up of species from multiple centers of diversity. 
In most cases sections along regional/geographical lines were polyphyletic when sampled, 
comprising eleven disjunct sections. In their results Tomentellae and Ulginosae were 
paraphyletic. Will et al. (2015) maintained that the five genera (Dorystaechas, Meriandra, 
Perovskia, Rosmarinus e Zhumeria) incorporated in Salvia should be kept as distinct genera 
and that Salvia should be subdivided into smaller and easier to handle groups. This course 
of action would leave only the clade (ca. 250 species; Walker & Sytsma, 2007) containing the 
type of Salvia (Salvia officinalis L.) as the taxa bearing the Salvia name (assuming no new 
genera are proposed within the “Salvia officinalis” clade) [26]. Will e Claßen-Bockhoff (2017) 
then proposed dividing Salvia into 6 genera: Salvia sensu stricto (s.s.). Lasemia, Ramona, 
Glutinaria, Pleudia e Polakia, based on ITS data (internal transcribed spacer), from 220 Salvia 
species. 86 of these were sequenced for the first time. The sequences were combined with 
the accessions available from GenBank [17]. The 4 main clades identified by Will and Claßen-
Bockhoff (2017) thanks to ITS data were (Clade I–IV): (1) Clade I (Salvia s.s.), (2) Clade II (most 
NW Salvia + Dorystaechas + Meriandra), (3) Clade III (SW Asian Salvia with Zhumeria) and IV 
(E Asian Salvia). Within Clade I, four principal lineages were identified: (1) subclade I-B, (2) 
subclade I-A, (3) S. taraxacifolia, the S. verticillata group, subclade I-C, and S. leriifolia as one 
weakly supported clade, and (4) subclade I-D [17]. The taxonomical treatment suggested by 
Will e Claßen-Bockhoff (2017) had meant that approximately 750 species of Salvia would 
have been transferred to the resuscitated genera Glutinaria, Lasemia, Ramona, Pleudia and 
Polakia, which would lead to ongoing taxonomic confusion because the boundaries between 
the genera are not morphologically distinct. Moreover, it was found that some ITS sequences 
utilized in Will and Claßen-Bockhoff (2017) were debatable, which could have come from 
species misindentified and/or GenBank uploading mistakes [19]. 
Broadly speaking about the concept of Salvia, Drew et al. 2017 considered the five genera to 
be as subgenera as Salvia embedded itself, according to phylogenetic, practical and 
taxonomical considerations. From recent classification by Hu et al. 2018 it would be better 
to keep a broad definition of Salvia as suggested by Drew et al. 2107. In 2018, Hu supported 
the idea of a broader definition of Salvia and he treats EA Salvia as subgenera, Glutinaria, 
identifying eight sections found inside the subgenera. All of these eight sections should all 
have the same taxonomic weight. Supporting the philosophy of Will and Claßen-Bockhoff 
(2017), EA Salvia should be handled as either eight genera or eight sections of a single genus. 
Considering EA Salvia as eight separate genera would be confusing; moreover, it seems 
unsustainable to consider EA Salvia as a single genus because Hu et al. were unable to 
discover any individual morphological feature that distinguishes EA Salvia from Salvia in the 
other centres of diversity [19]. So Hu et al. considered Salvia clade as a subgenus, including 















2.3 Name of plants and their importance – Do they really matter? 
 
The initial idea of our work was to study the quinone ortho and para diterpenes from a 
chemical point of view because of their phytochemical and pharmacological properties. 
However, during the study we realized that different classification of sage weren’t exactly as 
they should have been. Consequentely, this led to a correction of nomenclatural names and 
taxonomical classifications. In order to gather complete information about the distribution 
of these compounds within Salvia species, we performed a literature investigation, and we 
recently published the results as a review. 
The species considered in our review, according to the findings of the phylogenetic studies 
[30], [31]; [32], [17], [26] and regarding taxonomic treatment suggested by Drew and 
colleagues in 2017 and Hu and colleagues in 2018, belonged to subgenera Calosphace 
(Benth.) Benth., Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma, Glutinaria (Raf.) G.X.Hu, 
C.L.Xiang & B.T.Drew and to two other lineages tentatively named as “Salvia officinalis clade” 
“Salvia aegyptiaca clade” (Table 1 Appendix) [33]. 
 
2.4 Geografical distribution 
 
The genus Salvia is largely distributed in different countries including those where 
temperatures are milder and warmer like the Mediterranean, Central Asia, the Pacific 
Islands, tropical Africa, and America. The genus Salvia has a subcosmopolitan distribution, 
which is widely absent in the North and the majority of the low-lying tropical areas of the 
world for example the Amazon basin and central and west Africa. About 90 Salvia species 
are present in Turkey and half of them are endemic. Sixty species in Iran out of which 17 are 
endemic. Africa grows the largest amount of species, found in the northwest and the 
southern parts. Whereas there is no genus has been reported for western and central 
tropical Africa [34]. In Mexico, there are approximately 300 species of Salvia, of which 85–
88% are endemic [35]. The plants are typically 30-150 cm tall, herbaceous or suffruticose, 
and perennial, seldom biennial, or annual, with flowers of different colors [16]. 
The 130 species of Salvia considered in our work have distributed extensively in three regions 
of the world: 65 species come from central Asia/Mediterranean, 41 from eastern Asia, but 
only 24 from Central and South America. The division of the species displayed overlapping 
phytogeographic ranges reflecting the principal areas of the biodiversity of the genus [33].   
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3 Phytochemistry of Salvia L.: secondary metabolites (SM) 
 
Salvia L. species produced an array of secondary metabolites [36]. Unlike the past, secondary 
metabolites are considered to be a key components of active and potent defence mechanism 
[6] and are essential and necessary for the plant to ward off pathogens [37].  
We can classify plant natural products into three main groups, on the basis of their 
biosynthetic origins: the terpenoids, the alkaloids, and the phenylpropanoids and allied 
phenolic compounds [38]. The largest group of natural compounds are Terpenoids, also 
known as terpenes [39]. All terpenoids can be built using the C5 isoprene unit, even though 
structurally they have a very large diversity [40]. Terpenoids are classified into 
hemiterpenoids (C5), monoterpenoids (C10), sesquiterpenoids (C15), diterpenoids (C20), 
sesterterpenoids (C25), triterpenoids (C30), tetraterpenoids (C40, carotenoids), and 
polyterpenoids (C5n) based on the number of carbon atoms [41]. 
The main secondary metabolites of Salvia species are flavonoids and terpenoids. The aerial 
parts of Salvia species usually produce flavonoids and triterpenoids, whereas in the roots, 
the principal compounds are diterpenoids. Both sesquiterpenoids and sesterterpenoids are 
quite rare in Salvia species [42]. 
 
4 Biological activities considered in this thesis 
 
4.1 The impact of antimicrobial resistance 
 
The discovery of antibiotics is one of the key achievements of modern medicine [43]. The 
formal discovery of antibiotics occurred in 1928 [44], when Fleming discovered penicillin. He 
observed that some bacteria were inherently sensitive and others inherently resistant. There 
were already early warning signs of what was to come. In 1942, René Dubos foresaw 
bacterial resistance. “Rather than counter bacterial resistance with even more potent 
weapons”, he concluded that we should, “seek instead more peaceful coexistence with 
pathogens” [45]. The Nobel Prize was awarded to Fleming in 1945. He observed that initially 
sensitive bacteria could develop resistance, especially if exposed to low doses, and warned 
that if penicillin were to become cheap and easily available, ‘negligent’ use, might encourage 
resistance and failure of therapy [46]. In the early 1950s resistance to penicillin emerged not 
long after its introduction and therefore, related to patient deaths [44]. Antibiotics do not 
target human biochemical processes but those of another life form: bacteria. Bacteria can 
evolve and adadapt to their environment, thus developing several protective mechanisms 
so as to reduce their susceptibility to antibiotics (‘antibiotic resistance’) [43]. The antibiotic 
resistance becomes more serious when microorganisms, develop resistance not only to a 
single  antimicrobial agent, but also to several antimicrobials or chemical classes available in 
the market. These microorganisms are often referred as multidrug-resistant (MDR) [47]. The 
important spread of antibiotic resistance determinants among commensal, environmental 
and pathogenic bacteria has attained global dimensions [48]. Bacteria evolve not only by 
mutation, but also by allowing for horizontal gene transfer (HGT) within and between species 
[43]. Intrinsic and acquired bacterial mechanisms of resistance are both characterized by an 
irreversible phenotype. Note that these mechanisms are not influenced neither by 
antibiotics nor environment; certainly, the response of bacteria to signs such as the presence 
of antibiotics, especially at sub-inhibitory concentrations, or environmental conditions like 
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pH, anaerobiosis, cation level, is the the formation of biofilm [49]. Biofilms are structured 
microbial communities of surface-attached cells embedded in a self-produced matrix of 
extracellular polymeric substances (EPS) composed of proteins, lipids, nucleic acids, 
polysaccharides, and other components [47]. While bacteria are in the biofilm state, they 
are definitely more resistant to external attack, including antibiotics [50]. Bacteria 
embedded in biofilms experiment numerous changes in gene regulation that lead biofilm 
cells to become phenotypically and metabolically different from their planktonic 
counterparts [47]. Numerous nosocomial infections like those concerning the use of central 
venous catheters, urinary ones, prosthetic heart valves, and orthopaedic devices are notely 
associated with biofilms that adhere to the biomaterial surface [51]. Biofilm formation is 
present in 5 distinct stages for most species. Their definition is a combination of genetic and 
phenotype change. All species of bacteria have specific sets of environmental indication 
which will initiate biofilm [50]. The resistance problem is proved by the increase in the 
growing MIC values of the isolated microorganisms. At present, MIC values in patients can 
be of 16 g/mL and MICs of >128 g/mL, sporadically occur [49]. An attempt of traditional 
means to locally control or slow down the progress of antibiotic resistance in patients, based 
on a better antibiotic prescribing policies, are not up to global standards [48]. As a result, 
more recent pathogens with multidrug-resistance profiles like Acinetobacter baumannii 
have become apparent, such as “old” pathogens as Mycobacterium tuberculosis and 
Neisseria gonorrhoeae which presently are now resistant to frontline antibiotics [52]. 
Transmission of antibiotic-resistant bacteria in hospitals (and more generally in society) is 
facilitated by overcrowding and poor hygiene. Hospitals and other healthcare facilities are 
usually associated with antibiotic resistance [43]. Hospital pathogens tend to be the most 
resistant. This tends to favour firstly the emergence within hospitals of free-living 
opportunistic pathogens that are relatively antibiotic resistant, probably because of their 
exposure to natural antibiotics in the environment. Secondly, inherently sensitive organisms 
begin to acquire new, usually highlevel, resistance mechanisms [46]. The principal 
mechanisms of bacterial resistance to antimicrobials include drug inactivation, target 
modification, alteration in the accessibility to the target through drug efflux and decreased 
uptake, as well as over-expression of the drug target. The requirement of the new genetic 
programming by the cell in response to the presence of antibiotics is needed by all of these 
mechanisms [52]. The majority of the existing antibacterial leads have been derived from 
natural sources, which continue to be important for new lead discovery [53]. Therefore, it is 
possible to say that the antibiotic resistance is a phenomenon that has always existed, even 
before their use as treatment of infective diseases and agriculture or livestock. As of matter 
of fact, antibiotics are present everywhere in nature, for example micro-organisms and 
plants produce antimicrobials as secondary metabolites [49]. The plant kingdom is 
considered to be a source of new chemical compounds, which could be essential owing to 
their potentiality in medicine for the development of novel therapeutic agents. Several plant 
compounds have been considered as antibacterials and may be compared to antibiotics [52]. 
Unlike synthetic molecules, phytochemical products display an unmatched structural 
diversity with complex and novel multilayer mechanisms of action [47]. Phytochemicals are 
structurally distinct from micro-organism, derived from antibiotics and have different modes 
of action. Concerning the plant chemical ecology, plants produce antibacterial secondary 
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metabolites as part of their chemical defense strategy to preserve themselves against 
microbes in their environment. The accumulation of low-molecular-weight compounds that 
work as phytoalexins is a well known defence mechanism [54]. Various species of Salvia have 
been described as interesting sources of such bioactive compounds [54]; [55]. Useful 
phytochemicals with antimicrobial activity can be divided into several classes that include: 
phenolics and polyphenolics, terpenoids, alkaloids, lectins and peptides, and polyacetylenes. 
The principal subclasses are: simple phenols and phenolic acids, quinones, flavonoids, 
coumarins, tannins, terpenoids, alkaloids, lectins and polyketides, isothiocyanates, 
polyamines, sulfides, thiosulfinates, glycosides, phenanthrenes and stilbenes, and many 
others [47]. It is possible to categorize antimicrobial agents based on their main mechanisms 
of action. These mechanisms comprise: interference with cell wall synthesis (e.g., β-lactams 
and glycopeptide agents), inhibition of protein synthesis (macrolides and tetracyclines), 
interference with nucleic acid synthesis (fluoroquinolones and rifampin), inhibition of a 
metabolic pathway (trimethoprim-sulfamethoxazole), and disruption of bacterial membrane 
structure (polymyxins and daptomycin) [56]. Moreover, antibiotics have been classified on 
the basis of their chemical structure and how they kill bacteria or inhibit their growth [49]. 
Urgent strategies are necessary to confront the processes influencing antibiotic resistance 
pollution in the microbiosphere [48]. 
 
4.2 Effect on ectopic oxidative phosphorylation in rod outer segments of bovine retina 
 
Oxidative stress is a primary risk factor for inflammatory and degenerative retinopathies. 
Most of the energy needed by human cells is provided by mitochondria in the form of ATP 
[57]. The majority of ATP is synthesized during oxidative phosphorylation or 
photophosphorylation by the proton-translocating ATP synthase (FoF1-ATPase) [58]. The 
mitochondrial ATP synthase (F1Fo-ATPase) is a multisubunit, membrane-bound assembly 
central to biological energy conversion. F1 is a water-soluble catalytic complex composed of 
five subunits (α3β3γδε), with the catalytic site placed on the β subunit. F0 is made up of 
different membrane proteins (a, b, c, d, e, F6, A6L) and oligomycin sensitivity-conferring 
protein (OSCP), which helps the stalk region between F0 and F1. Moreover, a native peptide 
is also bound to the F1 under de-energized conditions which serves to inhibit the ATPase 
activity of the enzyme (called F1 inhibitor protein, IF1) [59]. The retinal rod outer segment 
(OS) is defined as a stack of disks surrounded by the plasma membrane, which contains 
proteins related to phototransduction, and also mitochondrial proteins involved in oxidative 
phosphorylation [60]. 
Bacterial energy metabolic pathways are mainly unexplored as drug targets both, for the 
resistant Gram-positive and Gram-negative bacteria. The production of ATP by bacteria, 
using the respiratory chain and ATP synthase, can be obtained either by substrate-level 
phosphorylation of fermentable carbon sources or by oxidative phosphorylation [61]. 
Diarylquinoline compounds have shown antimicrobial activity by blocking ATP synthase. 
Recent blocking of the ATP synthase enzyme by TMC207, has shown an effective strategy in 
the treatment of drug-resistant Mycobacterium tuberculosis. Furthermore, mycobacteria are 
very different from other Gram-positive or Gram-negative bacteria regarding their 
susceptibility for currently used antibacterials [61]. Diarylquinolines have shown activity 
against key Gram-positive pathogens (Staphylococcus aureus) [62]. Drug-resistant mutations 
were mapped to the ATP synthase enzyme, and biochemical analysis as well as drug-target 
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interaction studies reveal ATP synthase as a target for these compounds. The reduction of 
the ATP synthase expression plays a key role suppressing S. aureus growth and metabolism. 
Some polyphenolic phytochemicals are natural compounds showing a potent antioxidant 
activity. Furthermore, they act as ATP synthase inhibitors. For example resveratrol, a natural 
stilbene phytoalexin inhibitor of ATP synthase, targets the F1 component. It affects both 
ATPase and ATP synthase activity by binding between α and β subunits [63]. Polyphenols are 
known to have an inhibitory activity on ATP synthase both in mitochondria and in rod Outer 
Segments (OS). 
Taking into account that overall structure and energy transduction mechanism of the ATP 
synthase are conserved, from bacteria to human, and that exudates of Salvia spp are rich in 
terpenoids and in flavonoid aglycones, we performed a bioguided purification of the total 
extract on the basis of both the antimicrobial and ATP synthase inhibition activities, in order 
to investigate the possible molecular target of antimicrobial effect of Salvia tingitana. We 




5 Salvia species considered in this thesis 
 
5.1 Salvia corrugata 
Subgenus: Calosphace [64] 
Sectio: Corrugatae [64] 
In: Proceedings of the American Academy of Arts and 
Sciences 35(25): 538-539 1900. 
Distribution: Central or South America. Mountains, 
secondary scrubs. Alt. 2500-3000 m. [64] 
Synonyms: Sphacele gaudichaudii Briq. (in: Annuaire 
du Conservatoire et Jardin Botaniques de Genève 
2:182, 1898); Alguelagum gaudichaudii Briq. (nomen, 
in: Annuaire Conserv. Jard. Bot. Geneve 2:182, 1898) 
[65] 
Description:  
It is a frutex of the Andean Region (Azuay, Bolívar, Cañar, Chimborazo, Cotopaxi, Guayas, 
Loja, Tungurahua), Peru (Amazonas, Huancavelica, Lambayeque, Piura), frequent between 
1000-1500 m and 2500-4000 m [66]. It is widely cultivated as an ornamental plant and it is 
grown near the Mediterranean coastal area [67]. S. corrugata exhibits woody stems of white-
rust colour, owing to the presence of a dense pubescence. The internodes of the main 
branches are 5-10 cm long, while those of lateral ones from 0.5 to 1 cm. The leaves are 6-12 
cm long and 1.5-3 cm wide. They are oblong-lanceolate, acute or blunt, with a rounded-
truncated base. The petioles are 0.5-1 cm long and the inflorescences are organized in 
verticillasters with 5-10 mm bracts. Flowers show blue-purple corollas 2 cm long. The upper 








Distribution: S. Spain, NW. Africa [65] 
 
Synonyms: Sclarea tingitana (Etl.) Raf., Fl. Tellur. 3: 94 (1837) [65] 
 
Description:  
The species is an aromatic, woody-based, multi-
stemmed perennial shrub, till 100 cm; with erect stems, 
rigid, with sparse, eglandular and glandular hairs. Basal 
leaves with short petioles, ovate to oblong, 7 cm long, 
subcordate, obtuse, crenate to undulate, distinctly 
rugose, with frequent, tapering, eglandular hairs 
intermixed with sessile glands; cauline leaves few, 
smaller, sessile. Inflorescence is a broad, branched 
panicle; verticillasters 6-10, approximating above, 3-6-
flowered; bracts broadly ovate, 1-2 × 0.7-1.5 cm, with an 
acuminate apex. Calyx green, broad, 15-20 mm, not 
noticeably accrescent in fruit, strongly ridged, with 
diverging lips with spinulose apices, with long, eglandular multicellular hairs intermixed with 
short, sessile glands. Corolla white with a cream-yellow lower lip, 25-30 mm, c. 10 mm 
straight or gradually widening towards throat, esquamulate; upper lip. Nutlets 3 × 2.2 mm, 
prominently mucilaginous on wetting [10]. 
 
5.2.1 History 
Salvia tingitana has been cultivated since the end of the 17th century but its origin has for 
long been uncertain and confused. We believed that it was grown in Northen Africa as the 
word itself “tingitana” refers to the town now called Tangiers. In 2008 case studies by Foley, 
Hedge and Moller have given a more complete botanical and horticultural description of the 
plant. Comparisons and herbarum species and drawings were made so as to understand the 
plant confusing story. Some of the earliest specimens were taken from De Tannefort 
collection in the 1690’s, Alpini’s illustrations, entitled De Plantis Exoticis Libri Duo, in the 
1600’s. Arduino’s studies descriptions (Padua Botanical gardens) and Rivinus published 
drawing of a plant named Horminum tingitanum. However it was Etlinger in 1777 who 
described it scientifically and named the plant as S. tingitana. Today the only certain known 
locality is in Soudi Arabia but its long history has been associated with nearby countries like 
Egypt (see illustration Alpini- Syria, Aleppo, Tunis and Tangi). Over the centuries S. tingitana 
was mostly mentioned in the 18th and 19th century when it was also cultivated as an 
ornamental shrubs in Paris (Palais des Roi); for its aromatic properties in botanic gardens in 
Padua, Turin and Berlin. There were many published records of S. tingitana being cultivated 
in different parts of Europe like Britain, whereas fewer references were given in the 20th 
century. In recent times and today, however throughout the world there has been a new 
interest in growing S. tingitana in warmer parts of the world like California, South Africa, 
Australia and the Mediterranean with small differences in color. There are still some obscure 
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origins of S. tingitana. We believed that it was used and cultivated as a medicinal plant, being 
a strongly aromatic plant as far back as the Arabian Empire and then expanded to the North 
countries mentioned before. We also know that S. tingitana is a distinct species. This 
aromatic herb has been used in the past for ots health benefits (medical uses) and healing 
qualities. It also has anti-inflammatory and antioxidant properties, not to mention its strong 
aromatic flavor which is used in aromatic oils, the perfum industry as well as in working. 
5.2.2 Taxonomy 
S. tingitana was described over 230 years ago. However, an unexpected number of species 
have been considered to be closed allies of S. tingitana, or have been confused with it [10]. 
It has been confused especially with Salvia sclarea, but also with Salvia disermans, Salvia 
argentea, Salvia praecox, Salvia coarctata, Salvia spinosa and Salvia desoleana. Recently 
(1980s and 1990s), some botanists [68] debatabled that S. tingitana is only a cultivated form 
of S. sclarea and could be considered a synonym of it [10]. Recent chromosome analysis of 
Salvia species displays that S. tingitana is a distinct species. S. tingitana displays a 
chromosome count of 2n=42, which is unusual for the Salvia genus. More common are 
2n=14, 16, 20, and 22. Only S. merjamie, has been conclusively shown to have a chromosome 
count of 2n=42 so far. S. sclarea, on the contrary, has a count of 2n=22 chromosomes. 
Mucilage testing were used to compare S. tingitana with other possible related species. 
Those tests defined S. tingitana to be a unique species [10] Fig. 2. 








Among the numerous classes of terpenoids, I have decided to focus on the two main classes 
of compounds for my doctoral: Diterpene, paying more attention on Diterpene orto and para 




Diterpenes constitute a large group of C20 compounds [1] and they are the most diverse class 
of secondary metabolites with more than 10,000 different structures. The diterpenoids 
identified in the Lamiaceae family show around 50 different skeletons [33]. There are two 
different pathways in which diterpenes may be synthetized: the mevalonate pathway, via 
mevalonic acid (MVA), and the mevalonate-independent pathway, via deoxyxylulose 
phosphate (DXP). Diterpenoids biosynthesis is initiated in plastids, in which the common 
diterpenoids precursor geranylgeranyl diphosphate (GGPP) is synthesized de novo from 
isopentenyl diphosphate (IPP) and its isomer dimethylallyl diphosphate (DMAPP) via the 
action of geranylgeranyl diphosphate synthase (GGPPS), which is a type of the short-chain 
prenyltransferases (SC-PTSs) [69]. Diterpenes are constitued by head (isopropylidene end) 
to tail (alcohol end) of four isoprene (C5H8) building blocks [70]. These compounds are 
isolated in insects, marine organisms, fungi, and higher plants, precisely many of them have 
been isolated from Asteraceae and Lamiaceae [71]. The interest in the isolation of diterpenes 
is growing because of their biological activity, ecological function, use as templates for 
synthesis and taxonomic function [72].  
Based on the ring number, diterpenoids can be classified as follows: acyclic, bicyclic, tricyclic, 
tetracyclic, macrocyclic, and miscellaneous. Salvia is a genus known for the isolation of these 
compounds [73], many of which endowed with interesting biological activity. Antibacterial, 
cytotoxic, and cardiovascular activities have been extensively reported [74], [75]. We could 
divide Salvia diterpenoids in 2 categories. The first one concerns monocyclic and bicyclic 
diterpenoids containing labdanes, clerodanes, neoclerodanes, seco-clerodanes and other 
rearranged clerodanes. The second one includes tricyclic and tetracyclic diterpenes 
represented by pimaranes and abietanes including quinone abietanes, nor-abietanes, 
rearranged nor-abietanes, dinor-abietanes, seco-abietanes, tanshinones and other 
particular rearranged abietanes (e.g. Icetexane) [76].  
 
6.1 Focus on Diterpenes Quinones isolated from Salvia species 
 
Diterpenoid quinones have been systematized till 1994 considering their distribution, 
structure, chemistry and total synthesis. Moreover, the chemical and biological potentials of 
the diterpenoid quinone methides have been reconsidered [73]. Aromatic abietanes are 
characterized by an aromatic quinonoid C ring and a different degree of oxygenation at 
several positions [77]. Oxygenated abietane type diterpenes with a common ortho- or para- 
quinone chromophore are found principally in roots of Salvia species [33]. Many of these 
diterpene quinone could present aromaticity and a highly oxidation pattern bearing hydroxyl 
and carbonyl functionalities principally on C-20, C-11, C-7- and C-6 [73]. 
Recently, many new members of natural abietane-type diterpenoids with an aromatic C ring 
have been isolated and described in several specific reviews on naturally occurring 
diterpenoids by Professor Hanson [77] and present about 50 different skeletons. Abietanes 
isolated from Salvia species are often characterized by para-quinone abietanes presenting a 
11,14-p-benzoquinone on the C-ring, like horminone, acetylhorminone, royleanone, 
tanshinone etc. For example, royleanone was isolated from the aerial parts of S. ballotiflora 
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Benth. and S. regla Cav. [78]; [79] and the roots of S. aethiopis L. [80]. Various royleanone 
derivatives which showed hydroxy, methoxy and ethoxy group at C-7 and/or C-12, were 
identified from several Salvia species [33]. In few cases, also o-quinone C ring can be present 
in abietane structures isolated from Salvia species [74] like the 11,12-dioxo-abieta-8,13-dien 
which is isolated from S. napifolia [81]. A common rearrangement of abietanes is the 
icetexane skeleton that has been found in Chinese Salvia species [82]. The icetexane skeleton 
takes the formal name 9(10/20)-abeoabietane, indicating that it is believed to arise in Nature 
from a rearrangement of the abietane skeleton. Icetexanes can be classified into various 
subclasses based on the presence or absence of oxygenation at the C3, C11, C14 and C19 
positions [83]. Fruticuline A and demethylfruticuline A, which are two important icetexane 
diterpenes quinones, were isolated from the aerial parts of S. fruticulosa Benth and S. 
corrugata Vahl. S. milthiorrhiza Bunge afforded several norabietane type diterpenes called 
tanshinones with a 1,2-quinone in the C ring. 
To sum up 4 main groups of diterpene quinones can be classified in Salvia species: 11,12-
ortho-quinone abietane, 11,14-para-quinone abietane, seco-abietane quinones and abeo-
abietanes quinones. Table 2 (Appendix) shows all the isolated diterpene quinones from 1962 





6.2 Chemical investigation of roots of S. corrugata  
The methanolic extract of the roots of S. corrugata was fractionated by Si gel MPLC eluting 
with n-hexane/CHCl3/CH3OH at concentrations varying from 100:0:0 to 0:0:100 to obtain 12 
fractions (I–XII). Fraction IV (280.6 mg) (eluted with CHCl3, from 0.45 to 0.51 L) was purified 
by semi-preparative RP HPLC (eluents A: H2O, B: CH3OH, gradient: B 5% at time 0 min, B 100% 
at time 61 min, B 100% at time 70 min) to obtain 1’ (3.8 mg). Fraction VI (93.5mg) (eluted 
with CHCl3, from 0.78 to 0.96 L) was purified by semi-preparative RP HPLC (eluents A: H2O, 
B: CH3OH, gradient: B 5% at time 0 min, B 100% at time 61 min, B 100% at time 70 min) to 











Fig 3. Compounds isolated from the roots of S. corrugata: 7-O-methylhorminone (1’), Horminone (2’) 




6.2.1 Antimicrobial activity 
The antimicrobial activity of the methanolic extract of the roots of the 12 semi-purified 
fractions and of horminone (2’) and 7-O-acetylhorminone (3’) was assessed by determining 
Minimal Inhibitory Concentration (MIC) (μg/mL) values on several staphylococcal and 
enterococcal clinical strains, previously isolated from different clinical specimens and 
identified following the standard procedures [84]. MICs were obtained in line with the 
microdilution procedure detailed by the Clinical and Laboratory Standards Institute [85].  
Tables 3 and 4 
 
 






MIC values (µg/mL) of the methanolic extract of the roots, of the 4 active semi-purified 
fractions and of horminone and 7-O-acetylhorminone obtained on 9 staphylococcal clinical 
isolates. Fractions I, II, III, V, IX, X, XI and XII displayed MIC values >128 µg/mL. 
 
 
*=resistant to Methicillin; 




MIC values (µg/mL) of the methanolic extract of the roots, of the 3 active semi-purified 
fractions and of horminone and 7-O-acetylhorminone obtained on 7 enterococcal clinical 





IV VI VII VIII 2' 3'
S.aureus MB18* >128 8 16 64 64 8 16
S.epidermidis MB 22* >128 16 32 64 32 16 8
S.capitis MB71* >128 32 16 16 >128 8 8
S.haemolyticus MB115* >128 16 64 32 128 16 4
S.hominis MB124* >128 32 16 16 64 16 4
S.lugdunensis  MB96 >128 4 64 16 16 8 8
S.saprophyticus MB41 >128 8 8 16 >128 4 4
S.simulans MB94 >128 4 32 32 32 4 16




III IV VIII 2' 3'
E.faecalis MB 1° 128 >128 8 16 64 32
E.faecalis MB 76° 128 >128 8 16 32 64
E.faecium MB 2° 64 32 8 16 64 >128
E.faecium MB 116° 128 64 4 16 64 >128
E.gallinarum  MB141 64 >128 16 8 32 64
E.durans MB 113 128 >128 32 16 32 32
E.avium MB119 64 >128 8 16 16 32
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6.3 Chemical investigation of roots of S. tingitana 
Dryed roots (21.89 g) of S. tingitana were extracted with methanol. The methanolic extract 
(2.47 g) was fractionated by Si gel MPLC eluting with n-hexane/CHCl3/CH3OH at 
concentrations varying from 100:0:0 to 0:0:100 to obtain 11 fractions (Ic–XIc). Fraction IIIc 
was subsequently purified by CC on silica gel (MPLC; monitoring by TLC) with a n-hexane/ 
CHCl3 (8:2, 0.42 L) and mixtures of CHCl3-CH3OH (1:0, 0.57 L; 95:5, 0.45 L; 0:1, 0.06 L) into 14 
fractions (Ici-XIVci). Fraction IIIci (70.1 mg) (eluted with CHCl3-CH3OH 1:0, from 0.42 to 0.45 L) 
was purified by semi-preparative HPLC to obtain 1’’ (1.2 mg) and 2’’ (1.4 mg). Fraction Vci 
(153.8 mg) (eluted with CHCl3-CH3OH 1:0, from 0.51 to 0.60 L) was purified by semi-


















6.3.1 Antimicrobial activity 











°= resistant to Vancomycin; *= resistant to Methicillin  
 









*Methicillin resistant strain; **Vancomycin resistant strain 
The pure compound Hypargenin C which is isolated in sufficient quantities, displayed MIC 






S.aureus MB18* 16 4
S.aureus MB 6 8 2
S.epidermidis MB 22* 16 4
S.epidermidis MB93 32 4
S.capitis MB192* 16 2
S.haemolyticus MB193* 32 4
S.hominis MB194* 16 2
S.lugdunensis  MB129 8 2
S.warneri MB137* 4 2
S.simulans MB163* 16 4





E.faecalis MB 1** 16 2
E.faecalis MB 92 32 4
E.faecium MB 2 16 4
E.faecium MB 152** 16 2
E.durans MB113 32 4
E.gallinarum  MB105** 16 4
E.avium  MB119 16 4
E.casseliflavus MB159** 32 4





To date, sesterterpenoids are a largely unexplored class of terpenes comprising about 1,000 
members isolated from nature, which represent <2% of the reported terpene family 
members [86]. Sesterterpenoids come from geranylfarnesylpyrophosphate and are found 
mostly in fungi and marine organisms [87]. As other classes of terpenes, the structural 
diversity of sesterterpenes largely originates from the very first scaffold generating step, 
which in this case is catalyzed by sesterterpene synthases (STSs), a class of terpene synthase 
(TPS) [86]. Sesterterpenoids are terpenoids with C25 carbon frameworks derived from five 
isoprene units [88]. Norsesterterpenoids are compounds that contain C21–C24 and they are 
also grouped into sesterterpenoids. Sesterterpenoids can be classified into 6 subgroups, on 
the basis of the carbocycle numbers included in their molecular structures: linear, 
monocarbocyclic, dicarbocyclic, tricarbocyclic, tetracarbocyclic, and Miscellaneous 
sesterterpenoids [89]. 
Linear Sesterterpenoids 
The main source of linear sesterterpenoids is represented by marine organisms and 
particularly sponges. The terminal units often comprise either a furan, a y-lactone or a 
tetronic acid moiety [90]. Even if the structures of linear sesterterpenoids are very simple, 
many of them have important cytotoxic properties against human tumor cells, with an 
unknown mechanisms of action [89]. 
Monocarbocyclic Sesterterpenoids 
Various monocarbocyclic sesterterpenoid compounds have been demonstrated to have 
important cytotoxicities. Unfortunately, little is known regarding their functional 
mechanisms [89].  
Bicarbocyclic Sesterterpenoids 
Sesterterpenoids with a dicarbocyclic skeleton often display structures reminiscent of the 
clerodane and labdane diterpenoids [89]. The studies on the Australian sponge, Luflariella 
geometrica, have revealed the presence of a large number of related dicarbocyclic 
sesterterpenoids. These possess the same dicarbocyclic unit and differ in the nature of the 
side chain [90]. Several sesterterpenes display cytotoxicities against a variety of cancer cell 
lines [89]. 
Tricarbocyclic Sesterterpenoids 
Many of these sesterterpenoids have also been found to display cytotoxicities [89]. 
TetracarbocycIic Sesterterpenoids 
The majority of tetracarbocyclic sesterterpenoids belong to the scalarane series [90]. This 
class of sesterterpenes are emerging as a class of interesting compounds showing significant 
activities against cancer cells. Scalaranes have been reported to have broad and important 
cytotoxicities against tumor cells [89]. 
Miscellaneous sesterterpenoids 
Different studies demonstrate that miscellaneous sesterterpenoids display significant 
cytotoxicities against tumor cells [89]. 
 
7.1 Sesterterpenes isolated from Lamiaceae family 
Many sesterterpenes were isolated from the Lamiaceae family and have been involved in 
plant defense mechanisms [86]. Within this family the main species that produce 
sesterterpenoids are: Leucosceptrum canum Sm, Colquhounia coccinea var mollis, Scutellaria 
violacea var. sikkimensis Hook.f. 
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Leucosceptrum canum Sm is a species characterized by small, cream-white flowers arranged 
in dense, terminal spikes [91]. It is a small tree, locally known as Bhusure in Nepal, is 
distributed in the temperate Himalayans regions, Myanmar, and China [92]. The species is 
known as a honey plant, and in 1929 Cowan & Cowan remarked that, ‘‘a quantity of sweet 
juice exudes from the flowers, and this is sucked by Paharia herdsmen, and by many birds’’. 
The former are probably less efficient than the latter as pollinators, although, and it can 
therefore be assumed that the plant is ornithophilous. [91]. 
Colquhounia coccinea var. mollis (Schlechtendal) Prain is a large shrub 1/2 m high distributed 
mainly in the southwest of China, with vivid whorls of orange-scarlet flowers [93]. Scutellaria 
plants, belonging to the Lamiaceae family, include about 350 species, and are widely 
distributed in template zones and tropical zones of Europe, North America, and East Asia. 
They have been used as traditional medicines in many countries. Scutellaria violacea var. 
sikkimensis Hook.f is distributed in high altitude regions of Yunnan and Sichuan Provinces 
[94]. It was found that Leucosceptrum canum and Colquhounia coccinea var mollis, hold two 
exclusive classes of defensive sesterterpenoids, which are leucosceptroids and 
colquhounoids, respectively. They are closely related owing to their common 5/6/5 core 
structure but are distincted from each other on the basis of differences in stereochemistry 
at C-6 and C-7 and subsequently modifications [88]. Leucosesterterpenone and 
leucosterlactone are two tetracyclic sesterterpenoids isolated from L. canum [87]. Further 
investigation led to the isolation and identification of more than 100 defensive 
sesterterpenoids from the leaves and flowers of the above two plants. Moreover, Choudhary 
and collegues reported the isolation of different sesterterpenoids from L. canum of Nepalese 
origin. The skeletons of these sesterterpenoids are diverse from those discovered in the 
Chinese plant. Sesterterpenoids were also reported to be present in two important food 
crops, wheat (Triticum aestivum) and potato (Solanum tuberosum) [88].  
 
7.2 Sesterterpenes isolated from Salvia species 
The first sesterterpene lactone, salvisyriacolide, has been isolated from the aerial parts of S. 
syriaca by Rustaiyan and collegues in Iran [13]. Sesterterpenes have been also isolated from 
S. hypoleuca, S. sahendica, S. mirzayanii, S. lachnocalyx, S. limbata, S. palaestina, S. 
yosgadensis, S. aethiopis and S. dominica. Note that seven of these species belong to the 
flora of Iran and the first four are endemic. Sesterterpenes have been usually isolated from 
the aerial parts of Salvia. spp. Salvileucolide methyl ester, for example, was isolated as the 
major constituent from aerial parts of S. hypoleuca and S. sahendica [34]. Two new 
sesterterpenes lactones, yosgadensolide A (6α,14-dihydroxymanoyloxide-15,17- dien-16,19-
olide) and yosgadensolide B (6α, 16-dihydroxymanoyloxide- 14,17-dien-16,19-olide) and 
their epimers with rare skeleton were isolated from the aerial parts of S. yosgadensis [13]. 
Furthermore, the chemical investigation of S. yosgadensis gave five 19,20-
dinorsesterterpenes, yosgadensonol, 13-epi-yosgadensonol [34]. Five sesterterpene 
lactones were also isolated from S. lachnocalyx [96]. Three new sesterterpenes were isolated 
from the aerial parts of S. palaestina and two new unusual dinorsesterterpenes 6-dehydroxy-
yosgadensonol and 6-dehydroxy-13-epiyosgadensonol were also found from the aerial parts 
of S. limbata [13]. 3-epi-salviaethiopisolide and salviaethiopisolide, two 19,20-
dinorsesterterpenes, were isolated from S. aethiopis collected from Salamanca of Spain. The 
fractions of the aerial parts of S. hypoleuca gave six sesterterpene lactones, with a lactone 
ring between C-4 and C-6 [34]. Twenty-four tricyclic sesterterpenoids were isolated from the 
aerial parts of S. dominica and all of them contain a differentially functionalized decalin and 
30 
 
furan-2-one rings joined with a substituted pentane side chain. Furthermore, 
salvidominicolide A, salvidominicolide B, two new sesterterpenes, were isolated from this 
species by Hasan and collegues (2016). Five new manoyloxide-type sesterterpenoids from S. 
mirzayanii have been isolated [97] along with other two sesterterpenes [98]; [99]. 
In conclusion, the reported sesterterpenoids are bicyclic and mostly sesterterpene lactones. 
Many of them contain a differentially functionalized decalin and furan-2-one rings joined 
with a substituted pentane side chain [100]. 
 
7.3 Biological and pharmacological properties of sesterterpenes 
Plant sesterterpenoids have been shown to exhibit a broad range of biological activities, such 
as antiinflammatory, anticancer, cytotoxic, and antimicrobial bioactivities, as well as 
phytotoxicity and plant defense [101], serving as insect antifeedant and antifungal agents, 
as cytostatic agents against human lung cancer cell, as inhibitors of tubulin tyrosine ligase, 
as prolylendopeptidase inhibitors, and as enhancers of interleukin-2 gene expression [88]. 
Nevertheless, the exact biological function and precise binding partners of these bioactive 
compounds are frequently unknown, thus they can be defined as “orphan” molecules [101]. 
Sesterterpenes show inhibitory activity against parasitic protozoa, suppression of the 
expression of cyclooxygenase-2 and inducible nitric oxide synthase. They are inhibitors of 
hypoxia-inducible factor-1 (HIF-1) [102]. Many sesterterpenes inhibit the activity of the 
human secreted type IIA phospholipase A2 (PLA2) which is involved in the pathogenesis of a 
variety of inflammatory diseases via the production of arachidonic acid. Thus, secreted PLA2 
has been considered an important target for the development of anti-inflammatory drugs 
[102]. Moreover, some sesterterpenoids possess multifunctional activities. For example, 
manoalide showed both anti-inflammatory and antimicrobial activities. It is important to 
note that many sesterterpenoids can suppress the growth of tumor cells in vitro and so they 
can be seen as promising candidates for anticancer drugs. Unfortunatly, their functional 
mechanisms and molecular targets are not known so far [89].  
The structural diversity and the relevant biological activities of sesterterpenoids have made 





7.4 Extraction of aerial parts of S. tingitana 
For the isolation of surface constituents, fresh aerial parts (10.3 kg) of S. tingitana were 
immersed in CH2Cl2 for 20 s to afford 103.0 g of a mixture of secretion product and cuticular 
constituents (”exudate”). The exudate was partitioned with n-hexane affording two 
fractions, namely “fraction n-hexane - soluble” (85.8 g) and “fraction n-hexane - insoluble” 
(17.7 g).  
The fraction “n-hexane - insoluble” was chromatographed in aliquots of 1.0 g on Sephadex 
LH-20 (53x2.5 cm; CHCl3-CH3OH 7:3 as eluent, 0.24 L; monitoring by TLC) to afford six 
fractions (Ia-VIa): fraction Ia (0.2 g) (from 0.00 to 0.12 L) with waxy compounds, fraction IIa 
(1.4 g) (from 0.12 to 0.14 L), fraction IIIa (8.6 g) (from 0.14 to 0.18 L), fraction IVa (3.9 g) (from 
0.18 to 0.20 L), fraction Va (1.6 g) (from 0.20 to 0.22 L) and fraction VIa (0.6 g) (from 0.22 to 
0.24 L).  
Fraction IIa was separated by CC on silica gel (MPLC; monitoring by TLC) with a mixture of n-
hexane-CHCl3 (8:2, 0.36 L) and mixtures of CHCl3-CH3OH (1:0, 0.96 L; 9:1, 0.30 L; 1:1, 0.36 L; 
0:1, 0.42 L) into 13 fractions (1ai-13ai). Fraction 9ai (139.0 mg) (eluted with CHCl3-CH3OH 1:1, 
from 1.14 to 1.70 L) was purified by semi-preparative HPLC to obtain 3 (1.6 mg) and 10 (4.7 
mg). 
Fraction IIIa was separated by CC on silica gel (MPLC; monitoring by TLC) with a mixture of n-
hexane-CHCl3 (8:2, 0.42 L) and mixtures of CHCl3-CH3OH (1:0, 0.24 L; 1:1, 0.48 L; 0:1, 0.42 L) 
into 25 fractions (1aii-25aii). Fraction 9aii (306.2 mg) (eluted with CHCl3-CH3OH 1:0, from 
0.60 to 0.75 L) was purified by semi-preparative HPLC to obtain 2 (27.7 mg), 22 (4.5 mg), 23 
(5.4 mg), and 24 (4.0 mg). Fraction 10aii (498.9 mg) (eluted with CHCl3-CH3OH 1:0, from 0.75 
to 0.84 L) was purified by semi-preparative HPLC to obtain 2 (3.9 mg), 5 (4.7 mg), 11 (16.7 
mg), and 24 (5.8 mg). Fraction 12aii (263.0 mg) (eluted with CHCl3-CH3OH 1:0, from 1.05 to 
1.20 L) was purified by semi-preparative HPLC to obtain 5 (21.8 mg) and 11 (38.2 mg). 
Fraction 13aii (97.3 mg) (eluted with CHCl3-CH3OH 1:0, from 1.20 to 1.32 L) was purified by 
semi-preparative HPLC to obtain 5 (10.4 mg) and 11 (8.3 mg). Fraction 14aii (81.1 mg) (eluted 
with CHCl3-CH3OH 9:1, from 1.32 to 1.50 L) was purified by semi-preparative HPLC to obtain 
5 (6.0 mg). Fraction 15aii (87.7 mg) (eluted with CHCl3-CH3OH 9:1, from 1.50 to 1.53 L) was 
purified by semi-preparative HPLC to obtain 5 (6.0 mg). Fraction 17aii (892.3 mg) (eluted with 
CHCl3-CH3OH 9.1, from 1.56 to 1.59 L) was purified by semi-preparative HPLC to obtain 3 (7.2 
mg), 6 (35.2 mg), and 12 (3.5 mg). Fraction 18aii (675.0 mg) (eluted with CHCl3-CH3OH 9.1, 
from 1.59 to 1.62 L) was purified by semi-preparative HPLC to obtain 9 (4.6 mg) and 10 (6.6 
mg). Fraction 19aii (1502.7 mg) (eluted with CHCl3-CH3OH 9.1, from 1.62 to 1.68 L) was 
purified by semi-preparative HPLC to obtain 1 (2.1 mg), 7 (16.4 mg), 10 (19.1 mg), 12 (9.8 
mg), 13 (4.3 mg), and 14 (23.0 mg). Fraction 20aii (146.2 mg) (eluted with CHCl3-CH3OH 1:0, 
from 1.68 to 1.71 L) was purified by semi-preparative HPLC to obtain 14 (61.8 mg). 
Fraction IVa was separated by CC on silica gel (MPLC; monitoring by TLC) with a mixture of n-
hexane-CHCl3 (8:2, 0.39 L) and mixtures of CHCl3-CH3OH (1:0, 0.78 L; 95:5, 0.33 L; 0:1, 0.21 
L) into 15 fractions (1aiii-15aiii). Fraction 7aiii (33.3 mg) (eluted with CHCl3-CH3OH 1:0, from 
0.87 to 0.96 L) was purified by semi-preparative HPLC to obtain 15 (1.9 mg). Fraction 8aiii 
(43.1 mg) (eluted with CHCl3-CH3OH 1:0, from 0.96 to 1.17 L) was purified by semi-
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preparative HPLC to obtain 16 (4.2 mg). Fraction 9aiii (333.1 mg) (eluted with CHCl3-CH3OH 
95:5, from 0.96 to 1.17 L) was purified by semi-preparative HPLC to obtain 15 (14.9 mg) and 
16 (4.2 mg). Fraction 10aiii (141.4 mg) (eluted with CHCl3-CH3OH 95:5, from 1.17 to 1.23 L) 
was purified by semi-preparative HPLC to obtain 3 (2.6 mg), 16 (7.1 mg), and 25 (4.6 mg). 
Fraction 11aiii (55.6 mg) (eluted with CHCl3-CH3OH 95:5, from 1.23 to 1.26 L) was purified by 
semi-preparative HPLC to obtain 6 (3.2 mg) and 8 (2.1 mg). Fraction 13 aiii (92.1 mg) (eluted 
with CHCl3-CH3OH 95:5, from 1.29 to 1.38 L) was purified by semi-preparative HPLC to obtain 
14 (1.0 mg) and 16 (1.0 mg). Fraction 14aiii (48.0 mg) (eluted with CHCl3-CH3OH 95:5, from 
1.38 to 1.50 L) was purified by semi-preparative HPLC to obtain 14 (7.1 mg). 
Fraction Va was separated by CC on silica gel (MPLC; monitoring by TLC) with n-hexane (0.54 
L) and mixtures of CHCl3-CH3OH (1:0, 0.51 L; 95:5, 0.42 L; 0:1, 0.39 L) into 13 fractions (1aiv-
13 aiv). Fraction 10aiv (174.1 mg) (eluted with CHCl3-CH3OH 95:5, from 1.35 to 1.41 L) was 
purified by semi-preparative HPLC to obtain 23 (13.3 mg). 
The fraction “n-hexane - soluble” was chromatographed in aliquots of 1.0 g on Sephadex LH-
20 (53x2.5 cm; CHCl3-CH3OH 7:3 as eluent, 0.26 L; monitoring by TLC) to afford seven 
fractions (Ib-VIIb): fraction Ib (3.1 g) (from 0.00 to 0.12 L) with waxy compounds, fraction IIb 
(5.6 g) (from 0.12 to 0.14 L), fraction IIIb (14.7 g) (from 0.14 to 0.16 L), fraction IVb (31.4 g) 
(from 0.16 to 0.18 L), fraction Vb (16.1 g) (from 0.18 to 0.20 L), fraction VIb (3.2 g) (from 0.20 
to 0.22 L), and fraction VIIb (0.8 g) (from 0.22 to 0.24 L). 
Fraction IIb was separated by CC on silica gel (MPLC; monitoring by TLC) with mixtures of n-
hexane-CHCl3 (1:0, 1.23 L; 6:4, 0.27 L) and mixtures of CHCl3-CH3OH (1:0, 1.17 L; 95:5, 0.15 L; 
0:1, 0.42 L) into 23 fractions (1bi-23bi). Fraction 18bi (763.6 mg) (eluted with CHCl3-CH3OH 
1:0, from 2.52 to 2.55 L) was separated by CC on silica gel (MPLC; monitoring by TLC) with n-
hexane (0.48 L) and mixtures of CHCl3-CH3OH (1:0, 0.68 L; 95:5, 0.33 L; 0:1, 0.15 L) into 10 
fractions (1bii-10bii). Fraction 5bii (73.0 mg) (eluted with CHCl3-CH3OH 1:0, from 0.78 to 0.90 
L) was purified by semi-preparative HPLC to obtain 2 (6.6 mg) and 11 (2.1 mg). Fraction 8bii 
(eluted with CHCl3-CH3OH 95:5, from 1.32 to 1.44 L) was purified by semi-preparative HPLC 
to obtain 3 (85.6 mg), 8 (2.8 mg), and 11 (89.3 mg). Fraction 19bi (1136.4 mg) (eluted with 
CHCl3-CH3OH 1:0, from 2.55 to 2.58 L) was separated by CC on silica gel (MPLC; monitoring 
by TLC) with n-hexane (0.42 L) and mixtures of CHCl3-CH3OH (1:0, 0.78 L; 95:5, 0.42 L; 0:1, 
0.09 L) into 10 fractions (1biii-10biii). Fraction 8biii (321.6 mg) (eluted with CHCl3-CH3OH 1:0, 
from 1.23 to 1.50 L) was purified by semi-preparative HPLC to obtain 3 (2.3 mg), 10 (15.5 
mg), and 11 (12.7 mg). 
Fraction IIIb was separated by CC on silica gel (MPLC; monitoring by TLC) with a mixture of n-
hexane-CHCl3 (6:4, 0.63 L) and mixtures of CHCl3-CH3OH (1:0, 1.14 L; 95:5, 0.15 L; 0:1, 0.66 
L) into 24 fractions (1biv-24biv). Fraction 11biv (611.7 mg) (eluted with CHCl3-CH3OH 1:0, 
from 0.78 to 0.84 L) was separated by CC on silica gel (MPLC; monitoring by TLC) with n-
hexane (0.39 L) and mixtures of CHCl3-CH3OH (1:0, 0.63 L; 95:5, 0.60 L; 0:1, 0.09 L) into 14 
fractions (1bv-14bv). Fraction 4bv (100.8 mg) (eluted with CHCl3-CH3OH 1:0, from 0.51 to 
0.60 L) was purified by semi-preparative HPLC to obtain 26 (2.4 mg). Fraction 6bv (137.7 mg) 
(eluted with CHCl3-CH3OH 1:0, from 0.78 to 0.90 L) was purified by semi-preparative HPLC to 
obtain 4 (6.0 mg). Fraction 12biv (eluted with CHCl3-CH3OH 1:0, from 0.84 to 0.87 L) was 
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purified by semi-preparative HPLC to obtain 4 (9.1 mg). Fraction 14 biv (504.2 mg) (eluted 
with CHCl3-CH3OH 1:0, from 0.99 to 1.05 L) was purified by semi-preparative HPLC to obtain 
23 (36.1 mg). Fraction 16 biv (484.4 mg) (eluted with CHCl3-CH3OH 1:0, from 0.99 to 1.05 L) 
was purified by semi-preparative HPLC to obtain 22 (1.6 mg) and 23 (3.8 mg). Fraction 17 biv 
(1502.6 mg) (eluted with CHCl3-CH3OH 1:0, from 1.17 to 1.32 L) was purified by semi-
preparative HPLC to obtain 2 (27.4 mg). Fraction 20 biv (742.5 mg) (eluted with CHCl3-CH3OH 
1:0, from 1.56 to 1.77 L) was purified by semi-preparative HPLC to obtain 15 (168.5 mg). 
Fraction 21 biv (135.3 mg) (eluted with CHCl3-CH3OH 95:5, from 1.77 to 1.83 L) was purified 
by semi-preparative HPLC to obtain 15 (32.8 mg). 
Fraction IVb was separated by CC on silica gel (MPLC; monitoring by TLC) with a mixture of n-
hexane-CHCl3 (6:4, 0.75 L) and mixtures of CHCl3-CH3OH (1:0, 1.08 L; 95:5, 0.30 L; 0:1, 0.42 
L) into 18 fractions (1bvi-18bvi). Fraction 3bvi (1.8 g) (eluted with n-hexane-CHCl3 6:4, from 
0.15 to 0.18 L) was purified by semi-preparative HPLC to obtain 17 (5.6 mg) and 27 (33.4 mg). 
Fraction 4bvi (759.8 mg) (eluted with n-hexane-CHCl3 6:4, from 0.18 to 0.21 L) was purified 
by semi-preparative HPLC to obtain 27 (7.2 mg). Fraction 5bvi (10.53 g) (eluted with n-
hexane-CHCl3 6:4, from 0.21 to 0.51 L) was separated by CC on silica gel (MPLC; monitoring 
by TLC) with n-hexane (0.45 L) and mixtures of CHCl3-CH3OH (1:0, 0.84 L; 95:5, 0.36 L; 0:1, 
0.06 L) into 6 fractions (1bvii-6bvii). Fraction 3 bvii (780.5 mg) (eluted with CHCl3-CH3OH 1:0, 
from 0.51 to 0.63 L) was purified by semi-preparative HPLC to obtain 15 (254.6 mg) and 23 
(22.5 mg). Fraction 4 bvii (5.11 g) (eluted with CHCl3-CH3OH 1:0, from 0.63 to 0.78 L) was 
separated by CC on silica gel (MPLC; monitoring by TLC) with n-hexane (0.45 L) and mixtures 
of CHCl3-CH3OH (1:0, 0.84 L; 95:5, 0.36 L; 0:1, 0.06 L) into 23 fractions (1bviii-23bviii). Fraction 
13bviii (318.4 mg) (eluted with CHCl3-CH3OH 1:0, from 0.96 to 1.05 L) was purified by semi-
preparative HPLC to obtain 23 (6.8 mg). Fraction 14bviii (770.9 mg) (eluted with CHCl3-CH3OH 
1:0, from 0.96 to 1.05 L) was purified by semi-preparative HPLC to obtain 15 (258.1 mg). 
Fraction 15bviii (741.4 mg) (eluted with CHCl3-CH3OH 95:5, from 1.05 to 1.17 L) was purified 
by semi-preparative HPLC to obtain 15 (292.3 mg). Fraction 17bviii (635.2 mg) (eluted with 
CHCl3-CH3OH 95:5, from 1.29 to 1.32 L) was purified by semi-preparative HPLC to obtain 15 
(131.0 mg). Fraction 17bviii (635.2 mg) (eluted with CHCl3-CH3OH 95:5, from 1.29 to 1.32 L) 
was purified by semi-preparative HPLC to obtain 15 (67.0 mg). Fraction 6bvi (2.24 g) (eluted 
with n-hexane-CHCl3 6:4, from 0.51 to 0.75 L) was separated by CC on silica gel (MPLC; 
monitoring by TLC) with n-hexane (1.00 L) and mixtures of CHCl3-CH3OH (1:0, 1.05 L; 95:5, 
0.60 L; 0:1, 0.06 L) into 10 fractions (1bix-10bix). Fraction 5bix (270.4 mg) (eluted with CHCl3-
CH3OH 95:5, from 1.26 to 1.29 L) was purified by semi-preparative HPLC to obtain 15 (233.5 
mg). Fraction 7bvi (3.17 g) (eluted with CHCl3-CH3OH 1:0, from 0.75 to 0.84 L) was separated 
by CC on silica gel (MPLC; monitoring by TLC) with n-hexane (0.42 L) and mixtures of CHCl3-
CH3OH (1:0, 0.54 L; 95:5, 0.75 L) into 18 fractions (1bx-18bx). Fraction 14 bx (188.7 mg) eluted 
with CHCl3-CH3OH 95:5, from 1.26 to 1.29 L) was purified by semi-preparative HPLC to obtain 
15 (148.0 mg). Fraction 12bvi (1.31 g) (eluted with CHCl3-CH3OH 95:5, from 1.83 to 1.86 L) 
was separated by CC on silica gel (MPLC; monitoring by TLC) with n-hexane (0.45 L) and 
mixtures of CHCl3-CH3OH (1:0, 0.54 L; 95:5, 0.72 L) into 14 fractions (1bxi-14bxi). Fraction 
11bxi (1.31 g) (eluted with CHCl3-CH3OH 95:5, from 1.35 to 1.47 L) was purified by semi-
preparative HPLC to obtain 8 (7.1 mg), 10 (3.3 mg), and 12 (1.4 mg). Fraction 13bvi (342.6 
mg) (eluted with CHCl3-CH3OH 95:5, from 1.86 to 1.89 L) was purified by semi-preparative 
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HPLC to obtain 1 (1.7 mg), 8 (1.5 mg), 10 (2.6 mg), 12 (1.7 mg), 13 (6.0 mg), and 14 (10.8 mg). 
Fraction 14bvi (296.7 mg) (eluted with CHCl3-CH3OH 95:5, from 1.89 to 1.92 L) was purified 
by semi-preparative HPLC to obtain 11 (2.7 mg), 12 (81.5 mg) and 14 (18.3 mg). Fraction 
17bvi (54.5 mg) (eluted with CHCl3-CH3OH 95:5, from 2.13 to 2.19 L) was purified by semi-
preparative HPLC to obtain 11 (1.2 mg).  
Fraction Vb was separated by CC on silica gel (MPLC; monitoring by TLC) with a n-hexane 
(0.39 L) and mixtures of CHCl3-CH3OH (1:0, 0.84 L; 95:5, 0.39 L; 0:1, 0.06 L) into 16 fractions 
(1bxii-16bxii). Fraction 3bxii (2.5 g) (eluted with CHCl3-CH3OH 1:0, from 0.39 to 0.54 L) was 
separated by CC on silica gel (MPLC; monitoring by TLC) with a n-hexane (0.39 L) and mixtures 
of CHCl3-CH3OH (1:0, 0.54 L; 95:5, 0.72 L; 0:1, 0.06 L) into 14 fractions (1bxiii-14bxiii). Fraction 
3bxiii (125.9 mg) (eluted with CHCl3-CH3OH 1:0, from 0.48 to 0.60 L) was purified by semi-
preparative HPLC to obtain 27 (8.9 mg). Fraction 5bxiii (116.3 mg) (eluted with CHCl3-CH3OH 
1:0, from 0.66 to 0.75 L) was purified by semi-preparative HPLC to obtain 15 (10.1 mg), 17 
(17.3 mg) and 18 (4.9 mg). Fraction 6bxiii (177.9 mg) (eluted with CHCl3-CH3OH 1:0, from 
0.75 to 0.89 L) was purified by semi-preparative HPLC to obtain 17 (17.3 mg) and 19 (1.6 mg). 
Fraction 9bxiii (249.9 mg) (eluted with CHCl3-CH3OH 95:5, from 0.93 to 0.99 L) was purified 
by semi-preparative HPLC to obtain 21 (3.0 mg). Fraction 11bxii (355.1 mg) (eluted with 
CHCl3-CH3OH 95:5, from 1.32 to 1.35 L) was purified by semi-preparative HPLC to obtain 15 
(10.0 mg). Fraction 13bxii (237.7 mg) (eluted with CHCl3-CH3OH 95:5, from 1.41 to 1.47 L) 
was purified by semi-preparative HPLC to obtain 13 (2.8 mg) and 16 (2.1 mg).  
Fraction VIb was separated by CC on silica gel (MPLC; monitoring by TLC) with a n-hexane 
(0.24 L) and mixtures of CHCl3-CH3OH (1:0, 0.93 L; 95:5, 0.45 L; 0:1, 0.07 L) into 20 fractions 
(1bxiv-20bxiv). Fraction 5 bxiv (312.7) (eluted with CHCl3-CH3OH 1:0, from 0.39 to 0.45 L) was 
purified by semi-preparative HPLC to obtain 27 (47.7 mg). Fraction 6 bxiv (46.4) (eluted with 
CHCl3-CH3OH 1:0, from 0.45 to 0.51 L) was purified by semi-preparative HPLC to obtain 27 
(10.4 mg). Fraction 13 bxiv (74.5) (eluted with CHCl3-CH3OH 1:0, from 1.02 to 1.17 L) was 
purified by semi-preparative HPLC to obtain 20 (2.7 mg). Fraction 17bxiv (87.1) (eluted with 




Thus, the surface extract of the aerial parts of S. tingitana afforded one nor-sesterterpene 
(1), eight new sesterterpenes (2  ̶9), and five known sesterterpenes, along with other known 
compounds including five labdane and one abietane diterpene, one sesquiterpene and four 
flavonoids. 
The absolute configuration of compounds 1  ̶ 9 were first studied by electronic circular 
dichroism (ECD). Vibrational circular dichroism (VCD) was used in the cases where sufficient 
material was available. VCD spectra of compounds 2, 3, 6 and 7 were recorded and compared 
to their calculated spectra at the B3LYP/6-31+G(d,p) level of theory (Figures 8, S17, S26 and 
S58, Supporting Information). Similarity indices SimVA (Vibrational Absorption) and SimVCD 
were calculated with VCD SpecTech31 using scaling factors between 0.8 and 1.2 (Figures 8, 
S17, S26 and S58, Supporting Information). The scaling factor corresponding to the maximal 





Fig. 5. Known compounds isolated from aerial parts of S. tingitana: salvileucolide methylester 
(10) [103], salvileucolide-6,23-lactone (11) [103], 8α,15(S)-dihydroxylabd-13(14),17-dien-
23,6α-16(S),19-diolide (12) [101] , 6α,8α,23-trihydroxy-labd-13(14),17-dien-16(R),19-olide 
(13) [101], 6α,8α,15(S)-trihydroxy-23-carboxymethyllabd-13(14),17-dien-16(S),19-olide (14) 
[101], sclareol (15) [104] , 14α-epoxysclareol (16) [105], manool (17) [106], 6β-
hydroxysclareol (18) [105], (8α,12Z)-12,14-labdadien-8-ol (19) [107], hinokiol (20) [108], β-
eudesmol (21) [109], 3',4',5,6,7-pentamethoxy-flavone (22) [110], salvigenin (23) [111], 
eupatorin (24) [112], cirsimaritin (25) [113]. 
 
 




A molecular formula of C24H38O5 for compound 1, obtained as a colorless amorphous powder, 
was established from positive ion mode HRESIMS data ([M + Na]+, m/z 429.2559) indicating 
six indices of hydrogen deficiency. The IR spectrum showed absorption bands at 3369, 1738, 
and 1644 cm−1, indicating the presence of hydroxy, carbonyl, and olefinic groups. The 1H 
NMR spectrum (Table 8) exhibited signals corresponding to five methyls (δH 0.78, H3-25; δH 
1.18, H3-22; δH 1.36, H3-24; δH 1.66, H3-21; δH 2.15, H3-20), two oxymethynes (δH 3.97, ddd, 
J = 11.0, 10.0, 4.8 Hz, H-6; δH 4.88, dd, J = 7.2, 5.1 Hz, H-16) and two trisubstituted olefinic 
protons (δH 5.06, H-14; δH 5.83, H-18). 1H − 1H COSY and 1D TOCSY measurements allowed 
to establish the spin systems C-1 – C-3, C-5 – C-7, C-9 – C-12, C-14 – C-16. The NMR signals 
and the degree of insaturation suggested that the structure must be tricyclic. The downfield 
shift of C-4 (δC 74.3), C-3 (δC 42.0) and C-5 (δC 59.7) suggested the presence on an oxygenated 
group at position 4, confirmed by HMBC correlations H-2 / C-4, H-3 / C-4, H-5 / C-4 and H3-
24 / C-4. This data and the comparison with related sesterterpenes led to establish that 1 
was a C-23 nor-sesterterpene. The HMBC correlations H-5 / C-6, H-6 / C-5, H2-7 / C-6 
confirmed the location of the other hydroxyl group at C-6. The presence of a α,β-unsaturated 
butenolide moiety [114], [100] at C-15 was inferred on the basis of the proton resonance of 
H-18, the carbonyl resonance at C-19 (δC 172.6), the HMBC correlations H2-15 / C-17, H-16 / 
C-18, H-18 / C-16, H-18 / C-17 and H-18 / C-19, and H3-20 / C-16 and H3-20 / C-18, and the 
long range COSY coupling between CH3-20 and H-18. NOESY experiment displayed 
correlations between H-6, H3-22, H3-24 and H3-25, and correlation of H-5 with H-9, indicating 
a trans junction of the decalin system and the β-orientation of H-6 and of the CH3-24. The E 
configuration of Δ13 double bond was established from the 13C chemical shift of C-21 [114]. 
Compound 1 exhibited a strong negative CE at 209 nm and a shoulder at 245 nm (Figures S7, 
S15, S42, S57 and S66, Supporting Information). ECD was not suited to establish the absolute 
configuration for this compound. Compound 1 was elucidated as 4β,6α,8α-trihydroxy-labd-
13(14),17-dien-16,19-olide. 
Compound 2, a colorless amorphous powder, had a molecular formula of C26H40O5. 
(HRESIMS m/z 455.3037 [M + Na]+, index of hydrogen deficiency = 7). The NMR data of 2 
(Table 8) were very similar those of salvileucolide methylester [103], with the exception of 
the presence of a methylene group at C-6 (δH 1.35, 1.51; δC 23.7) instead of an 
hydroxymethine, confirmed by HMBC correlations H2-6/C-5, H2-6/C-7, H2-6/C-8, H2-6/C-10 
and H2-7/C-6. J values of H-5 (δH 1.77, dd, J = 12.0, 2.3 Hz) and NOESY experiment allowed to 
assign the same relative configuration of salvileucolide methylester [103]; [115]. Particularly, 
NOE correlations were observed between H-5 and H-9, and between H3-22, H3-24 and H3-
25, coherent with the β-orientation of H3-22, H3-24, H3-25, and the A/B trans ring junction of 
the decaline system. Compound 2 showed a strong negative CE at 209 nm and a shoulder at 
245 nm (Figures S7, S15, S42, S57 and S66, Supporting Information). For compound 2, the 
maximal SimVCD value of the calculated spectrum for the absolute configuration 
(4R,5R,8R,9R,10S,16R) was 0.379, compared to 0.281 for (4R,5R,8R,9R,10S,16S). This 
suggested a better fit of (4R,5R,8R,9R,10S,16R). Visual evaluation of the experimental and 
calculated VCD spectra showed a significantly better fit of the bands at 1644, 1106, 1065 and 





High-resolution mass spectrometry of 3 a colorless amorphous powder, produced a sodiated 
molecular ion at m/z 471.3029 [M + Na]+, consistent with a molecular formula of C26H40O6 
indicating seven degrees of unsaturation. On the basis of NMR spectroscopic data (Table 8), 
the gross structure of 3 appear similar to 6α,8α,(15S)-trihydroxy-23-carboxymethyl-labd-
13(14),17-dien-(16S),19-olide, [101] except for the presence of a methylene group at 
position C-6 (δH 1.37, 1.58; δC 23.1). The attribution was confirmed by the connectivity of H2-
6 in the COSY spectrum with H-5 (δH 1.79) and H2-7 (δH 1.48 and 1.82), and in the HMBC 
spectrum with C-5, C-7, C-8 and C-10, as well as by the other HMBC correlations H-5/C-6 and 
H-7/C-6. The NOESY experiment, showing NOE correlations of H3-22 with H3-24 and H3-25, 
and of H-5 with H-9, and the 13C resonance of C-21 confirmed the relative stereochemistry 
of the bicyclic ring and the E geometry of the ∆13 double bond reported for the similar 
compound [101]; [114]. For compound 3, two negative CEs at 209 nm and 244 nm, and a 
positive CE at 228 nm were observed (Figures S24, S49, Supporting Information). Since this 
compound possessed a hydroxy group at C-15, the positive CE at 228 nm was characteristic 
for the chirality of carbon 15. However, the calculated spectra did not sufficiently match with 
the experimental data. This lack of fit can be explained by the absence of major 
chromophores and the flexibility of the side chain. Thus, ECD was not suited to establish the 
absolute configuration for this compound. For these reasons, vibrational circular dichroism 
(VCD) was used. For compound 3, similarity analysis gave no clear preference to either of the 
calculated spectra. By visual comparison of the major CEs in the experimental spectrum at 
1497, 1346, 1299, 1249, 1198, 1171 and 1063 cm-1 to the calculated spectra, the absolute 
configuration was determined as (4R,5R,8R,9R,10S,15R,16R). Thus, compound 3 was 
identified as (4R,5R,9R,10S)-(8R,15R)-Dihydroxy-23-carboxymethyl-labd-13(14),17-dien-
(16R),19-olide. 
The HRESIMS (positive mode) of compound 4 displayed a pseudomolecular ion peak at m/z 
437.3054 [M + Na]+ equating to eight degrees of unsaturation and corresponding to the 
molecular formula C26H38O4. Compound 4 was isolated as a colorless amorphous powder. 
The IR spectrum exhibited absorption bands for carbonyl (1726 cm-1), olefinic (1661 cm-1) 
and conjugated ether groups (1246 cm-1). The 13C NMR data (Table 9) showed 26 carbon 
signals, consisting of six methyls, seven methylenes, four methines (two of them were sp2 
carbons), four quaternary carbons, one carboxylic carbon and resonances for one furan ring. 
The 1H NMR spectrum (Table 9) exhibited resonances of four olefinic protons (δH 6.16, H-15; 
δH 6.22, H-18; δH 6.26, H-14; δH 7.24, H-19), and one methyl belonging to an methoxyl group 
(δH 3.66, H3-OMe). Compound 4 has four rings, as four degrees of unsaturation accounted 
for the carbonyl group and the three double bonds. The NMR data suggested the presence 
of a manoyloxide scaffold [96]. The location of the carboxymethyl group (δC 179.3; δH 3.66, 
s) at C-23 was based on the chemical shift of C-4, C-23 and C-24, and HMBC correlations of 
H-3, H-5 and H3-24 with C-23. The HMBC correlations H-14 / C-16, H-14 / C-17 and H-15 / C-
16 confirmed the presence of a furan moiety (δC 116.8, C-16; δC 148.6, C-17; δC 114.7, C-18 
and δH 6.22, d, J = 1.0 Hz, H-18; δC 140.9, C-19 and δH 7.24, d, J = 1.0 Hz, H-19) at C-15. NOESY 
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experiments showed cross-peaks between H3-22, H3-24 and H3-25, and between H-5 and H-
9, that confirm the relative stereochemistry of the manoyloxide scaffold [96]. The full relative 
stereochemistry, especially at position 13, could not be elucidated owing to the overlapping 
of the signals of H3-21 and H3-22. For compound 4, two positive CEs at 221 nm and at 274 
nm (stronger) were measured (Fig. S34, Supporting Information). By comparing the 
experimental with the calculated ECD spectra, the absolute configuration could be 
determined, in part, as (4R,5R,8R,9R,10S), whereas the configuration at C-13 could not be 
established. Compound 4 was identified as (4R,5R,9R,10S)-Manoyloxide-14,16,18-trien-
(14Z)-19,16-oxide-23-methoxy oic acid. 
High-resolution mass spectrometry of 5 a colorless amorphous powder, produced a sodiated 
molecular ion at m/z 455.2798 [M + Na]+, consistent with a molecular formula of C26H40O5  
On the basis of NMR spectroscopic data (Table 2), The 1H and 13C NMR spectra (Table 9) 
showed similarities with 2, except for the presence of a 6,23-epoxide, supported by HMBC 
correlations of H-6 (δC 73.6, C-6 and δH 3.72, ddd, J = 11.4, 11.3, 4.4 Hz) with C-4 and C-23, 
and HMBC correlations of H-23 (δC 112.6, C-23 and δH 4.43, s) with C-6. The relative 
stereochemistry at C-4, C-5, C-6, C-9, and C-10 was established based on the coupling 
constants of H-5 (δH 1.49, d, J = 11.4), H-6 (δH 3.72, ddd, J = 11.4, 11.3, 4.4) and H-9 (δH 1.09, 
t, J = 5.2, 5.2) and the NOESY correlations of H-6 with H3-22, H3-24 and H3-25, and of H-5 with 
H-9 and H3-OMe/C-23. The E geometry of the ∆13 double bond was inferred from the 13C 
chemical shift of C-21. Compound 5 exhibited a strong negative CE at 209 nm and a shoulder 
at 245 nm (Figures S7, S15, S42, S57 and S66, Supporting Information). Compound 5 was 
identified as 8α-Hydroxy,23α-O-methyl-23,6α-epoxy-labd-13(14),17-dien-16,19-olide. 
The molecular formula of compound 6, a colorless amorphous powder, was established to 
be C26H40O6 on the basis of HRESIMS (m/z 471.2880 [M + Na]+), with seven degrees of 
unsaturation. The 1H and 13C NMR data of 6 (Table 9) were very similar to those of 5. The 
only difference was in the hydroxylation of C-15 (δH 4.66, dd, J = 8.6, 3.5 Hz, H-6; δC 69.2). 
HMBC correlation of H-16 to C-15 confirmed the presence of the OH at this position (Table 
9). The relative stereochemistry of compound 6 was established considering the NOESY 
interactions of H-6 with H3-22, H-23, H3-24 and H3-25, and on the 13C chemical shift of C-21, 
as for compound 5. For compound 6, two negative CEs at 209 nm and 244 nm, and a positive 
CE at 228 nm were observed (Figures S24, S49, Supporting Information). Since both 
compounds possessed a hydroxy group at C-15, the positive CE at 228 nm was characteristic 
for the chirality of carbon 15. However, the calculated spectra did not sufficiently match with 
the experimental data. This lack of fit can be explained by the absence of major 
chromophores and the flexibility of the side chain. Thus, ECD was not suited to establish the 
absolute configuration for this set of compounds. For these reasons, vibrational circular 
dichroism (VCD) was performed. The similarity analysis for compound 6 showed a clear 
preference for (4R,5R,6S,8R,9R,10S,15R,16R,23S) as the absolute configuration with a 
maximal SimVCD value of 0.483. A visual inspection of the major CEs 1454, 1221, 1204, 1170, 
1077 and 1046 cm-1 confirmed this. Therefore, the absolute configuration of compound 6 





Compound 7, a colorless amorphous powder, had a molecular formula of C25H38O5. 
(HRESIMS m/z 441.2611 [M + Na]+, index of hydrogen deficiency = 7). The NMR data of 7 
(Table 10) strongly suggested the similarity of 7 with 5 with the exception for the presence 
of a hydroxy instead of the metoxy group at C-23 (δH 4.43, s, H-23; δC 111.1), confirmed by 
the HMBC correlation H3 24 / C-23. ROESY correlations of H-6 with H3-22, H3-24 and H3-25, 
of H 23 with H3-24, as well as the 13C chemical shift of C-21 corroborated the same relative 
configuration as for compound 5. Compound 7 exhibited a strong negative CE at 209 nm and 
a shoulder at 245 nm (Figures S7, S15, S42, S57 and S66, Supporting Information). For these 
reasons, vibrational circular dichroism (VCD) was used. For compound 7, both calculated VCD 
spectra showed an excellent fit, with maximal SimVCD values of 0.468 for 
(4R,5R,6S,8R,9R,10S,16S,23S) and 0.369 for (4R,5R,6S,8R,9R,10S,16R,23S). Visual inspection 
of major CEs at 1642, 1393, 1341, 1283, 1222, and 1124 cm-1 and, in particular, a broad 
positive CE between 1100 and 1045 cm-1 indicated the absolute configuration of 7 as 
(4R,5R,6S,8R,9R,10S,16R,23S). Compound 7 was identified as (4R,5R,6S,9R,10S,23S)-
(8R,23α)-Dihydroxy-23,6α-epoxy-labd-13(14),17-dien-(16R),19-olide. 
Compound 8 had a molecular formula C25H40O4 as deduced from HRESIMS (m/z 427.2868 [M 
+ Na]+), indicating seven degrees of unsaturation The NMR data for 8 (Table 10) were very 
similar to those of 2, with the exception of the presence of an hydroxymethyl group (δH 3.47, 
d, J = 11.0 and 3.06, d, J = 11.0, H2-23; δC 72.0) instead of the methoxycarbonyl, confirmed 
by HMBC correlations H-5 with C-23 and H2-23 with C-3, C-4, C-5, C-24. The relative 
stereochemistry of 8 was identical to that of 2. Compound 8 exhibited a strong negative CE 
at 209 nm and a shoulder at 245 nm (Figures S7, S15, S42, S57 and S66, Supporting 
Information). ECD was not suited to establish the absolute configuration for this compound. 
Thus, compound 8 was identified as 8α,23-Trihydroxy-labd-13(14),17-dien-16,19-olide. 
Compound 9 was obtained as colorless amorphous powder. Its molecular formula was 
determined to be C25H44O3 on the basis of the [M + Na]+ peak observed at m/z 415.3167in 
the positive-ion HRESIMS, indicating four degrees of unsaturation. The IR spectrum of 9 
exhibited hydroxy group (3369 and 1022 cm−1) and olefinic groups (1663 and 1647 cm−1) 
absorption peaks. The 13C NMR spectrum (Table 10) revealed a total of 25 carbon resonances 
for six methyl, eight methylenes, one hydroxymethylene (δC 58.4), four methines, one 
oxymethine (δC 70.5) and five quaternary carbons. Two of the four degrees of hydrogen 
deficiency could be accounted by the NMR data (two double bonds) (Table 10). Thus, it was 
apparent that only two rings were present in the structure. The observation was confirmed 
by the loss of the carbonyl signal at C-19 (δH 4.18, dd, J = 12.6, 6.8 and 4.04, dd J = 12.6, 6.9, 
H2-19; δC 72.0), compared to compound 1, and by the chemical shifts of H-16 (δH 4.49, t, J = 
6.9 and C-16; δC 70.5), indicating the absence of the α,β-unsaturated butenolide moiety. 
COSY and 1D TOCSY experiments provided evidence of the spin systems H-1 / H-3, H-5 / H-
7, H-11 / H12, H-14 / H-16 and H-18 / H-19. The planar structure of 9 could be constructed, 
according to HMBC correlations (Table 10). Determination of the relative stereochemistry of 
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9 hinged upon the NOESY correlations involving H-5 with H-9 and H3-22 with H3-24 and H3-
25, and upon H-14 (δH 4.49, dd, J = 6.9, 6.9) and H-18 (δH 5.50, dd, J = 6.9, 6.8) coupling 
constants. For compound 9, only one positive CE was observed at 201 nm (Figure S74, 
Supporting Information), and the calculated spectra did not match with the experimental 
data due to the absence of a lactone ring leading to increased conformational flexibility and 
























Fig. 8. Comparison of experimental and computed VCD in CDCl3 spectra for compound 6 (A). 
Similarities (SimVA and SimVCD) between experimental and computed VA and VCD spectra 
of 6 were plotted as functions of wavenumber scale factor (B). 4R stands for 
4R5R6S8R9R10S23S. The wavenumber scale factor corresponding to the maximal SimVA 





7.4.2 Spectroscopic data 
Compound 1: colorless gum; [α]D25 –8 (c 0.1, CH3OH); UV (CH3OH) λmax (log ε) 201 (4.52) nm; 
ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –0.48 (209 nm), –0.03 (246 nm); IR (KBr) ν max 3369, 
2928, 2858, 1756 sh, 1738, 1667, 1643, 1458, 1442, 1389, 1300, 1262, 1173 (sh), 1154, 1124, 
1095, 1069, 1040, 1023, 983, 933, 888, 847, 736, 702 cm-1; 1H NMR (CDCl3, 600 MHz) and 13C 
NMR (CDCl3, 150 MHz), see Table 8; HRESIMS (positive-ion mode) m/z 429.2559 [M + Na]+ 
(calcd for C24H38O5, 429.2617). 
Compound 2: colorless amorphous powder; [α]D25 –4 (c 0.2, CH3OH); UV (CH3OH) λmax (log 
ε) 205 (4.37) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –4.97 (209 nm), –0.76 (246 nm); IR (KBr) 
ν max 3444, 2929, 2868, 1754, 1726, 1645, 1452, 1446, 1388, 1299, 1248, 1170, 1151, 1136, 
1081, 1065, 983, 935, 849, 805, 736, 701 cm-1; 1H NMR (CDCl3, 600 MHz) and 13C NMR (CDCl3, 
150 MHz), see Table 8; HRESIMS (positive-ion mode) m/z 455.3037 [M + Na]+ (calcd for 
C26H40O5Na, 455.2774). 
Compound 3: colorless amorphous powder; [α]D25 +2 (c 0.1, CH3OH); UV (CH3OH) λmax (log 
ε) 208 (3.94) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –0.94 (207 nm), +0.69 (223 nm), –0.58 
(244 nm); IR (KBr) ν max 3401, 2923, 2852, 1759 (sh), 1728, 1645, 1456, 1388, 1297, 1249, 
1170, 1151, 1115, 1064, 1037, 985, 850, 803, 735, 666 cm-1; 1H NMR (CDCl3, 600 MHz) and 
13C NMR (CDCl3, 125 MHz), see Table 8; HRESIMS (positive-ion mode) m/z 471.3029 [M + 
Na]+ (calcd for C26H40O6Na, 471.2723). 
Compound 4: colorless amorphous powder; [α]D25 +27 (c 0.1, CH3OH); UV (CH3OH) λmax (log 
ε) 210 (3.37), 269 (3.48) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε +1.09 (221 nm), +1.46 (274 
nm); IR (KBr) ν max 3400 (w), 2929, 2867, 2333, 1727, 1661, 1456, 1387, 1246, 1170, 1142, 
1093, 1077, 1061, 968, 957, 890, 840, 734, 709 cm-1; 1H NMR (CDCl3, 600 MHz) and 13C NMR 
(CDCl3, 150 MHz), see Table 9; HRESIMS (positive-ion mode) m/z 437.3054 [M + Na]+ (calcd 
for C26H38O4, 437.2668). 
Compound 5: colorless amorphous powder; [α]D25 –4 (c 0.2, CH3OH); UV (CH3OH) λmax (log 
ε) 205 (4.65) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –10.86 (209 nm), –2.17 (242 nm); IR 
(KBr) ν max 3436, 2925, 2869, 2310, 1756, 1741, 1668, 1644, 1457, 1443, 1387, 1298, 1266, 
1173, 1148, 1101, 1048, 983, 961, 929, 890, 845, 739, 707 cm-1; 1H NMR (CDCl3, 600 MHz) 
and 13C NMR (CDCl3, 150 MHz), see Table 9; HRESIMS (positive-ion mode) m/z 455.2798 [M 
+ Na]+ (calcd for C26H40O5Na, 455.2773). 
Compound 6: colorless amorphous powder; [α]D25 +46 (c 0.04, CH3OH); UV (CH3OH) λmax 
(log ε) 212 (4.06) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –3.46 (209 nm), +1.00 (225 nm), –
1.82 (244 nm); IR (KBr) ν max 3401, 2925, 2862, 2312, 1759, 1738, 1666, 1641, 1458, 1440, 
1387, 1303, 1268, 1174, 1152, 1101, 1036, 988, 961, 928, 912, 890, 845, 736, 701, 669 cm-1; 
1H NMR (CDCl3, 600 MHz) and 13C NMR (CDCl3, 150 MHz), see Table 9; HRESIMS (positive-ion 
mode) m/z 471.2880 [M + Na]+ (calcd for C26H40O6Na, 471.2723). 
Compound 7: colorless amorphous powder; [α]D25 +14 (c 0.4, CH3OH); UV (CH3OH) λmax (log 
ε) 209 (4.04) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –8.06 (210 nm), –1.39 (244 nm); IR (KBr) 
ν max 3430, 3058, 2930, 2869, 2715, 1756 (sh), 1732, 1644, 1455, 1445, 1387, 1301, 1262, 
1171, 1151, 1072, 1053, 982, 962, 937, 892, 867, 847, 736, 701 cm-1; 1H NMR (CDCl3, 600 
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MHz) and 13C NMR (CDCl3, 150 MHz), see Table 10; HRESIMS (positive-ion mode) m/z 
441.2611 [M + Na]+ (calcd for C25H38O5Na, 441.2253). 
Compound 8: colorless amorphous powder; [α]D25 –10 (c 0.2, CH3OH); UV (CH3OH) λmax (log 
ε) 201 (4.45) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε –7.63 (209 nm), –1.20 (244 nm); IR (KBr) 
ν max 3411, 2927, 2970, 1756 (sh), 1739, 1666, 1644, 1510, 1456, 1442, 1386, 1300, 1264, 
1173, 1152, 1122, 1100, 1066, 1047, 983, 938, 885, 848, 737, 703 cm-1; 1H NMR (CDCl3, 600 
MHz) and 13C NMR (CDCl3, 150 MHz), see Table 10; HRESIMS (positive-ion mode) m/z 
427.2868 [M + Na]+ (calcd for C25H40O4Na, 427.2824). 
Compound 9: colorless amorphous powder; [α]D25 +10 (c 0.06, CH3OH); UV(CH3OH) λmax (log 
ε) 201 (4.47) nm; ECD (CH3OH, c 0.4 mM, 0.1 cm); Δε +7.75 (201 nm); IR (CH2Cl2) ν max 3369, 
2925, 2854, 1723 (w), 1663, 1647, 1455, 1387, 1263, 1158, 1125, 1083, 1065, 1046, 1022, 
937, 907, 846, 738, 607 cm-1; 1H NMR (CDCl3, 600 MHz) and 13C NMR (CDCl3, 150MHz), see 
Table 10; ESIMS2 m/z (rel. int.) 397 [(M-H2O) + Na]+ (100), 385 [(M-CH2O) + Na]+ (18), 369 





Table 8. 1H and 13C NMR Spectroscopic Data of Compounds 1, 2 and 3 (CDCl3, 600 MHz) 
 1  2  3 
position C, type H HMBC  C, type
  H HMBC  C, type
  H HMBC 
1 
 
38.9, CH2 1.60b 
1.05b 
2, 3, 5, 9, 10  38.7, CH2 1.67b  
1.04, ddd (13.0, 12.5, 3.8)  
2, 3, 5, 10, 25  39.6, CH2 1.68b 
1.07b 
2, 10, 24, 25 
2 18.6, CH2 1.62b 
1.53b 
1, 3  17.6, CH2 1.61b 
1.54b 
1, 3, 4  17.8, CH2 1.62b 
1.55b 
1, 3, 4 
3 42.0, CH2 1.76b 
1.44b 
1, 2, 4, 5, 24  37.0, CH2 1.73, m 
1.53b 
1, 2, 4, 5, 24  37.2, CH2 1.73, m 
1.56b 
2, 4, 5, 23, 24 
4 73.4, C - -  47.7, C - -  47.8, C - - 
5 59.7, CH 1.43b 1, 4, 6, 7, 9, 10, 24, 25  50.6, CH 1.77, dd (12.0, 2.3) 1, 4, 6, 7, 9, 10, 23, 
24, 25 
 50.7, CH 1.79b 4, 5, 6, 7, 9, 10, 23, 
24, 25 
6 67.9, CH 3.97, ddd (11.0, 
10.0, 4.8) 
5  23.7, CH2 1.51b  
1.35b 
5, 7, 8, 10  23.1, CH2 1.58b 
1.37b 
5, 7, 8, 10 
7 53.2, CH2 2.19, d (12.0, 4.8) 
1.63b 
5, 6, 8, 9, 22  44.2, CH2 1.82, ddd (12.1, 3.2, 3.1) 
1.47, m 
5, 6, 8, 9  44.6, CH2 1.82b 
1.48b 
5, 6, 8, 9 
8 72.8, C - -  74.1, C - -  74.4, C - - 
9 59.2, CH 1.15, dd (4.1, 4.1) 8, 10, 11, 12, 25  61.3, CH 1.09b 1, 8, 10, 11, 12  61.5, CH 1.12b 1, 5, 7, 8, 10, 11 
10 38.6, C - -  39.1, C - -  37.1, C - - 
11 22.9, CH2 1.59b 
1.37b 
8, 9, 10, 12  23.4, CH2 1.52b 
1.34b 
8, 9, 10, 12, 13  23.8, CH2 1.59b 
1.38b 
8, 9, 12, 13 
12 42.1, CH2 2.11b 
2.08b 
9, 11, 13, 14, 21  43.2, CH2 2.11b 
2.09b 
9, 11, 13, 14, 21  43.2, CH2 2.19b 
2.13b 
9, 11, 13, 14 
13 140.1, C - -  141.2, C - -  144.3, C - - 





















a J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments were confirmed by DQF-COSY, 1D-TOCSY and HSQC experiments. b Overlapped signal 
 
15 29.6, CH2 2.68, ddd (15.0, 
7.1, 5.2) 
2.28, ddd (15.0, 
7.1, 5.2),  
13, 14, 16, 17  30.5, CH2 2.67, ddd (14.2, 6.5, 5.5) 
2.32, ddd (14.2, 6.8, 5.5) 
13, 14, 16, 17  67.8, CH 4.65, dd (8.6, 1.0) 13, 14 
16 83.7, CH 4.89, t (5.2, 5.2) 14, 15, 17, 18  84.5, CH 4.89, t (5.5, 5.5) 14, 15, 17, 18  87.1, CH 4.81, d (1.0) 14, 15 
17 167.6, C - -  168.4, C - -  166.7, C - - 
18 116.4, CH 5.83, br s 16, 17, 19, 20  117.5, CH 5.85, s 16, 17, 19, 20  118.3, CH 5.91, s 16, 17, 19 
19 172.6, CO - -  173.4, CO - -  173.3, CO - - 
20 13.3, CH3 2.06, s 16, 17, 18  14.1, CH3 2.06, s 16, 17, 18  14.8, CH3 2.15, s 16, 17, 18 
21 16.0, CH3 1.66, s 12, 13, 14  16.5, CH3 1.66, s 12, 13, 14  17.3, CH3 1.77, s 12, 13, 14 
22 24.3, CH3 1.18, s 7, 8, 9  23.9, CH3 1.11, s 7, 8, 9  24.6, CH3 1.13b 7, 8, 9 
23 23.1, CH3 1.34, s 3, 4, 5  179.3, C - -  179.3, CO - - 
24 - - -  16.6, CH3 1.13, s 3, 4, 5, 23  16.6, CH3 1.14b 3, 4, 5, 23 
25 15.8, CH3 0.79, s 1, 5, 9, 10  16.0, CH3 0.82, s 1, 5, 9, 10  16.5, CH3 0.84, s 1, 5, 9, 10 
OMe - - -  52.1, CH3 3.67, s 23  52.2, CH3 3.67, s 23 
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Table 9. 1H and 13C NMR Spectroscopic Data of Compounds 4, 5 and 6 (CDCl3, 600 MHz)a 
 4  5  6 
position C, type H HMBC  C, type H HMBC  C, type H HMBC 
1a 
1b 
38.7, CH2 1.66b 
1.00, ddd (13.0, 12.0, 
2.7) 
2, 3, 5, 9, 10, 25  40.9, CH2 1.64b  
0.97, ddd (13.0, 12.8, 
5.6) 
2, 3, 5, 9, 10, 25  42.0, CH 1.62b 
0.90b 
2, 3, 5, 9, 10, 25 
2a 
2b 
17.8, CH2 1.63b 
1.54b 
1, 3, 4  19.1, CH2 1.63b 
1.59b 
1, 3, 4, 10  19.9, CH2 1.58b 
1.53b 
1, 3, 4, 10 
3a 
3b 
37.1, CH2 1.74b 
1.54b 
1, 2, 4, 5, 23, 24  31.4, CH2 1.57b 
1.45b 
1, 2, 4, 5, 23, 24  32.4, CH2 1.51b 
1.38b 
2, 4, 5 
4 47.7, C - -  43.5, C - -  44.5, C - - 
5 51.0, CH 1.80, dd (13.2, 1.9) 1, 3, 4, 6, 7, 9, 10, 
23, 24, 25 
 56.5, CH 1.49, d (11.4) 4, 6, 7, 9, 10, 23, 
24, 25 




22.8, CH2 1.38, dddd (13.3, 
13.2, 13.2, 3.1) 
1.10b 
4, 5, 7, 8, 10  73.6, CH 3.72, ddd (11.4, 11.3, 
4.4) 
4, 5, 10, 23  74.8, CH 3.65, ddd (11.4, 11.3, 
4.4) 
4, 5, 10 
7a 
7b 
42.7, CH2 1.71b 
1.45b 
5, 6, 8, 9, 22  51.1, CH2 2.36 b 
1.50b 
5, 6, 8, 9, 22  52.3, CH2 2.28, dd (11.2, 4.4) 
1.50b 
5, 6, 8, 9, 22 
8 76.1, C - -  75.4, C - -  76.4, C - - 
9 58.6, CH 1.33, dd (11.5, 2.4) 1, 5, 8, 10, 11, 12, 
25 
 60.0, CH 1.09, t (5.2, 5.2) 1, 7, 8, 10, 11, 
22, 25 
 61.1, CH 1.06b 7, 8, 10, 11, 12, 25 
10 36.4, C - -  36.4, C - -  36.4, C - - 
11a 
11b 
16.1, CH2 1.58b  
1.52b   
8, 9, 10, 12, 13  22.9, CH2 1.58b 
1.37b 
8, 9, 10, 12, 13  24.2, CH2 1.62b 
1.39b 
8, 9, 10, 12, 13 
12a 
12b 
36.4, CH2 2.24, ddd (12.7, 2.9, 
2.7) 
1.55b 
9, 11, 13, 14  41.5, CH2 2.17, ddd (14.0, 8.4, 
8.0) 
2.12, ddd (14.0, 8.8, 
5.6)  
9, 11, 13, 14, 21  42.9, CH2 2.18, ddd (14.2, 8.2, 
8.2) 
2.06b 
9, 11, 13, 14, 21 
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a J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments were confirmed by DQF-COSY, 1D-TOCSY and HSQC experiments. b Overlapped signal. 
  
13 73.2, C - -  141.4, C - -  145.1, C - - 
14 136.7, CH 6.26, d (16.5) 12, 13, 15, 16, 21  116.2, CH 5.02, t (7.1, 7.1) 12, 15, 16, 21  123.2, CH 5.16, d (8.6) 12, 21 
15a 
15b 
112.6, CH 6.16, d (16.5) 13, 14, 16, 17  30.3, CH2 2.72, ddd (15.0, 7.1, 
4.7) 
2.32 b 
13, 14, 16, 17  69.2, CH 
 
4.66, dd (8.6, 3.5) - 
16 116.8, C - -  84.5, CH 4.91, t (4.7, 4.7) 14, 15, 17, 18, 
19 
 88.0, CH 4.80, d (3.5) 14, 15, 17, 18 
17 148.6, CH3 - -  168.3, C - -  168.0, C - - 
18 114.7, CH 6.22, d (1.8) 16, 17, 19, 20  117.9, CH 5.88, s 16, 17, 19, 20  119.3, CH 5.84, s 16, 17, 19, 20 
19a 
19b 
140.9, CH 7.25, d (1.8) 16, 17, 18  173.5, CO - -  174.4, CO - - 
20 10.2, CH3 2.06, s 17, 18  14.1, CH3 2.06, s 16, 17, 18  15.9, CH3 2.10, s 16, 17, 18 
21 33.1, CH3 1.23, s 12, 13, 14  16.4, CH3 1.65, s 12, 13, 14  18.1, CH3 1.66, s 12, 13, 14 
22 24.5, CH3 1.22, s 7, 8, 9  24.7, CH3 1.12, s 7, 8, 9  25.8, CH3 1.05, s 7, 8, 9 
23 179.0, C - -  112.6, CH 4.43, s 4, 5, 6, 24  113.6, CH3 4.35, s 4, 5, 6, 24, 1’ 
24 16.4, CH3 1.12, s 3, 4, 5, 23  19.6, CH3 1.01, s 3, 4, 5, 23  20.1, CH3 0.94, s 3, 4, 5, 23 
25 16.3, CH3 0.75, s 1, 5, 9, 10  15.4, CH3 0.83, s 1, 5, 9, 10  16.3, CH3 0.84, s 1, 5, 9, 10 
OMe 52.0, CH3 3.66, s -  54.9, CH3 3.34, s 23  55.8, CH3 3.27, s 23 
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Table 10. 1H and 13C NMR Spectroscopic Data of Compounds 7, 8 and 9 (CDCl3, 600 MHz)a 
 7  8  9 
position C, type H HMBC  C, type H HMBC  C, type H HMBC 
1a 
1b 
39.2, CH2 1.67b  
0.96b  
-  39.6, CH2 1.60b 
0.93, ddd (13.3, 13.0. 
3.3) 
2, 3, 9, 10, 25  40.3, CH2 1.63b 
0.94b 
2, 3, 5, 10, 25 
2a 
2b 
18.1, CH2 1.70b  
1.62b  
-  17.9, CH2  1.62b 
1.49b 
1, 3, 4  19.1, CH2 1.56b 
1.42b 
1, 3, 4 
3a 
3b 
30.6, CH2 1.59b  
1.47b  
-  35.3, CH2 1.46b 
1.22b 
1, 2, 4, 5, 24  43.0, CH2 1.36 b 
1.14b 
1, 2, 3, 4 
4 42.2, C - -  37.8, C - -  39.0, C - - 
5 55.5, CH 1.51b -  48.8, CH 1.24b 1, 3, 4, 6, 7, 9, 
10, 23, 24, 25 
 56.5, CH 0.91b 1, 6, 7, 10, 23, 24 
6a 
6b 
72.3, CH 3.70, dd (11.3, 11.1, 
4.2) 
-  20.4, CH2 1.58b  
1.26b  
5, 7, 8, 10  21.8, CH2 1.63b 
1.24b 
5, 7, 8, 10 
7a 
7b 
49.8, CH2 2.38 b 
1.57b 
-  44.3, CH2 1.48b,  
1.84, ddd (13.9, 3.0, 
3.0) 
5, 6, 8, 9, 22  44.6, CH2 1.83, dt (12.2, 3.1, 
3.1) 
1.36b 
5, 6, 8, 9 
8 74.1, C - -  74.0, C - -  74.3, C - - 
9 59.4, CH 1.13b 7, 8  60.6, CH 1.05, t (4.2, 4.2) 8, 10, 11, 12, 22, 
25 
 61.6, CH 1.03, t (4.0, 4.0) 8, 10, 11, 12 
10 35.2, C - -  39.2, C - -  38.9, C - - 
11a 
11b 
22.1, CH2 1.64b 
1.42b  
-  23.4, CH2 1.53b 
1.32, dddd (14.1, 9.0, 
5.4, 5.3)  
8, 9, 10, 12  23.4, CH2 1.46b 
1.37b 
8, 9, 10, 12 
12a 
12b 
41.2, CH2 2.14b 
2.12b 
-  42.9, CH2 2.10b 
2.07b 
9, 11, 13, 14, 21  43.2, CH2 2.09b  
2.05b  
9, 11, 13, 14, 21 
13 139.8, C - -  141.2, C - -  140.4, C - - 
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a J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments were confirmed by DQF-COSY, 1D-TOCSY and HSQC experiments. b Overlapped signal
14 115.4, CH 5.03, t (7.2, 7.2) -  116.4, CH 5.02, t (6.8, 6.8) 12, 15, 16, 21  119.8, CH 5.13, t (7.4, 7.4) 12, 15, 16, 21 
15a 
15b 
29.2, CH 2.72, ddd (14.9, 7.2, 
5.5) 
2.32 b  
-  30.2, CH2 2.70, ddd (14.9, 6.8, 
4.9) 
2.31, ddd (14.9, 6.8, 
4.9)  
13, 14, 16, 17  34.5, CH 2.34, ddd (14.0, 7.4, 
6.9) 
2.19, ddd (14.0, 7.4, 
6.9) 
14, 16, 17 
16 83.2, CH 4.91, t (5.5, 5.5) -  84.5; CH 4.90, t (4.9, 4.9) 14, 15, 17, 18  70.5, CH 4.49, t (6.9, 6.9) 14, 15, 17, 18, 20 
17 167.2, C - -  168.4, C - -  141.0, C - - 
18 116.5, CH 5.86, s -  117.7, CH 5.87, s 16, 17, 19, 20  126.3, CH 5.50, dd (6.9, 6.8) 16, 19, 20 
19a 
19b 
172.3, CO - -  173.5, CO - -  58.4, CH2 4.18, dd (12.6, 6.8) 
4.04, dd (12.6, 6.9)  
17, 18 
20 13.2, CH3 2.07, s 16, 17, 18  14.1, CH3 2.06, s 16, 17, 18  18.4, CH3 1.75, s 16, 17, 18 
21 16,6, CH3 1.66, s 12, 13, 14  16.0, CH3 1.66, s 12, 13, 14  16.7, CH3 1.64, s 12, 13, 14 
22 24.0, CH3 1.15, s 7, 8, 9  23.9, CH3 1.12, s 7, 8, 9  24.1, CH3 1.11, s 7, 8, 9 
23 111.1, C17 4.43, s -  72.0, CH2 3.47, d (11.0) 
3.06, d (11.0) 
3, 4, 5, 24  33.8, CH3 0.85, s 3, 4, 24 
24 17.3, CH3 1.00, s 3, 4, 5, 23  17.6, CH3 0.72, s 3, 4, 5, 23  15.8, CH3 0.78, s 3, 4, 5, 23 
25 15.7, CH3 0.87, s 1, 5, 9, 10  16.5, CH3 0.83, s 1, 5, 9, 10  15.9, CH3 0.79, s 1, 5, 9, 10 
OMe - - -  - - -     
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7.4.3 Antibacterial activity 
7.4.3.1 Microorganisms 
A total of 30 strains (27 clinical strains and 3 isolates of marine origin) previously isolated 
from different specimens and identified according to standard procedures [84] and by MALDI 
TOF Vitek MS™ Biomérieux were employed in this study. Twenty-four strains belonged to 
seventeen Gram-positive species [Staphylococcus aureus, S. epidermidis, S. saprophyticus, S. 
capitis, S. warneri, S. simulans, S. lugdunensis, S. haemolyticus, S. hominis, Streptococcus 
agalactiae (MB 149), S. pneumoniae (MB 35), Enterococcus faecium, E. faecalis, E. avium, E. 
casseliflavus, E. durans and E. gallinarum], four were clinical strains of Gram-negative species 
[Escherichia coli (MB 123), Proteus mirabilis (MB 14), Moraxella catarrhalis (MB 15) and 
Klebsiella pneumoniae (MB 11)], and two were clinical strains of fungi [Candida albicans (MB 
31) and C. glabrata (MB 8)]. Among the Gram-positive organisms, two S. aureus strains were 
methicillin- and multidrug-resistant (MRSA) [116]; [117] (MB 18, MB 188). Two S. epidermidis 
were methicillin- and multidrug-resistant (MRSE) (MB 165, MB 169). S. saprofiticus MB41, S. 
simulans MB 94 and S. lugdunensis MB 96 were methicillin-susceptible, while S. capitis MB 
71, S. warneri MB 74, S. haemolyticus MB 115 and S. hominis MB 124 were all methicillin-
resistant isolates. One E. faecalis was vancomycin-susceptible (MB 76), and three were 
vancomycin-resistant (VRE) (MB 1, MB 19, MB 51). One E. faecium was vancomycin-
susceptible (MB 2), and two were VRE (MB 3, MB 152). E. faecalis MB 19 and MB 51, and E. 
faecium MB 3 were of marine origin, being isolated from sea water of the Ligurian west coast. 
E. avium MB 119 and E. durans MB 113 were vancomycin susceptible while E. casseliflavus 
and E gallinarum were vancomycin resistant.  
 
7.4.3.2 Active constituents and control antibiotics 
The preparation of solutions of test compounds and control antibiotics, including 
susceptibility testing were carried out as previously described [118] Minimum inhibitory 
concentrations (MICs) were obtained following the microdilution procedure as detailed 
[118]. 
The total extract, the two n-hexane - insoluble and soluble fractions and the relative 13 sub-
fractions (Ia-VIa and Ib-VIIb) showed a broad range of potencies against 12 representative 
clinical strains (Table S1, Supporting Information). The total extract showed MIC values of 
128 μg/mL on Staphylococcus aureus, S. epidermidis, Enterococcus faecium and E. faecalis 
strains while MIC >128 μg/mL were found against the two other species of Gram positive 
(Streptococcus agalactiae and S. pyogenes), the four Gram negative (Escherichia coli, Proteus 
mirabilis, Moraxella catarrhalis and Klebsiella pneumoniae) and the two mycetes (Candida 
albicans and C. glabrata) isolates. Similarly, the two n-hexane-soluble and insoluble fractions 
and the relative 13 sub-fractions displayed a broad range of activity against the Gram-positive 
species but displayed no potency on the tree Gram negative isolates nor on the two Candida 
strains (Table S1, Supporting Information). 19 compounds out of the 25, isolated in suitable 
amount for biological assays, were analyzed for antibacterial activity by determining MIC 
values on a panel of 30 microbial clinical strains, mainly Gram-positive pathogens, belonging 
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to different clinically relevant species of Staphylococcus and the Enterococcus genera. As 
depicted in Table 11, interesting results were obtained particularly for Staphylococci and 
Enterococci, while MIC values above 128 μg/ml were obtained for S. agalactiae, S. pyogenes, 
the 4 Gram negative species and the two mycetes (data not shown). Note that the isolated 
compounds displayed different antimicrobial activities against several Enterococcus and 
Staphylococcus species. Manool (17) and sclareol (15), hawever, showed MIC values which 
go from 4 to 64 μg/mL. Sclareol and manool displayed the lowest MIC values among the other 
pure compounds. Particularly, Sclareol was active against several staphylococcal and 
enterococcal species of clinical interest with very uniform MIC values, which go from 32 to 
64 μg/ml (Table 11). Manool, on the contrary, was particularly powerful against the 
enterococcal genera, reaching MIC values of 4 μg/ml on several Enterococcal species isolates 
(Table 11). Nevertheless we couldn’t demonstrate any valuable effect of these two labdane 
diterpenes against the selected aerobic Gram negative species, Souza and colleagues [119] 
reported antimicrobial activity of the same compounds also against few Gram negative 
periodontal bacteria, maybe because these organisms were endowed with an anaerobic 
metabolism. We couldn’t confirm any significant antimicrobial activity of manool against S. 
aureus as reported by Ulubelen, [120] maybe because of the clinical origin and the multidrug 




Table 11. MIC Values of compounds 2-8, 10-17, 22-25a  
 
bacterial strains  2  3  4  5  6  7  8  10  11  12  13 
S. aureus MB 18*  >128  128 (286)  128 (309)  128 (296)  128 (286)  >128  128 (317)  128 (286)  128 (308)  128 (296)  >128 
S. aureus MB 
188*  128 (296)  >128  >128  128 (296)  >128  >128  >128  >128  >128  >128  >128 
S. epidermidis MB 
165*  128 (296)  >128  128 (309)  64 (148)  >128  >128  128 (317)  128 (286)  128 (308)  128 (296)  >128 
S. epidermidis MB 
169*  >128  128 (286)  64 (155)  64 (148)  128 (286)  >128  >128  >128  >128  >128  >128 
S. saprophyticus 
MB 41  128 (296)  128 (286)  128 (309)  128 (296)  128 (286)  >128  128 (317)  >128  >128  >128  >128 
S. capitis MB 71*  64 (148)  128 (286)  64 (155)  32 (74.1)  128 (286)  >128  128 (317)  128 (286)  64 (154)  128 (296)  >128 
S. warneri MB 
74*  64 (148)  64 (143)  128 (309)  64 (148)  >128  >128  128 (317)  128 (286)  128 (308)  128 (296)  >128 
S. simulans MB 
94  >128  >128  >128  128 (296)  >128  >128  >128  >128  >128  >128  >128 
S. lugdunensis 
MB 96  128 (296)  128 (286)  >128  128 (296)  >128  >128  >128  >128  128 (308)  >128  >128 
S. haemolyticus 
MB 115*  128 (296)  >128  >128  128 (296)  >128  >128  >128  >128  >128  128 (296)  >128 
S. hominis MB 
124*  128 (296)  128 (286)  128 (309)  64 (148)  128 (286)  >128  128 (317)  128 (286)  >128  >128  >128 
E. faecalis MB 1°  32 (74.1)  64 (143)  >128  128 (296)  64 (143)  >128  128 (317)  64 (143)  64 (154)  64 (148)  >128 
E. faecalis MB 
19°§  64.0 (148)  64 (143)  128 (309)  64 (148)  128 (286)  >128  32 (79.2)  128 (286)  128 (308)  128 (296)  >128 
E. faecalis MB 
51°§  128 (296)  128 (286)  128 (309)  128 (296)  64 (143)  >128  64 (158)  64 (143)  64 (154)  128 (296)  >128 
E. faecalis MB 76  64 (148)  64 (143)  128 (309)  128 (296)  64 (143)  >128  64 (158)  128 (286)  128 (308)  128 (296)  >128 
E. faecium MB 2  128 296  128 (286)  128 (309)  128 (296)  128 (286)  >128  128 (317)  128 (286)  >128  128 (296)  >128 
E. faecium MB 
3°§  64 (148)  64 (143)  128 (309)  128 (296)  64 (143)  >128  128 (317)  128 (286)  128 (308)  128 (296)  >128 
E. faecium MB 
152°  128 (296)  128 (286)  >128  64 (148)  128 (286)  >128  64 (158)  64 (143)  128 (308)  64 (148)  >128 




MB 159°  128 (296)  64 (143)  128 (309)  64 (148)  128 (286)  >128  64 (158)  64 (143)  128 (308)  128 (296)  >128 
E. durans MB 113  128 (296)  128 (286)  >128  128 (296)  >128  >128  >128  128 (286)  >128  128 (286)  >128 
E. gallinarum MB 




bacterial strains  14  15  16  17  22  23  24  25  O  V 
S. aureus MB 18*  128 (276)  32 (104)  128 (395)  >128  >128  128 (390)  >128  >128  256 (638)  n.t. 
S. aureus MB 188*  >128  32 (104)  128 (395)  >128  128 (344)  >128  >128  >128  512 (1275)  n.t. 
S. epidermidis MB 165*  128 (276)  64 (207)  128 (395)  >128  >128  >128  >128  >128  256 (638)  n.t. 
S. epidermidis MB 169*  >128  64 (207)  128 (395)  >128  128 (344)  128 (390)  >128  >128  256 (638)  n.t. 
S. saprophyticus MB 41  >128  32 (104)  128 (395)  >128  >128  >128  >128  >128  1 (2.49)  n.t. 
S. capitis MB 71*  128 (276)  32 (104)  128 (395)  >128  128 (344)  128 (390)  >128  128 (407)  256 (638)  n.t. 
S. warneri MB 74*  64 (138)  32 (104)  64 (198)  >128  128 (344)  128 (390)  >128  >128  128 (319)  n.t. 
S. simulans MB 94  >128  64 (207)  128 (395)  >128  >128  >128  >128  >128  0.25 (0.62)  n.t. 
S. lugdunensis MB 96  >128  32 (104)  64 (198)  >128  >128  >128  >128  128 (407)  0.5 (1.25)  n.t. 
S. haemolyticus MB 115*  128 (276)  64 (207)  128 (395)  >128  >128  >128  >128  >128  16 (39.9)  n.t. 
S. hominis MB 124*  64 (138)  32 (104)  128 (395)  >128  128 (344)  128 (390)  >128  >128  16 (39.9)  n.t. 
E. faecalis MB 1°  64 (138)  32 (104)  32 (99)  16 (55)  32 (86)  64 (195)  64 (186)  64 (204)  n.t.  32 (22.1) 
E. faecalis MB 19°§  128 (276)  32 (104)  64 (198)  32 (110)  128 (344)  64 (195)  64 (186)  128 (407)  n.t  32 (22.1) 
E. faecalis MB 51°§  64 (138)  64 (207)  32 (99)  16 (55)  64 (172)  128 (390)  128 (372)  128 (407)  n.t  64 (44.2) 
E. faecalis MB 76  128 (276)  64 (207)  64 (198)  32 (110)  128 (344)  128 (390)  64 (186)  128 (407)  n.t  128 (88.3) 
E. faecium MB 2  128 (276)  32 (104)  64 (198)  4 (14)  128 (344)  128 (390)  128 (372)  128 (407)  n.t  2 (1.38) 
E. faecium MB 3°§  128 (276)  32 (104)  32 (99)  8 (28)  128 (344)  64 (195)  >128  64 (204)  n.t  128 (88.3) 
E. faecium MB 152°  64 (138)  64 (207)  64 (198)  8 (28)  64 (172)  64 (195)  128 (372)  127 (407)  n.t  256 (177) 
E. avium MB 119  64 (138)  64 (207)  32 (99)  8 (28)  128 (344)  128 (390)  64 (186)  64 (204)  n.t  1 (0.69) 
E. casseliflavus MB 159°  128 (276)  64 (207)  64 (198)  16 (55)  64 (172)  128 (390)  128 (372)  128 (407)  n.t  4 (2.76) 
E. durans MB 113  64 (138)  32 (104)  64 (198)  16 (55)  128 (344)  64 (195)  >128  128 (407)  n.t  1 (0.69) 
E. gallinarum MB 111°  128 (276)  64 (207)  32 (99)  4 (14)  64 (172)  64 (195)  64 (186)  32 (102)  n.t  16 (11) 
 
a MIC values, expressed in μg/mL and micromolarity (μM), of the pure compounds on the selected bacterial strains; *: Methicillin resistant 




7.4.4 Time killing curves  
For the two labdane diterpenes, sclareol (15) and manool (17), as well as for salvileucolide 
methylester (10) and salvileucolide-6,23-lactone (11), that displayed the best antimicrobial 
activity with respect to other isolated sesterterpenes, the mechanism of action on the most 
clinically relevant and susceptible species such as S. aureus, S. epidermidis, E. faecium and E. 
faecalis was investigated. Time killing curves, carried out on selected representative resistant 
and multi-resistant isolates, are shown in Fig. 9. All the four compounds were proved to be 
active with a clear bacteriostatic mechanism, because they prevented the growth of the 
starting inoculum of the bacterium or produced a decrease from the starting inoculum 
concentration that ranged from 1 to 2 log within the 24 hours. 
 
 
Figure 9. Effect of salvileucolide methylester (10), salvileucolide-6,23-lactone (11), sclareol 
(15) and manool (17) on viable cell number of selected susceptible Enterococcal strains. 
Time-kill curves were recorded in the absence or presence of the selected compounds at a 





7.4.5 ATP production in purified mammalian ATP synthase 
The n-hexane-insoluble and soluble fractions, the thirteen sub-fractions (Ia-VIa and Ib-VIIb) 
and the nineteen pure compounds were investigated for the modulation of ATP synthase 
activity. Purified mammalian rod outer segments (OS) were utilized as a subcellular system 
allowing the rapid assay of the oxidative phosphorylation. In fact, the OS are composed of a 
stack of membranous disks, naturally sealed vesicles expressing the molecular machinery for 
the complete oxidation of glucose, thereby comprising the tricarboxylic acid cycle [121], and 
the five complexes of respiration [122]; [123]. This could get some indication of a possible 
correlation between the antibacterial activity and the modulation of the ATP synthase, in 
view of deeper investigations. Resveratrol, a known inhibitor of rod OS ATP synthase, was 
used as a positive control [63]. The data were verified by one-way ANOVA (performed in 
MATLAB 2019a), and differences among groups evaluated with the Bonferroni test (p < 0.05) 
(Figures 10 and S77, Supporting Information). The extract and the majority of sub-fractions 
showed activity (Fig. S77 Supporting Information). ANOVA singled out five groups among the 
nineteen compounds. The group with the most interesting activity comprised compounds 
10, 11, 15 and 17, that showed an inhibition of ATP production of 60, 79, 70 and 60%, 
respectively. The differences within this group were not statistically significant. The obtained 
data, showing inhibition of ATP production in the OS (Figure 10) by the four pure compounds, 
could suggest an inhibitory action on the oxidative phosphorylation [63]; [124]; [125]. The 
inhibition of ATP hydrolysis activity was also evaluated, as some plant metabolites were 
shown to be able to hinder also the clockwise rotation, which accomplishes for the reversal 
of the ATP synthetic activity of the enzyme, producing ATP lysis [126]; [127]. The effect of 
extract, fractions, sub-fractions and pure compounds on this activity are shown in Figures 11 
and S78 (Supporting Information). At a concentration of 80 ug/mL, manool (17) inhibited 
ATP hydrolysis by 92%. ANOVA analysis showed that this compound had a mode of action 
that was distinctly different from the others (Fig. 11). The ability to inhibit also ATP hydrolysis 






Figure 10. Effect of compounds on ATP synthesis among groups tested with one-way ANOVA. The 
null hypothesis is rejected and 5 groups of action can be identified. 
 
 
Figure 11. Effect of compounds on ATP hydrolysis among groups tested with one-way ANOVA. The 
null hypothesis is rejected, and 2 groups of action can be identified. The most active group contains 





7.4.6 Molecular modeling 
Molecular dynamics (MD) simulation studies and ligand-protein binding energy evaluations 
were performed in order to evaluate how 17 could interact with ATP synthase. Our analysis 
focused on the F1 catalytic domain of the protein (F1-ATPase), since several plant 
compounds such as resveratrol, piceatannol and quercetin are known to interact with F1-
ATPase inhibiting ATP synthesis and hydrolysis. Precisely, X-ray structures of bovine F1-
ATPase in complex with these compounds revealed a common binding site located among 
the α and β subunits of the protein, constituting the crown domain, and the C-terminal tip 
of the γ-subunit that is known to rotate inside the crown domain in association with ATP 
synthesis and hydrolysis. These ligands are thus supposed to inhibit ATP synthase activity by 
impeding this rotation, thus disrupting the catalytic machinery of the protein [126]. For this 
reason, manool was docked into the X-ray structure of bovine F1-ATPase in complex with 
quercetin (PDB code 2JJ2) [126] using a thorough AUTODOCK [128] procedure that produced 
good results in both virtual screening and pose prediction studies [129]; [101]. The docking 
protocol generated 200 different docking solutions, which were then clustered on the basis 
of their reciprocal root-mean square (RMSD) deviation using a threshold of 2.0 Å (see 
Materials and Methods for details), thus producing a total of three different clusters of 
poses. For each of these clusters, the docking solution associated with the best estimated 
binding energy was selected as a representative binding mode and further studied through 
MD simulations. The MD protocol was first applied on the reference X-ray structure of bovine 
F1-ATPase in complex with quercetin (PDB code 2JJ2), [126] which was subjected to a total 
of 30 ns MD simulation. The complex showed a remarkable stability during the simulation, 
since after less than 5 ns the system attained an equilibrium and during the rest of the 
simulation it maintained an approximately constant value of total energy. Moreover, the 
bound ligand showed an average RMSD of its position with respect to the starting 
coordinates of 2.0 Å (Fig. S79 Supporting Information). The same MD protocol was thus 
applied on the three ATPase-manool complexes in order to evaluate the stability of the 
binding modes predicted by docking. The results were then analyzed in terms of RMSD of 
the ligand disposition during the simulation concerning its coordinates in the starting 
complex. The analysis highlighted a high stability for pose 3, in which the ligand maintained 
an average RMSD of about 1.9 Å during the whole simulation (Fig. 12). On the contrary, the 
other two binding poses predicted by docking did not show enough stability. In both cases 
the ligand moved considerably from its initial binding disposition, as demonstrated by the 
high RMSD of its coordinates with respect to the starting pose that reached values around 9  ̶
10 Å. Based on these results, we could already consider both pose 1 and 2 as unreliable 
binding dispositions with respect to pose 3. However, in order evaluate the different binding 
modes form an energetic point of view, relative binding free energy evaluations were 
performed on all the three ATPase-manool complexes with the aim of identifying the most 
energetically reliable binding mode [130]. Ligand-protein binding energies were calculated 
using the Molecular Mechanic-Poisson Boltzmann surface area (MM-PBSA) method [131] on 
the MD trajectories relative to the last 15 ns of simulation (Table S2 Supporting Information). 
The analysis clearly confirmed the reliability of pose 3, whose estimated ligand-protein 
binding affinity (-21.4 kcal/mol) exceeded of about 9  ̶12 kcal/mol those evaluated for pose 
1 and pose 2 (Table S2, Supporting Information). Fig.13 displays the minimized average 
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structure of F1-ATPase complexed with the manool in binding mode 3, as obtained from the 
last 15 ns of MD simulation. Due to its lipophilic nature, the ligand predominantly forms 
hydrophobic interactions with the binding site residues. The bicyclic core of the ligand 
strongly interacts with P320, as well as with V276, T318 and Q330, while its lateral chain 
shows lipophilic interactions with A278, V279, A293, I263, constituting a small subpocket 
together with by K260, E264 and E292. Interestingly the terminal vinyl group of manool 
shows a NH-π interaction with the backbone nitrogen of A278 [132]. Despite the polar 
portion of the ligand is limited to its hydroxyl group, this moiety is able to establish strong H-
bonds with both K260 and E264 that account for a not negligible contribution to the total 
ligand-protein binding energy (Table S2, Supporting Information) and probably promotes the 





Figure 12. MD analysis of the three binding modes predicted by docking manool (17) into F1-
ATPase. The plot shows the RMSD of the ligand disposition during the simulation with 




Figure 13. Minimized average structure of manool (17) complexed with F1-ATPase in binding 
mode 3. Hydrogen bonds are represented as black dashed lines. The ligand molecular surface 





7.4.7 Evaluation of ATP production 
Finally, the ATP production in the presence or absence of manool (17) by E. faecalis MB 1 
(VRE) and E. faecium MB 152 (VRE) was evaluated in whole-cell assay, where the bacteria 
were supplied with nutrients, after incubation of two hours. This timing was chosen because 
the duplication time of Enterococcus spp. is approximately 30 min [133]. An important 
reduction of the ATP amount of bacterial cells was observed in E. faecium (inhibited by 30%) 
(Fig. 14). The data on ability to regenerate ATP of bacteria are to be considered with caution 
as the pool of steady state ATP is dependent on many processes (glycolysis, substrate-level 
phosphorylation, oxidative phosphorylation, nutrient uptake systems) affecting its 
consumption and production. These results displayed that a correlation between the in vivo 
antibacterial effect and the modulation of ATPase activity could be hypothesized for manool 














Figure 14. ATP levels determined by measuring luminescence levels and comparing with an 
ATP standard curve. Amount of ATP (pmol/cfu) produced by E. faecalis MB 1 (VRE) and E. 
faecium MB 152 (VRE) in the absence and in the presence of manool (17) (5 x MIC) at time 
of inoculum and after 2 hours of incubation at T = 37 oC. Results are expressed as mean ± SD 
of three separate experiments, with three replicates per experiment. Statistically significant 
differences between treatment and control groups were determined using Student’s t-test 




10. General experimental procedures 
10.1 Solvents for extraction and chromatographic purposes 
Dichloromethane was utilized as extraction solvent for the fresh aerial parts of Salvia. 
Solvents or mixtures of them, from n-hexane to methanol with an increasing degree of 
polarity were utilized for classic chromatographic methods on column of Sephadex LH-20 or 
Silica gel, to yield the semi-purified groups of fractions. Analytical grade solvents were 
filtered two times before their use in medium pressure liquid chromatography, removing 
any trace of impurities. Mixtures of deionized water and methanol at a decreasing degree of 
polarity were utilized for solid reverse-phase extractions, n-hexane (2.5L), dichloromethane 
(2.5L), chloroform (2.5L), methanol (2.5L) were of analytical grade and purchased from VWR-
BDH Prolabo (Lutterworth, Leichestershire, England). Analytical grade solvents were utilized 
for all chromatographic purposes, with the exception of HPLC, were HPLC-grade and 
purchased from VWR-BDH Prolabo. HPLC-grade water (MilliQ) was prepared using a 
commercial water purification system (Millipore Synergy 185, Millipore, Billerica, MA 
Massachusetts, USA). 
10.2 Extraction techniques 
In addiction to the extraction with dichloromethane, freeze-dried samples, roots and leaves 
were extracted by homogenizing with a high throughput homogenizer, Precellys 24 (Bertin, 
France) at 5000 rpm for 30 s and a Precellys kit: 7mL hard tissue homogenizing mix CK28, 
050 Preps, Cat.N°03961-1-302 (ceramic beads mix), using methanol. 
10.3 Chromatographic techniques 
Silica gel 60 F254 coated aluminium sheets (Merck, 20x20 cm, 0.2 mm layer thickness) were 
used for TLC (thin layer chromatography), to analyze each separation. A mixture of CHCl3-
CH3OH-HCOOH (10:0.5:0.1) was utilized as mobile phase, and spots were detected by UV 
light at 254 and 366 nm, and subsequently spraying 50% H2SO4, followed by heating. 
Various column chromatography have been utilized for the separations of complex mixtures, 
comprising both Sephadex, less accurate method, and silica gel, with a better separation 
capacity. With the stationary phase, mixtures can be separated by adsorption, partition, ion 
exchange or size exclusion processes. Based on the affinity of plant constituents for 
stationary phase and the different solvents or solvent mixtures with increasing polarity 
flushing, different extracts were obtained. Sephadex LH-20(GE Healthcare, Little Chalfont, 
Buckinghamshire, UK), was utilized for preliminary column chromatography, always using a 
solvent blend composed by chloroform and methanol in proper proportions for the whole 
analysis time; Silica gel 60 was purchased from Merck and was of 230-400 meshes. In this 
latter case, solvent or solvents blends, from the most lipophilic to the most polar, were 
utilized for column chromatography. 
MPLC (medium pressure liquid chromatography) was carried out on Normal Phase Si60 
Cartridge Supervarioflash and LiChroprep RP-18 (40-63 um) (Merck, Darmstadt, Germany). 
For the use of a medium pressure, MPLC provided to keep a regular flux of solvents (mobile 
phase) through the packed silica gel (stationary phase) into columns characterized by a large 
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diameter. The choice of columns depended on the quantities of fractions to load. We utilized 
SuperVarioPrep cartridge D40 with outer dimensions LxD 185x 47 mm, SuperVarioFlash D26 
(135x33mm), D22 (122x 24 mm), containing 70, 25 and 10g of silica gel respectively. 
The solid phase extraction (SPE) was carried out by loading the complex sample into a 
preconditioned extraction cartridge, containing a chromatographic sorbent, both in normal 
phase with SPE Strata SI-1 Silica Cartridge and reverse-phase with SPE Strata C18-E 
Cartridges, either 55um, 70 A particle size and pore size, respectively; 500 mg /3 mL capacity 
(Phenomenex, Torrance, California, USA). 
Analytical HPLC was carried out on a Thermofisher Dionex Ultimate 3000 SD 
chromatographic system, comprising a Dionex LPG-3400 SD pump, ACC-3000 auto-sampler 
column compartment, SR-3000 UltiMate 3000 solvent rack without degasser, VWD-34000 
RS detector Chromeleon 7 Workstation Secure at fixed wavelength (Thermo Fisher Scientific, 
Waltham, Massachusetts, USA). For analytical HPLC, a Symmetry 300 C18 column, or a 
XBridge Shield RP18 column, 4.6 x 250mm ID, 5um particle size (Waters Corporation, Milford, 
Massachusetts, USA) were utilized, at room temperature, flow rate from 0.5 to 1 mL/min, 
sample loop and injection volume 20 uL. The elution mixtures were composed of CH3OH-
acidified H2O or CH3CN-H2O, at various appropriate ratios, mostly using a linear gradient. 
Semi-preparative HPLC utilized to purify fractions after classical chromatographic methods, 
was performed with a Waters W600 pump equipped with a Rheodyne Delta 600 injector, a 
2414 refractive index detector, and a 2998 photodiode array detector (all Waters). For semi-
preparative HPLC, C18 columns, SymmetryPrep C18, 7.8 x 300mm ID, 7um particle size, 
XBridge Prep Shield RP18, 10 x 250mm ID, 5um particle size, uBoundapack C18, 7.8 x 300mm 
ID, 10 um particle size (Waters) were utilized, at room temperature, flow rate from 1.0 to 
2.0 mL/min, sample loops of 100uL. The elution mixture was composed of CH3OH-H2O at 
appropriate ratios, using a linear gradient. Data acquisition was controlled by Empawer 2 
software (Waters). UV spectra were recorded with an HP 8453 diode array 
spectrophotometer (Hewlett Packard, Palo Alto, California, USA).  
LC/MS analyses were performed using a system consisting of an Agilent 1100 
chromatography apparatus coupled with an API200 ESI mass spectrometer equipped by a 
triple quadrupole analyser. Chromatography separation was performed on a Luna C18 
column, 2.0 x 100 mm ID, 5 um particle size (Phenomenex, Torrance, CA, USA) using 0.1% 
formic acid in water (A) and (CH3CN) (B) as mobile phase. Compound elution was attained 
performing a gradient of A:B from 45:55 to 10:90 over 10 min. injected volume 10 uL, flow 
rate 0.4 mL/min. The mass spectrometer operated in positive mode.  
 
10.4 Spectroscopic techniques and structural elucidation 
A Bruker DRX-600 (Bruker, Billerica, Massachusetts, USA) and Bruker Avance-500 (Bruker 
BioSpin GmbH, Rheinstetten, Germany) NMR spectrometers running the XWINNMR (Bruker 
software package) were used for mono-(1H and 13C NMR) and two-dimensional (COSY, 
HMBC, HSQC and ROESY) NMR experiments. Spectra were studied on MestreNova. 
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ECD spectra were measured in CH3OH on a Chirascan CD spectrometer and were analysed 
with Pro-Data V2.4 software. 
VCD spectra were recorded in CDCl3 on a Bruker PMA 50 accessory coupled to a Tensor 27 
Fourier transform infrared spectrometer. A photoelastic modulator (Hinds PEM 90, Hinds 
Instruments, Hilliboro, USA) was utilized to modulate the handedness of the circular 
polarized light. 
Optical rotations were measured with a Perkin-Elmer 241 polarimeter (Perkin Elmer, Inc. 
Waltham, Massachusetts, MA, USA) equipped with a sodium lamp (589nm) and a 10cm 
microcell. 
10.5 Spectrophotometric techniques used for biological analyses 
Spectrophotometric measurements were conducted both on an UV/Vis spectrophotometer 
SPECTROstarNano (BMG Labtech) and a Tecan SPECTRA III Microplate Reader-Screen, 
Spectra Rainbow spectrophotometer, by using 96-well microplates. Each measurement was 
done in triplicate. 
10.6 Microscopy technique 
Light microscopy experiments were conducted using an Olympus IX 81 microscope (10x 
objective) and processing Olympus XCellence RT software (Olympus, Tokyo, Japan). 
10.7 Purified bovine rod OS preparations.  
Purified bovine rod outer segments (OS) were set under dim red light at 4 °C from fourteen 
retinas, by sucrose/Ficoll continuous gradient centrifugation [134] in the presence of 
protease inhibitor cocktail (Sigma-Aldrich) and ampicillin (100 μg/mL). OS preparations were 
characterized for integrity of plasma membrane as previously reported [134]. 
10.8 ATP synthesis assay in rod OS.  
Rod OS (5 µg) [63] were incubated for 5 min at 37 °C in 50 mM Tris/HCl (pH 7.4), 5 mM KCl, 
1 mM EGTA, 5 mM MgCl2, 0.6 mM ouabain, 0.25 mM di(adenosine)-5-pentaphosphate 
(Ap5A, adenylate kinase inhibitor), 5 mM KH2PO4, 20 mM succinate, 0.35 mM NADH, and 25 
μg/mL ampicillin. ATP synthesis was induced by adding 0.1 mM ADP. Reaction was stopped 
with 7% perchloric acid. ATP concentration was measured by the luciferin/luciferase 
chemiluminescent method (Roche Diagnostics Corporation, Indianapolis, IN, USA) in a 
luminometer (Lumi-Scint, Bioscan Inc, Washington, DC, USA). Where necessary, the 
incubation medium contained the incubation medium contained 30 μM resveratrol or 80 
μg/mL of different purified S. tingitana extracts, sub-fractions or pure compounds.  
10.9 ATP hydrolysis assay in rod OS.  
The ATPase activity of rod OS was analyzed by the pyruvate kinase/lactate dehydrogenase 
system in which hydrolysis of ATP is coupled to the oxidation of NADH followed at 340 nm 
(ε340 for NADH = 6.22 mM-1·cm-1), as previously described [63]. Rod OS (40 μg) were added 
to a reaction mixture containing 50 mM HEPES, pH 7.4, 100 mM KCl, 150 mM NaCl, 1 mM 
EGTA, 2.5 mM MgCl2, 0.8 mM ouabain, 0.15 mM NADH, 0.4 mM Ap5A (adenylate kinase 
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inhibitor), 1.5 mM phosphoenolpyruvate, pyruvate kinase and lactate dehydrogenase, and 
25 μg/mL ampicillin. ATP hydrolysis was subsequently induced by adding 1 mM ATP. Where 
necessary, the incubation medium contained 80 μg of different purified S. tingitana extracts, 
sub-fractions or pure compounds. 
10.10 Determination of ATP concentration in bacterial culture in the presence of manool 
Strain was grown in Mueller Hinton II (MH II) Broth (BD Cat.# 297963;) at 37 °C overnight. 
The overnight culture was diluted 1:106 in 50 mL of fresh MH II Broth and incubated at 37 °C 
for 2 hours. Cultures were then diluted up to OD600 and, when necessary, manool was 
added at concentrations corresponding to 5 x MICs. Aliquots of samples were collected at 
two time points (0 and 2 hours) to determine ATP concentration using BacTiter-Glo™ 
Microbial Cell Viability Assay Reagent (Promega, Madison, WI). It is a luciferase – based assay 
and the ATP level is determined by measuring luminescence levels and comparing to an ATP 
standard curve. One hundred microliters of culture were mixed with an equal volume of 
BacTiter-Glo™ Microbial Cell Viability Assay Reagent in Eppendorf tubes and incubated at 
room temperature for 5 min. After incubation, luminescence was read in a luminometer 
(Lumi-Scint, Bioscan Inc, Washington, DC, USA). ATP standard solutions were prepared using 
adenosine 5-triphosphate disodium salt hydrate (A2383, Sigma Aldrich, St. Louis, MO), and 
a standard curve using ATP standard at concentrations between 1 and 0.001 pmol was 
recorded. ATP concentrations in bacterial samples were determined by comparison with the 
ATP standard curve for each assay. MH was included in all assays as the negative control. 
10.11 Computational methods.  
Conformational analysis was carried out with Schrödinger MacroModel 9.8 (Schrödinger, 
LLC, New York, USA) employing the OPLS2005 (optimized potential for liquid simulations) 
force field in H2O or chloroform for ECD or VCD calculations, respectively. The five 
conformers with the lowest energy were selected for geometrical optimization and energy 
calculation applying DFT with the Becke’s nonlocal three parameter exchange and 
correlation functional, and the Lee-Yang-Parr correlation functional level (B3LYP), using the 
6-31G(d, p) basis set and the SCRF method with the CPMC model for solvation (MeOH for 
ECD calculations) with the Gaussian 09 program package [135]. Vibrational evaluation was 
done at the same level to confirm minima. Excitation energy (denoted by wavelength in nm), 
rotator strength (Rstr), dipole velocity (Rvel), and dipole length (Rlen) were calculated in 
MeOH by TD-DFT/B3LYP/6-31G(d,p). ECD curves were obtained based on rotator strengths 
with a half-band of 0.3 eV using SpecDis v1.71.73  
Vibrational frequencies (given as wavenumbers in cm-1), rotator strength (Rstr), IR intensity 
(IRinten) and dipole strength (Rstr) were calculated in chloroform with B3LYP/6-31+G(d, p). 
VCD curves were obtained based on rotator strengths with a bandwidth of 7 cm-1 using 
CDspecTech v22.0.74, 75 ECD and VCD spectra were calculated from the spectra of individual 
conformers according to their contribution calculated by Boltzmann weighting. Comparison 
was done visually as by calculation of similarity indices (SimVA, SimVCD) which were 
generated by VCDspecTech v22.0.31 The SimVCD values were plotted against the scaling 
factors of the x axis, and graphs compared between the different stereoisomers. 
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10.12 Statistical analysis 
All determinations were performed in triplicate, and the results indicated as mean ± 
standard deviation (SD). Data were considered statistically significant at p ≤ 0.05. The null 
hypothesis of equality in action for all compounds was tested with one-way ANOVA [136]. In 
all cases the null hypothesis was rejected and the possible differences among formed groups 
were tested with the Bonferroni method. 
10.13 Docking Studies.  
Manool (17) was built using Maestro [137] and subjected to minimization with Macromodel 
[138], employing the generalized Born/surface area model to simulate a water environment. 
The conjugate gradient algorithm, the MMFFs force field and a distance-dependent dielectric 
constant of 1.0 were utilized for the minimization, performed until a convergence value of 
0.05 kcal/(Å·mol) was reached. The ligands were docked into the X-ray structure of bovine 
F1-ATPase in complex with inhibitor quercetin (PDB code 2JJ2) [126] using AUTODOCK4.2. 
[128] AUTODOCK TOOLS [139] were utilized to define the torsion angles in the ligand, to add 
the solvent model and to assign partial atomic charges (Kollman for the protein and 
Gasteiger for the ligand). A grid box of 56, 50, and 50 points in the x, y, and z directions, 
respectively, centered on the co-crystallized inhibitor was used to define the docking site for 
AUTODOCK calculations. The energetic maps required for docking were generated with a 
grid spacing of 0.375 Å and a distance-dependent function of the dielectric constant. The 
three ligands were docked using 200 Lamarckian genetic algorithm runs of the AUTODOCK 
search. During each docking run, 10’000’000 steps of energy evaluation were carried out and 
a maximum of 10’000’000 generations were simulated starting from an initial population of 
500 individuals. The final docking solutions were clustered together using a rms cut-off of 
2.0 Å and leaving all other settings as their defaults. The clusters of solutions with a 
population higher than 5%, i.e. including more than 5% of all the generated docking poses, 
were considered. 
10.14 Molecular Dynamic simulations. 
All simulations were carried out using AMBER 1485 using the X-ray structure of bovine F1-
ATPase in complex with quercetin (PDB code 2JJ2) already employed for docking. The initial 
and terminal segments of all protein monomers whose residues were placed more than 30 
Å away from the bound ligand were not taken into account in the simulations. All ligand-
protein complexes obtained by docking were solvated with a 15 Å water cap within a 
parallelepiped box; chloride ions were then added as counterions for neutralizing the 
system. General amber force field (GAFF) parameters were assigned to the ligands, while 
partial charges were calculated using the AM1-BCC method. Initially, the complexes were 
subjected to energy minimization through 5’000 steps of steepest descent followed by 
conjugate gradient, until a convergence of 0.05 kcal/(mol·Å2) was reached. The minimized 
systems were used as starting point for an MD simulations protocol composed of three steps. 
In the first one, 0.5 ns of constant-volume simulation were performed, raising the 
temperature of the system from 0 to 300 K. In the second step, the system was equilibrated 
through a 3 ns constant-pressure simulation where the temperature was kept constant at 
300 K by using the Langevin thermostat. In the third and last MD step, additional 26.5 ns of 
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constant-pressure simulation were performed, thus reaching a total simulation time of 30 
ns. In both the minimization and the three MD steps, a harmonic potential of 10 
kcal/(mol·Å2) was applied to the protein α carbons. All MD steps were run using particle 
mesh Ewald electrostatics and periodic boundary conditions, 86 while a cut-off of 10 Å were 
employed for the non-bonded interactions and SHAKE algorithm was used to keep rigid all 
bonds involving hydrogens. 
10.15 Binding Energy Evaluation.  
Relative binding free energy evaluations were performed using AMBER 14. The trajectories 
extracted from the last 15 ns of each simulation were used for the calculation, for a total of 
150 snapshots (at time intervals of 100 ps). Van der Waals, electrostatic and internal 
interactions were calculated with the SANDER module of AMBER 14, whereas the 
Poisson−Boltzman method was employed to estimate polar energies through the MM-PBSA 
module of AMBER 14 as previously reported [129]; [130]. Gas and water phases were 
represented using dielectric constants of 1 and 80, respectively, while nonpolar energies 
were calculated with MOLSURF program. The entropic term was considered as 
approximately constant in the comparison of the ligand-protein energetic interactions. 
10.16 Plant material 
Fresh aerial parts of Salvia tingitana Etl. were obtained from CREA FSO San Remo, Italy. The 
plant material is identified by Prof. Ammar Bader, and a voucher specimen (UQU-IT-2019/1) 
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Table 1. Salvia species containing quinone diterpenesa 
Species name [65] Protologue 
[65] 
Subgeneric classification Hedge’s ‘species-groups’ Molecular phylogenetic studies References 
Salvia 
absconditiflora 
Greuter & Burdet 
Willdenowia 
15: 77 (1985) 
Sect. Hymenosphace Benth. (as S. cryptantha) [140]  
 
Subg. Schraderia (Moench) Briq. Sect. Hymenosphace 
(as S. cryptantha) [141] 
Group C of Flora of Turkey 
[142] 




Sp. Pl.: 23 
(1753) 
Sect. Notiosphace Benth. [140], [144], [145]; 
 
Sect. Eremosphace (Notiosphaces Benth.) Bunge 
[146], [147]; 
 
Subg. Viasala Briq. Sect. Eremosphace Bunge [148], 
[149], [141] 
Group F of Salvia in Africa 
[11]  
 
Group 2 of Flora Iranica 
[150] 
Salvia clade III first lineage [30], 
[32]; 
 
Salvia s.l. clade III-A (Pleudia 
Raf.) [17]; 
 
S. aegyptiaca clade [19] 
[19], [140], [141], [17], 
[144], [145], [146], 
[147], [149], [11], [150], 





Veg. 12: 532 
(1913) 
Subg. Eusalvia Stib. (Subg. Salvia Benth.) Sect. 
Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Digitaloidites C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese clade, subclade iii [28];  
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17];  
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [17], [28], [152], 
[153] 
Salvia aethiopis L. Sp. Pl. 27 
(1753) 
Sect. Aethiopis Benth. [140], [145]; 
 
Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) [146];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. Ser. 
Lanatae Pobed. [141], [154] 
Group G of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [18], [17] 
[140], [141], [142], [17], 
[145], [146], [150], [30], 





Tabl. Encycl. i. 
68 (1791) 
Sect. Plethiosphace Benth. [155] 
 
Group F of Flora of Turkey 
[142] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [17];  
 
S. officinalis clade [19] 
[19], [142], [17], [30], 





Arbor. 65: 135 
(1984) 




3: 144 (1908) 
Sect. Audibertia Benth. Subsect. Jepsonia Epl. [158];  
 
Sect. Audibertia (Benth.) Epling. Subsect. Jepsonia Epl. 
Ser. Ramona (Greene) Neisess [159] 
 
 Salvia clade II [30], [32]; 
 
California Salvia clade 
(subclade Audibertia) [31] 




Subg. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
Sect. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
[31] 
Salvia argentea L. Sp. Pl. ed. 2: 
38 (1762) 
Sect. Aethiopis Benth. [140], [145], [156] §. 
Gongrosphaceae Sect. Gongrosphace Bunge [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141] 
Group R of Salvia in Africa 
[11];  
 
Group D of Flora of Turkey 
[142] 
Salvia s.s. clade I-C [17] [140], [141], [142], [17], 
[143], [145], [147], [11], 
[155], [156]  
Salvia arizonica 
A.Gray 
Syn. Fl. N. 
Amer. 2(1): 
370 (1878) 
Subg Calosphace Benth. Sect. Uliginosae Epl. [64];  
 
Subg. Calosphace Benth. Sect. Lanatae Epl. [66] 
  [64], [66] 
Salvia austriaca 
Jacq. 
Fl. Austriac. 2: 
8 (1774) 
Sect. Plethiosphace Benth. [140], [145], [147], [155]; 
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. B. Euplethiosphaceae Briq. [141]; 
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. Ser. Autriacae Pobed. [154] 
 Salvia clade I [30], [32];  
 
Salvia s.s. clade I-C [18], [17] 
[140], [141], [17], [145], 
[147], [30], [32], [154], 
[18], [155], [28] 
Salvia axillaris 





Sect. Calosphace Benth. §. Axillaeflorae Benth. [140];  
 
Sect. Calosphace Benth. §. Brachyantha D. Axilliflorae 
Benth. [145]; 
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Brachyanthae Benth. C. Axilliflorae Benth. [141];  
 
Subg. Calosphace Benth. Sect. Axillares Epl. [64]; 
 
Sect. Calosphace Epl. [161] 




Salvia s.l. clade II-A (Lasemia 
Raf.) [17]; 
 
Subg. Calosphace [19]; 
 
Axillares monotypic section 
[151] 
[19], [140], [141], [17], 
[145], [32], [151], [64], 






Sect. Calosphace Benth. §. Brachyantha D. Axilliflorae 
Benth. (as S. ballotaeflora) [140], [145]; 
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Brachyanthae Benth. C. Axilliflorae Benth. [141]; 
 
Subg. Calosphace Benth. Sect. Tomentellae Epl. (as S. 
ballotaeflora) [64] 
 Salvia clade II [30], [32]; 
 
Tomentellae clade III [29]; 
 
Tomentellae clade II [151] 
[140], [141], [145], [30], 





Sect. Plethiosphace Benth. (Species hujus sectionis 
dubia) [145]; 
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. B. Euplethiosphaceae Briq. [141] 
Group U of Salvia in Africa 
[11] 











Sect. Hymenosphace Benth. [163] Group A of Flora of Turkey 
[142] 




J. Linn. Soc., 
Bot. 38: 363 
(1908) 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. [152], [25] Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth. [19] 
 Chinese clade, subclade i, 
group i [28];  
 
Salvia s.l. clade IV-B (Glutinaria 
Raf.) [17];  
 
Subg. Glutinaria subclade 
Drymosphace (G7) (S. 
miltiorrhiza group) [19] 
[19], [17], [28], [152], 
[153], [25],  
Salvia bracteata 
Banks & Sol. 
Nat. Hist. 
Aleppo, ed. 2, 
2: 242 (1794) 
Sect. Eusphace Benth. [140], [145], [147];  
 
Subg. Salvia Benth. Sect. Eusphace Benth. §. Pinnatae 
Boiss. A. Fruticosae Boiss. [141];  
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [155] 
Group B of Flora of Turkey 
[142];  
 
Group 1 of Flora Iranica 
[150] 
Salvia s.s. clade I-D [17] [140], [141], [142], [17], 






Paris, sér. 8, 3: 
149 (1891) 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Digitaloidites C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 







Obshch. 1: 40 
(1923) 
Gen. Schraderia Medik. Sect. Holochilus Pobed. Ser. 
Bucharcae Pobed. (as Schraderia bucharica) (M. Pop.) 
Nevski [154]; 
 
Subg. Schraderia (Moench) Briq. Sect. Hymenosphace 
Benth. [149] 
Group with S. hydrangea 
DC. (E Turkey, N & W Iran), 
S. shelley Boiss. (S & W 
Iran), S. dracocephaloides 
Boiss. (Transcaucasus, NW 
Iran) and S. maymanica 
Hedge [165]; 
 
Group 1 of Flora Iranica 
[150] 
Salvia clade I [30], [32];  
 
Salvia s.s. clade I-D [17] 
[17], [149], [150], [30], 







Subg. Eusalvia Stib. (Subg. Salvia Benth.) Sect. 
Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Castaneae C.Y.Wu [153]; 
 
 Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17];  
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [17], [152], [153]  
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Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
Salvia 
campanulata 
Wall. ex Benth. 
Pl. Asiat. Rar. 
1: 67 (1830) 
Sect. Drymosphace Benth. [140], [145], [144]; 
 
Subg. Salvia Benth. Sect. Drymosphace Benth. [141]; 
 
Subg. Salvia Benth Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Campanulatae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Salvia s.l. clade IV (Glutinaria 
Raf.) [17];  
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [140], [141], [17], 
[145], [144], [153] 





Subg. Sclarea (Moench) Benth. Sect. Aethiopis Benth. 
(as S. lanata Roxb.) [144]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. (Sect. Aethiopis Benth.) §. Gongrosphace 
(Boiss.) Briq. (as S. lanata Roxb.) [141] 
Group 3 of Flora Iranica (as 
S. lanata Roxb.) [150] 
Salvia s.s. clade I-C (as S. lanata 
Roxb.) [17] 




Sp. Pl.: 26 
(1753) 
Sect. Hymenosphace Benth. §. Canariensis [140], 
[145];  
 
Subg. Schraderia (Monch) Briq. Sect. Nactosphace 
Briq. [141] 
Group H of Salvia in Africa 
[11] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [18], [17];  
 
S. officinalis clade [19] 
[19,140], [145], [141], 








Sect. Eusphace Benth. [145];  
 
Subg. Salvia Benth. Sect. Eusphace Benth. §. 
Simplicifoliae Boiss. [141];  
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [155] 
 Salvia clade I [30], [32];  
 
Salvia s.s. clade I-D [17] 










Subg. Jungia (Moench) Briq. [141] Sect. Calosphace 
Benth. §. Brachyantha E. Candicantes [145], [141];  
 
Subg. Calosphace Benth. Sect. Tomentellae Epl. [64] 
 Salvia clade II [30], [32]; 
 
(Tomentellae) [29];  
 
S. candicans + S. oaxacana 
clade [151] 
[141], [145], [64], [30], 
[32], [151], [29], [168] 
Salvia 
candidissima Vahl 
Enum. Pl. Obs. 
1: 278 (1804) 
Sect. Aethiopis Benth. [140], [145]; 
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141] 
Group D of Flora of Turkey 
[142];  
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [17] 
[140], [141], [142], [17], 
[143], [23], [145], [147], 








  Hedge Group D of Flora of 
Turkey [142]; 
 
Group 3 of Flora Iranica 
[150] 










 Hedge Group D of Flora of 
Turkey [142] 






Sect. Echinosphace Benth. [140], [145];  
 
Subg. Leonia (Llav. et Lex.) Benth. Sect. Echinosphace 
Benth. [141]; 
 
Sect. Audibertia Benth. Subsect. Echinosphace Epl. 
Ser. Douglasiana Epl. [158]; 
 
Sect. Echinosphace Benth. Subsect. Douglasiana Epl. 
Ser. Eplingia Neisess [159]; 
 
Subg. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
Sect. Echinosphace J.B.Walker, B.T.Drew, & 
K.J.Sytsma [31] 
 California Salvia clade 
(subclade Echinosphace) [31] 
[140], [141], [145], 






233 (1912)  
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Castaneae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese Clade, subclade iii [28];  
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [18], [17];  
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 








Subg. Sclarea Benth. Sect. Drymosphace Benth. sensu 
Stib. [169]; 
 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Sobiso (Raf.) G.X.Hu, 
A.Takano & B.T.Drew, comb. & stat. nov. ≡ Sobiso Raf. 
[19] 
 Chinese clade, subclade i, 
group i [28]; 
 
Salvia s.l. clade IV-B (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Sobiso (G8) (S. chinensis group) 
[19] 






Sp. Pl.: 27 
(1753) 
Sect. Aethiopis Benth. [140], [145], [155]; 
 
Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) [146];  
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don.) Briq. Subsect. Gongrosphaceae Briq. Ser. 
Ceratophyllae Pobed. [154]; 
 
Subg. Sclarea (Moench) Benth. Sect. Gongrosphace 
Benth. [149] 
Group G of Flora of Turkey 
[142]; 
 
Group 3 of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [140], [142], [17], [143], 
[23], [145], [146], [147], 





Orient. ser. 1, 
5: 8 (1844)  
Sect. Aethiopis Benth. [145], [155]; 
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141] 
Group D of Flora of Turkey 
[142] 
Salvia s.s. clade I-C [17] [141], [142], [17], [143], 





Bot. Gard. 27: 
260 (1940) 
Sect. Audibertia Benth. Subsect. Jepsonia Epl. [66]; 
 
Sect. Audibertia (Benth.) Epl. Subsect. Jepsonia Epl. 
Ser. Nivea (Benth.) Neisess [159]; 
 
Subg. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
Sect. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
[31] 
 Salvia clade II [30], [32]; 
 
California Salvia clade 
(subclade Audibertia) [31,170] 
[30], [32], [159], [31], 






Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) [146]; 
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141]; 
 
Sect. Aethiopis Benth. [155] 
Group 3of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [141], [17], [146], [147], 




Orient., ser. 2, 
4: 19 (1859) 
Sect. Aethiopis Benth. [172] Groups F and G of Flora of 
Turkey [142] 




Buc'hoz ex Etl. 
Salv.: 23 
(1777) 
Sect Calosphace §. Longiflorae [140]; 
 
Subg. Junga (Moench) Briq. [141] Sect. Calosphace 
Benth. §. Longiflorae L. Tubiflorae [145], [141]; 
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
[153]; 
 
Sect. Subrotundae Epl. [170] 
 Salvia clade II [30]; 
 
"Core Calosphace" [29], [151]; 
 
Subg. Calosphace [19] 
[19], [140], [141] (as S. 
coccinea L.), [145], [30], 








Sect. Pycnosphace [140], [145]; 
 
Subg. Leonia (Llav. et Lex.) Benth. Sect. Pycnosphace 
Benth. [141]; 
 
Sect. Audibertia Benth. Subsect. Pycnosphace Epl. 
[158]; 
 
Sect. Audibertia (Benth.) Epl. Subsect. Parishiella Epl. 
Ser. Pycnosphace (Benth. ex Epl.) Neisess [159]; 
 
Subg. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
Sect. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
[31] 
 Salvia clade II [30], [32]; 
 
California Salvia clade 
(subclade Audibertia) [31] 
[140], [141], [145], [30], 




Enum. Pl. Obs. 
1: 252 (1804) 
Sect. Calosphace Benth. §. Brachyanthae [140]; 
 
Subg. Jungia (Moench) Briq. [141] Sect. Calosphace 
Benth. §. Longiflorae D. Corrugatae Benth. [145], 
[141]; 
 
Subg. Calosphace Benth. [64] Sect. Corrugatae 
(Benth.) Epl. [64], [170] 
 
Sect. Calosphace Epl. [161] 
 Salvia clade II [30], [32]; 
 
"Uliginosae clade" Sect. 
Corrugatae [29], [151] 
 
[140], [141], [145], [30], 
[32], [151], [64], [161], 
[29], [170], [173] 
Salvia cuspidata 
Ruiz & Pav. 
Fl. Peruv. 1: 
23 (1798) 
Subg. Jungia (Moench) Briq. [141] Sect. Calosphace §. 
Brachyanthae [140], Bentham 1848, [141] F. 
Scorodoniae [145], [141]; 
 
Subg. Calosphace Benth. Sect. Tomentellae Epl. [64] 






Kew Bull. 62: 
186 (2007) 
Sect. Calosphace Benth. Sect. Brachyanthae [140]; 
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Brachyanthae Benth. E. Scorodonieae Benth. (as S. 
gilliesii) [141]; 
 Tomentellae clade II (as S. 
gilliesii) [29], [151] 
 
[140], [141], [151], [64], 




Subg. Calosphace Benth. Sect. Tomentellae Epl. [64] 
 
Sect. Calosphace Epl. [161] 
Salvia cyanescens 
Boiss. & Balansa 
Diagn. Pl. 
Orient., ser. 2, 
4: 19 (1859) 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge. [147]; 
 
Sect. Aethiopis Benth. [155] 
Group F of Flora of Turkey 
[142] 







Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Maximowiczianae C.Y.Wu [153] 
 Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17], [18] 







Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Maximowiczianae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Salvia clade III [32]; 
 
Chinese Clade, subclade iii [28];  
 
Salvia s.l. Clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [17], [32], [28], 







Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [19] 
 Chinese clade, subclade i, 
group i [28]; 
 
Salvia s.l. clade IV (Glutinaria 
Raf.) [17] 






1824: 6 (1824) 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. Ser. Nemorosae Pobed. [154];  
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. Subsect. Euplethiosphace Briq. Ser. 
Nemorosae Pobed. [153] 
 Salvia clade I according to 
Walker 2007 [32] [28]; 
 
Salvia s.s. clade I-C [18], [17]; 
 
S. officinalis clade [19] 









1: 96 (1885) 
Sect. Plethiosphace Benth. [143], [23] Group F of Flora of Turkey 
[142] 







Subg. Salvia Benth. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Digitaloidites C.Y.Wu [153]; 
 
 Salvia clade III second lineage 
[30], [32]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [18] [17]; 
[19], [17], [30], [32], 
[152], [153], [18] 
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Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
Salvia divaricata 
Montbret & 
Aucher ex Benth. 
Ann. Sci. Nat., 
Bot., sér. 2, 6: 
37 (1836) 
Sect. Eusphace Benth. [140], [145], [147]; 
 
Subg. Salvia Benth. Sect. Eusphace Benth. §. 
Simplicifoliae Boiss. [141]; 
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [143] 
Group E of Flora of Turkey 
[142] 
Salvia s.s. clade I-D [17] [140], [141], [142], [17], 






22: 326 (1937) 




Boiss & Kotschy 
Fl. Orient. 4: 
611 (1879) 
Sect. Aethiopis Benth. §. Homalosphaceae Sect. 
Homalosphace Bunge [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Homalosphaceae (Boiss.) Briq. [141]; 
 
Sect. Aethiopis Benth. Subsect. Gongrosphace 
(Bunge) Boiss. [163] 
Group F of Flora of Turkey 
[142] 








62: 236 (1925) 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Sect. Eurysphace Stib. Subsect. Perennes 
C.Y.Wu Ser. Brachylomae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [17], [28], [152], 
[153], [164] 
Salvia flava 





Subg. Salvia Sect. Eurysphace Subsect. Perennes 
C.Y.Wu Ser. Castaneae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 




Gard. Dict. Ed. 
8: 5 (1768) 
Sect. Eusphace Benth. (as S. triloba) [140]; 
 
Subg. Salvia Sect. Eusphace Benth. [Han 2010] §. 
Pinnatae Boiss. A. Fruticulosae Boiss (as S. triloba) 
[141]; 
Groups B and E of Flora of 
Turkey [142];  
 
Group A of Salvia in Africa 
[11] 
Salvia s.s. clade I-D [18], [17] [140], [141], [142], [17], 
[23], [11], [18], [155] 











Subg. Jungia (Moench) Briq. [141] Sect. Calosphace 
Benth. §. Brachyantha F. Scorodoniae [145], [141]; 
 
Subg. Calosphace Benth. Sect. Tomentellae Epl. [64]; 
 
Subg. Calosphace Benth. Sect. Scorodoniae Epl. [176] 
 Tomentellae clade I inside 
"Uliginosae clade" [29]; 
 
Tomentellae clade I inside 
"Uliginosae clade" [151] 
[141], [145], [151], [64], 
[29], [176]  
Salvia glutinosa L. Sp. Pl.: 26 
(1753)  
Subg. Salvia Benth. [141] Sect. Drymosphace Benth. 
[140], [145], [146], [141], [144], [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Glutinaria [19] 
Group E of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia clade III second lineage 
[30], [32]; 
 
Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Glutinaria (G4) [19] 
[19], [140], [141], [142], 
[17], [23], [144], [145], 
[146], [147], [150], [30], 








Subg. Sclarea (Moench) Benth. Sect. Aethiopis Benth. 
[152];  
 
Subg. Sclarea (Moench) Benth. Sect. Aethiopis Benth. 
Subsect. Homalosphaceae (Boiss.) Briq. Ser. 
Grandifoliae C.Y.Wu [153] 
 Salvia s.l. clade IV (Glutinaria 
Raf.) [17] 
[17], [152], [153]  




Subg. Salvia Benth. [141] Sect. Drymosphace Benth. 
[140], [145], [141], [144] 
 Salvia clade III second lineage 
[30], [32] 
 
Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17] 
[140], [141], [17], [144], 






Subg. Gymnosphace (Benth.) Stib. [152]; 
 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Honaniae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth. [19] 
 Chinese clade, subclade i, 
group i [28]; 
 
Salvia s.l. Clade IV (Glutinaria 
Raf.) [17]; 
 




Subg. Glutinaria subclade 
Drymosphace (G7) (S. 
miltiorrhiza group) [19] 
Salvia hydrangea 




Subg. Schraderia (Monch) Briq. [141] Sect. 
Hymenosphace Benth. [146], [141] §. Mediterraneo-
Ponticae [145]; 
 
Sect. Hymenosphace [147]; 
 
Gen. Schraderia Medik. Sect. Holochilus Pobed. Ser. 
Bucharcae Pobed. (as Schraderia dracocephaloides 
(Boiss.) Pobed. [154] 
Group A of Flora of Turkey 
[142];  
 
Group 1 of Flora Iranica 
[150] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-D [18], [17] 
[141], [142], [17], [145], 
[146], [147] (as S. 
dracocephaloides), 
[150], [30], [32], [154], 
[18], [177] 
Salvia hypargeia 
Fisch. & C.A.Mey. 
Ann. Sci. Nat., 
Bot., ser. 4, 1: 
34 (1854) 
Sect. Eusphace Benth. [178]; 
 
Sect. Aethiopis Benth. [143], [23] 
Group E of Flora of Turkey 
[142] 




Bull. Soc. Bot. 
France 2: 581 
(1855) 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141]; 
 
Sect. Plethiosphace Benth. [179] 
Group P of Salvia in Africa 
[11] 




Fl. URSS 21: 
659 (1954) 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don.) Briq. Subsect. Gongrosphaceae Briq. Ser. 
Kopetdaghenses Pobed. [154] 





66: 584 (1977) 
Subg. Allagospadonopsis Briq. Ser. Appendiculatae 
C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Sobiso (Raf.) G.X.Hu, 
A.Takano & B.T.Drew, comb. 
& stat. nov. ≡ Sobiso Raf. [19] 
 Chinese clade, subclade i, 
group ii [28]; 
 
Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Sobiso (G8) (S. chinensis group) 
[19] 




Bull. Acad. Int. 
Géogr. Bot. 
25: 25 (1915) 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Sect. Eurysphace Subsect. Perennes 
C.Y.Wu Ser. Castaneae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese Clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) (as S. kiaometiensis f. 
pubescens) [17];  
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [17], [28], [152], 
[153] 
Salvia korolkovii 




Gen. Schraderia Medik. Sect. Odontochilus Pobed. 
Series. Bucharcae Pobed. (as Schraderia korolkovii) 
(Rgl. Et Schmalh.) Pobed [154] 
 Salvia s.s. clade I-D [17] [17], [154] 
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99: 50 (1952) 
Sect. Hymenosphace Benth. [180] 
 
Group C of Flora of Turkey 
[142] 
Salvia s.s. clade I-D [18], [17] [142], [17], [18], [180] 
Salvia lachnocalyx 
Hedge 
Fl. Iranica 150: 
455 (1982) 
- Group 3 of Flora Iranica 
[150] 







Subg. Jungia (Moench) Briq. [141] Sect. Calosphace 
Benth. § Brachyantha H. Rudes [145], [141]; 
 
Subg. Calosphace Benth. Sect. Uliginosae Epl. [64] 




5: 49 (1817) 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. B. Euplethiosphaceae Briq. [141] 
Group T of Salvia in Africa 
[11];  
 
Group 3 of Flora Iranica 
[150] 







Sect. Calosphace § Brachyanthae [140]; 
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Brachyanthae Benth. A. Angustifoliae Benth. [141]; 
 
Subg. Calosphace Benth. Sect. Lavanduloideae Epl. 
[64] 
 Salvia clade II [30], [32]; 
 
"Core Calosphace" [29]; 
 
"Core Calosphace", 
Lavanduloideae clade [151] 
[140], [141], [30], [32], 






Sect. Aethiopis Benth. (as S. leriaefolia) [145]; 
 
Sect. Homalosphace Aethiopis spec. Benth. (as S. 
leriaefolia) [146]; 
 
Sect. Aethiopis Benth. §. Homalosphaceae (as S. 
leriaefolia) [147];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Homalosphaceae (Boiss.) Briq. (as S. 
leriaefolia) [141]; 
 
Subg. Sclarea (Moench) Benth. Sect. Homalosphace 
Benth. [149] 
Group 3 of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [141], [17], [145], [146], 






Sect. Aethiopis Benth. [145], [155];  
 
Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) [146];  
 
Group D of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [141], [142], [17], [145], 
[146], [147], [150], 
[154], [155],  
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Sect. Aethiopis Benth. §. Gongrosphaceae [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don.) Briq. Subsect. Gongrosphaceae Briq. Ser. 




J. Linn. Soc., 
Bot. 26: 285 
(1890) 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Maximoviczianae C.Y.Wu [153];  
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 





Yunnan. 6: 59 
(1984) 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Honaniae C.Y.Wu [153]; 
  
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth. [19] 
 Chinese clade, subclade i, 
group i [28]; 
 
Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Drymosphace (G7) (S. 
miltiorrhiza group) [19] 
[19], [17], [28], [153] 
Salvia mellifera 
Greene 
Pittonia 2: 236 
(1892) 
Sect. Audibertia Benth. Subsect. Parishiella Epl. [158]; 
 
Sect. Audibertia (Benth.) Epl. Subsect. Parishiella Epl. 
Ser. Stachyoides Neisess [159]; 
 
Subg. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
Sect. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
[31] 
 Salvia clade II [30], [32]; 
 
Salvia s.s. clade II-C [17]; 
 
California Salvia clade 
(subclade Audibertia) [31] 
[159], [158], [160], [31], 




China Bor.: 50 
(1833) 
Subg. Salvia Benth. [141] Sect. Drymosphace Benth. 
(as S. miltiorhiza) [145], [141]; 
 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. [152] Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth. [19] 
 Salvia clade III [30], [32]; 
 
Clade III + Chinese and 
Japanese Salvia [171]; 
 
Chinese clade, subclade i, 
group i [28]; 
 
Salvia s.l. clade IV-B (Glutinaria 
Raf.) [18], [17]; 
 
[19], [141], [17], [145], 
[30], [32], [28], [152], 
[153], [18] [171] 
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Subg. Glutinaria subclade 
Drymosphace (G7) (S. 






66: 148 (1977) 
    
Salvia miltiorrhiza 
var. miltiorrhiza 
 Subg. Sclarea Benth. Sect. Drymosphace Benth. [181], 
[25] 
 Salvia s.l. clade IV-B (Glutinaria 
Raf.) [17] 
[17], [25], [181] (as S. 
miltiorrhiza f. alba),  
Salvia montbretii 
Benth. 
Ann. Sci. Nat., 
Bot., ser.2, 6: 
42 (1836) 
Sect. Aethiopis Benth. (as S. monbretii) [140], [145];  
 
Sect. Aethiopis Benth. §. Homalosphaceae Sect. 
Homalosphace [147];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Homalosphaceae (Boiss.) Briq. [141] 
Group E of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [140], [141], [142], [17], 
[145], [147], [150]  
Salvia 
moorcroftiana 
Wall. ex Benth. 
N. Wallich, Pl. 
Asiat. Rar. 1: 
67 (1830) 
Sect. Aethiopis Benth. (as S. moorcroftiana) [140], 
[145], [144]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141]; 
 
Subg. Sclarea (Moench) Benth. Sect. Homalosphace 
Benth. [149] 
Group 3 of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [140], [141], [17] [144], 







Sect. Hymenosphace Benth. [140] §. Mediterraneo-
Ponticae [145] 
Groups B and C of Flora of 
Turkey [142];  
 
Group 1 of Flora Iranica 
[150] 
Salvia s.s. clade I-D [17] [140], [142], [17], [143], 





Sect. Audibertia Benth. Subsect. Parishiella Epl. [158];  
 
Sect. Audibertia (Benth.) Epl. Subsect. Parishiella Epl. 
Ser. Stachyoides Neisess [159]; 
 
Subg. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
Sect. Audibertia J.B.Walker, B.T.Drew, & K.J.Sytsma 
[31] 
 Salvia clade II [30], [32]; 
 
California Salvia clade 
(subclade Audibertia) [31] 







66: 582 (1977) 
Subg. Salvia Sect. Drymosphace Benth. [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth. [19] 
 Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Drymosphace (G7) (S. 
miltiorrhiza group) [19] 






Vindob. 2: 71 
(1773) 
Subg. Covola (Medik.) Briq. [141] Sect. Hemisphace 
Benth. [140], [145], [141], [155] 
Group F of Flora of Turkey 
[142] 
Verticillata group [17] [140], [141], [142], [17], 
[145], [23], [155] 
Salvia nemorosa 
L. 
Sp. Pl. ed. II. 
35 (1762) 
Sect. Plethiosphace Benth. [146], [155]; 
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. [149] B. Euplethiosphaceae Briq. [141];  
 
Subg. Sclarea (Moench) Benth. Subsect. 
Gongrosphaceae Briq. Ser. Nemorosae Pobed. [154] 
Group F of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
 [141], [142], [143], 






Batavi 2: 107 
(1865) 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Nipponicae C.Y.Wu [153];  
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Glutinaria [19] 
 Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Glutinaria (G4) [19] 
[19], [17], [153], [171], 
[27] 
Salvia nutans L. Sp. Pl.: 27 
(1753) 
Sect. Plethiosphace Benth. [140], [145], [155], [147]; 
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. B. Euplethiosphaceae Briq. [141];  
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. Subsect. Gongrosphaceae Briq. Ser. Nutantes 
Pobed. [154] 
Group F of Flora of Turkey 
[142] 
Salvia s.s. clade I-C [17] [140], [141], [142], [17], 





Acad. Arts 35: 
536 (1900) 
Subg. Calosphace Benth. Sect. Conzattiana Epl. [64]  (Conzattiana) [29]; 
 
Salvia s.l. clade II-A (Lasemia 
Raf.) [17]; 
 
S. candicans + S. oaxacana 
clade [151] 
[17], [151], [64], [29] 
Salvia officinalis L. Sp.Pl.: 23 
(1753) 
Sect. Eusphace Benth. [140], [145];  
 
Subg. Salvia Benth. Sect. Eusphace Benth [25]. §. 
Simplicifoliae Boiss. [141];  
 
Subg. Eusalvia Pobed. Sect. Eusphace Benth. Ser. 
Officinales Pobed. [154]; 
 
Subg. Salvia Stib. Sect. Eusphace Stib. Subsect. 
Simplicifolia Boiss. Ser. Officinales Pobed [153] 
 Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-D [18], [17]; 
 
S. officinalis clade [19] 
[19], [140], [141], [17], 
[145], [154], [30], [32], 












Eur. 5(4): 2482 
(1927) 
Sect. Eusphace Benth. [140];  
 
Subg. Salvia Benth. Sect. Eusphace Benth. §. 
Simplicifoliae Boiss. (as S. lavandulaefolia) [141]; 
 
Sect. Salvia (as S. lavandulifolia) [155] 
Group A of Salvia in Africa 
(as S. lavandulifolia) [11] 
Salvia s.s. clade I-D (as S. 
lavandulifolia) [17] 







Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Maximoviczianae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 









Subg. Eusalvia Pobed. Sect. Eusphace Benth. Ser. 
Pachystachyae Pobed [154] 
Group A of Flora of Turkey 
[142] 






Sect. Aethiopis Benth. [23], [145]; 
 
Sect. Homalosphace Aethiopis spec. Benth. [146];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Homalosphaceae (Boiss.) Briq. [141] 
Group E of Flora of Turkey 
[142];  
 
Group Q of Salvia in Africa 
[11];  
 
Group 3 of Flora Iranica 
[150] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [17], [18] 
[146], [141], [142], [17], 
[23], [145], [11], [150], 






Sin. 19: 245 
(1981) 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [19] 
 Chinese clade, subclade i, 
group i [28]; 
 








Sect. Aethiopis Benth. [145], [155];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141] 
Group Q of Salvia in Africa 
[11] 
Salvia s.s. clade I-C (as S. 
phlomoides spp. phlomoides) 
[17] 
[141], [17], [145], [11], 
[155] 
Salvia pisidica 
Boiss & Heldr. ex 
Benth. 
Prodr. 12: 269 
(1848) 
Sect. Eusphace Benth. [145], [147];  
 
Subg. Salvia Benth. Sect. Eusphace Benth. §. Pinnatae 
Boiss. A. Fruticosae Boiss. [141];  
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [23] 
Group A of Flora of Turkey 
[142] 






Prodr. Fl. Nov. 
Holland.: 501 
(1810) 
Subg. Leonia (Llav. & Lex) Benth. Sect. Notiosphace 
Benth. [149], [154]; 
 
Sect. Notiosphace Benth. [140], [145], [144]; 
 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Sclarea (Moench) Benth. Sect. Notiosphace 
Benth. [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Notiosphace Benth. [19] 
 Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Chinese clade, subclade ii [28]; 
 
Salvia s.l. clade IV-C (Glutinaria 
Raf.) [17], [18]; 
 
Subg. Glutinaria subclade 
Notiosphace (G2) [19] 
[19], [140], [17], [144], 
[145], [149], [28], [152], 
[153], [154] (as S. 
plebeja), [18], [171], 




Not. Pl. Asiat. 
4: 199 (1854) 
Sect. Notiosphace Benth. [144]; 
 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Plectranthoidites C.Y.Wu [153] 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Notiosphace Benth. [19] 
 Salvia s.l. clade IV [18] 
 
Subg. Glutinaria subclade 
Plectranthoides (G7) [19] 
[19], [144], [153], [18]  
Salvia 
potentillifolia 




Sect. Eusphace Benth. (as S. potentillaefolia) [145];  
 
Subg. Salvia Benth. Sect. Eusphace Benth. §. Pinnatae 
Boiss. A. Fruticosae Boiss. [141]; 
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [23] 
Group A of Flora of Turkey 
[142] 
Salvia s.s. clade I-D [17] [141], [142], [17], [23], 
[145] 
Salvia pratensis L. Sp.Pl.: 25 
(1753) 
Sect. Plethiosphace Benth. [140], [145], [155], [147];  
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. B. Euplethiosphaceae Briq. [141];  
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. Subsect. Gongrosphaceae Briq. Ser. Pratenses 
Pobed. [154] 
 Salvia clade I [[30] [32] 
 
Salvia s.s. clade I-C [18], [17] 
[140], [141], [17], [145], 




J. Linn. Soc., 
Bot. 29: 316 
(1892) 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Hiantes C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 




J.Bot. 8: 74 
(1870) 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [153]; 
 
 Chinese clade, subclade i, 
group ii [28]; 
 
[19], [28], [153] 
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Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Sobiso (Raf.) G.X.Hu, 
A.Takano & B.T.Drew, comb. & stat. nov. ≡ Sobiso Raf. 
[19] 
Subg. Glutinaria subclade 







ser.3, 27: 526 
(1882) 
Subg. Salvia Benth. Sect. Drymosphace Benth. [141];  
 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Stib. Sect. Eurysphace Stib. Subsect. 
Perennes Ser. Digitaloidites C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Salvia clade III second lineage 
[30], [32]; 
 
Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
[19], [141], [17], [30], 







Sect. Calosphace Benth. §. Longiflorae H. Inflatae 
[145];  
 
Subg. Calosphace Benth. Sect. Erythrostachys Epl. [64] 
 Sect. Erythrostachys [29];  
 
Erythrostachys clade [151] 
[145], [151], [64], [29] 
Salvia recognita 
Fisch. & C.A.Mey. 
Ann. Sci. Nat., 
Bot., sér. 4, 1: 
33 (1854 
Subg. Salvia Benth. Sect. Eusphace Benth. §. Pinnatae 
Boiss. A. Fruticosae Boiss. [141];  
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [23] 
Group B of Flora of Turkey 
[142] 
Salvia s.s. clade I-D [17] [141], [142], [17] [143], 
[23] 
Salvia regla Cav. Icon. 5: 33 
(1799)  
Sect. Calosphace Benth. Sect. Longiflorae [140], [145];  
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Longiflorae Benth. H. Inflatae Benth. [141];  
 
Subg. Calosphace Benth. Sect. Erythrostachys Epl. 
[64]; 
 
Sect. Platycheilos Epl. [161] 




Prodr. 12: 280 
(1848) 
Sect. Aethiopis Benth. [145];  
 
Sect. Homalosphace Aethiopis spec. Benth. [146];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Homalosphaceae (Boiss.) Briq. [141];  
 
Sect. Aethiopis Benth. §. Homalosphaceae Sect. 
Homalosphace Bunge [147]; 
Group with S. chorassanica 
Bunge (NW Iran), S. 
lasearica Rech f. (SE Iran), S. 
sahendica Boiss. & Buhse 
and S. frigida Boiss. (Irani 
Ajerbaidjan) and S. 
chrysophylla Stapf [165] 
 
Salvia s.s. clade I-C [17] [141], [17], [145], [146], 





Subg. Sclarea (Moench) Benth. Sect. Gongrosphace 
Benth. [149] 







sér. 3, 27: 527 
(1882) 
Subg. Salvia Benth. Sect. Drymosphace Benth. [141];  
 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Annuae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Annuae (C.Y.Wu) C.L.Xiang & 
H.Peng stat. nov. ≡ Subsect. Annuae C.Y.Wu. [19] 
 Salvia clade III second lineage 
[30], [32]; 
 
Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Annuae (G5) [19] 
[19], [141], [17], [30], 
[32], [28], [152], [153] 
Salvia sahendica 






Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) [146];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141];  
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147]; 
 
Sect. Aethiopis Benth. [155] 
Group 3 of Flora Iranica 
[150] 







Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Brachylomae C.Y.Wu [153] 
 Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17] 
[19], [140], [141], [17], 
[143], [23], [145], [146], 
[147], [149], [152], 
[153] 
Salvia sclarea L. Sp. Pl.: 27 
(1753)  
Sect. Aethiopis Benth. [140], [145], [155], [143], Celep 
2010];  
 
Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) [146];  
 
Subg. Sclarea Sect. Aethiopis [25]; 
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Gongrosphaceae (Boiss.) Briq. [141] Ser. 
Sclareae Pobed [154];  
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147];  
 
Group R of Salvia in Africa 
[11];  
 
Group D of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [18], [17]; 
 
S. officinalis clade [19] 
[142], [17], [11], [150], 
[30], [32], [28], [154], 
[18], [155], [25], [171] 
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Sect. Calosphace Benth. §. Brachyantha F. 
Scorodoniae [140], [145];  
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Brachianthe Benth. E. Scorodonieae [141];  
 
Subg. Calosphace Benth. Sect. Atratae [64];  
 Salvia clade II [32]; 
 
"Core Calosphace" [29] 







Subg. Jungia (Moench) Briq. [141] Sect. Calosphace 
Benth. §. Longiflorae [140] H. Inflatae [145], [141]; 
 
Subg. Calosphace Benth. Sect. Erythrostachys Epl. [64] 
 Sect. Erythrostachys [29] [140], [141], [145], [64], 
[29] 
Salvia sinica Migo J. Shanghai 
Sci. Inst. Sect. 
3, 3: 226 
(1937) 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth. [19] 
 Chinese clade, subclade i, 
group i [28]; 
 
Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Drymosphace (G7) (S. 
miltiorrhiza group) [19] 






Sect. Calosphace Benth. §Brachyantha E. Candicantes 
[145], [141]; 
 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. (as S. 
pauciflora) [152];  
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Brachylomes C.Y.Wu [153] 
 Salvia s.l. clade IV-A (Glutinaria 
Raf.) (as S. pauciflora) [17] 
[19], [17], [145] (as S. 
pauciflora), [141] (as S. 
pauciflora), [28], [152], 








Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Ser. Castaneae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 
 
Salvia syriaca L. Syst. Nat. ed. 
10, 2: 854 
(1759) 
Sect. Aethiopis Benth. [140], [145];  
 
Sect. Homalosphace Aethiopis spec. Benth. [146];  
 
 Salvia s.s. clade I-C [17] [140], [141], [17], [143], 




Sect. Aethiopis Benth. §. Homalosphaceae Sect. 
Homalosphace Bunge [147];  
 
Subg. Sclarea (Moench) Benth. Sect. Stenarrhena 
(Don) Briq. §. Homalosphaceae (Boiss.) Briq [141];  
 
Sect. Stenarrhena (Don) Briq. (Sect. Aethiopis Benth.) 






Fl. Orient. 4: 
598 (1879) 
Subg. Salvia Benth. Sect. Eusphace Benth. §. Pinnatae 
Boiss. A. Fruticosae Boiss. [141];  
 
Sect. Eusphace Benth. [147];  
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [143], [23] 
Group A of Flora of Turkey 
[142] 






Sect. Eremosphace Nothiosphace Benth. [146], [147]; 
 
Subg. Viasala Briq. Sect. Eremosphace Bunge [141];  
Group 2 of Flora Iranica 
[150] 
Salvia clade III first lineage [30], 
[32]; 
 
Salvia s.l. clade III-A/C (Pleudia 
Raf.) [17] 
[141], [17], [146], [147], 
[150], [30], [32],  
Salvia texana 
(Scheele) Torr. 
Rep. U.S. Mex. 
Bound. 2(1): 
132 (1858) 
Nearest to Heterosphace Benth. [184]; 
 
Gen. Salviastrum Scheele (as Salviastrum texanum 
Scheele) [141] 
 Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-B [17] 







Sect. Calosphace Benth. §. Brachyantha [140]; 
 
Subg. Jungia (Moench) Briq. [141] Sect. Calosphace 
Benth. §. Brachyantha E. Candicantes [145], [141];  
 
Subg. Calosphace Benth. Sect. Flocculosae Epl. [64] 
 Salvia clade II [32]; 
 
"Core Calosphace" [29]; 
 
"Core Calosphace", S. 
chamaedryoides + S. thymoides 
clade [151] 
[140], [141], [145], [32], 
[151], [64], [29] 
Salvia tiliifolia 
Vahl 
Symb. Bot. 3: 
7 (1794) 
Sect. Calosphace Benth. §. Micranthae (as S. 
tiliaefolia) [140], [145]; 
 
Subg. Jungia (Moench) Briq. Sect. Calosphace Benth. 
§. Micranthae B. Phthartae Briq. (as S. tiliaefolia) 
[141]; 
 
Subg. Calosphace Benth. Sect. Angulatae Epl. Subsect. 
Tiliaefoliae (as S. tiliaefolia) [64];  
 
Sect. Angulatae [170] 
 Salvia clade II [30], [32]; 
 
"Core Calosphace" [29]; 
 
"Core Calosphace", Angulatae 
clade [151]; 
 
Subg. Calosphace [19] 
[19], [140], [141], [145], 






Gard. Dict. ed. 
8: n.º 2 (1768) 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [143], [23] Group E of Flora of Turkey 
[142] 






prepr. 6: 355 
(1879) 







Paris, sér.8, 3: 
150 (1891) 
Sect. Lanatae [66]; 
 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Annuae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Annuae (C.Y.Wu) C.L.Xiang & 
H.Peng stat. nov. ≡ Subsect. Annuae C.Y.Wu. [19] 
 Chinese clade, subclade iii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Annuae (G5) [19] 








Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. [152]; Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Substoloniferae (C.Y.Wu) 
C.L.Xiang & B.T.Drew stat. nov. ≡ Ser. Substoloniferae 
C.Y.Wu [19] 
 Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Chinese clade, subclade ii [28]; 
 
Salvia s.l. clade IV-A (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Substoloniferae (G3) [19] 




J. Bot. 8: 75 
(1870) 
Subg. Salvia Benth. Sect. Drymosphace Benth. [141]; 
 
Subg. Eusalvia Stib. Sect. Eurysphace Stib. [152]; 
 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Annuae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Annuae (C.Y.Wu) C.L.Xiang & 
H.Peng stat. nov. ≡ Subsect. Annuae C.Y.Wu. [19] 
 Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Annuae (G5) [19] 
[19], [141], [17], [28], 
[152], [153], [25], [181] 
Salvia vasta 
H.W.Li 
Bull. Bot. Res., 
Harbin. 3: 67 
(1983) 
Subg. Sclarea (Moench) Benth. Sect. Drymosphace 
Benth. Ser. Miltiorrhizae C.Y.Wu [19] 
 
  [19], [185], [186] 
Salvia verbenaca 
L. 
Sp. Pl.: 25 
(1753) 
Sect. Plethiosphace Benth. [140], [145], [155], [147], 
[156];  
Group T of Salvia in Africa 
[11];  
Salvia clade I [30], [32]; 
 
[140], [141], [142], [17], 




Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. B. Euplethiosphaceae Briq. [141] Ser. 
Verbenacae Pobed. [154] 
 
Group F of Flora of Turkey 
[142] 




Sp. Pl.: 26 
(1753) 
Sect. Hemisphace Benth [140], [145], [146], [155], 
[156], [147]; 
 
Subg. Covola (Medik.) Briq. [154] Sect. Hemisphace 
Benth [141]; 
 
Sect. Plethiosphace Benth. [155] 
Group F of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia clade I [30], [32]; 
 
S. verticillata group [17];  
 
S. officinalis clade [19] 
[19], [142], [140], [141], 
[17], [143], [23], [145], 
[146], [147], [150], [30], 






Sect. Plethiosphace Benth. [140], [145], [146], [155], 
[156], [147];  
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. [Hedge 1970] B. Euplethiosphaceae Briq. 
[141];  
 
Subg. Sclarea (Moench) Benth. Sect. Plethiosphace 
Benth. Subsect. Gongrosphaceae Briq. Ser. Pratenses 
Pobed. [154] 
Groups F and G of Flora of 
Turkey [142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia s.s. clade I-C [17] [140], [141], [142], [17], 
[143], [23], [145], [146], 
[147], [150], [154], 
[155], [156] 
Salvia viridis L. Species 
Plantarum 1: 
24 (1753) 
Subg. Sclarea (Moench) Benth. [154] Sect. Horminum 
Benth. [140], [146], [141], [156], [147], Pobedimova 
1954 Flora of the URSS]; 
 
Sect. Plethiosphace Benth. [155] 
Group S of Salvia in Africa 
[11];  
 
Group F of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 
Salvia clade I [30], [32]; 
 
Salvia s.s. clade I-C [17] 
[140], [141], [142], [17], 
[143], [23],  [146], 
[147], [11], [150], [30] 
[32], [154], [155], [156] 
Salvia viridis L. 
'Blue Denim' 





Veg. 39: 176 
(1936) 
Subg. Salvia Benth. Sect. Eurysphace Stib. Subsect. 
Perennes C.Y.Wu Stib. Ser. Hiantes C.Y.Wu [153];  
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Eurysphace Stib. [19] 
 Salvia s.l. clade IV (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Eurysphace (G6) [19] 




Fl. Orient. 4: 
599 (1879) 
Subg. Salvia Benth. Sect. Eusphace Benth. §. Pinnatae 
Boiss. A. Fruticosae Boiss. [141];  
 
Sect. Eusphace Benth. [147]; 
 
Sect. Salvia Hedge (Sect. Eusphace Benth.) [143], [23] 
Group A of Flora of Turkey 
[142] 
Salvia s.s. clade I-D [17] [141], [142], [17], [143], 





Boiss. ex Benth. 
Prodr. 12: 284 
(1848) 
Sect. Aethiopis Benth. (as S. xanthochila) [145];  
 
Sect. Gongrosphace Briq. (sect. Aethiopis Benth. ex 
parte) (as S. xanthochila) [146];  
 
Sect. Aethiopis Benth. §. Gongrosphaceae Sect. 
Gongrosphace Bunge [147] 
Group D of Flora of Turkey 
[142];  
 
Group 3 of Flora Iranica 
[150] 









Subg. Sclarea Benth. Sect. Drymosphace Benth. [152] 
Ser. Miltiorrhizae C.Y.Wu [153]; 
 
Subg. Glutinaria (Raf.) G.X.Hu, C.L.Xiang & B.T.Drew, 
comb. & stat. nov. Sect. Drymosphace Benth [19] 
 Clade III + Japanese and 
Taiwanese Salvia [171]; 
 
Chinese clade, subclade i, 
group ii [28]; 
 
Salvia s.l. clade IV-B (Glutinaria 
Raf.) [17]; 
 
Subg. Glutinaria subclade 
Drymosphace (G7) (S. 
plectranthoides group) [19] 





Table 2. Structures of abietane diterpene quinones isolated from Salvia species 
c. n. Trivial name Structure Salvia species (organs) 
1 Royleanone 
 
S. aethiopis L. (roots) [187] 
S. anastomosans Ramamoorthy (roots) [188] 
S. austriaca Jacq. (hairy roots) [189] 
S. ballotiflora Benth. (aerial parts) [190] 
S. barrelieri Etl. (roots) [191] 
S. blepharochlaena Hedge & Hub.-Mor. (NS) [192] 
S. bucharica Popov (roots; NS) [193,194] 
S. cana Wall. ex Benth. (whole plant) [195] 
S. deserta Schangin (NS) [196,197] 
S. fruticosa Mill. (roots) [193] 
S. hydrangea DC. ex Benth. (roots) [194] 
S. korolkovii Regel & Schmalh. (roots) [194] 
S. kronenburgii Rech. f. (roots) [198] 
S. lanigera Poir. (roots) [199] 
S. mellifera Greene (roots) [200] 
S. moocroftiana Wall. ex Benth. (roots) [201] 
S. nemorosa L. (roots) [202] 
S. nutans L. (roots) [203] 
S. officinalis L. (whole plant) [204] 
S. officinalis subsp. lavandulifolia (Vahl) Gams 
(roots) [205] 
S. pachystachya Trautv. (aerial parts) [206] 
S. phlomoides Asso (roots) [207] 
S. pratensis L. (roots) [208] 
S. prionitis Hance (roots) [209] 
S. regla Cav. (aerial parts) [210] 
S. tomentosa Mill. (roots) [211] 






S. bracteata Banks & Sol. (roots) [213] 
S. cana Wall. ex Benth. (NS) [193] 
S. eriophora Boiss. & Kotschy (roots) [214] 
S. jaminiana de Noè (roots) [215] 
S. lanigera Poir. (roots) [216] 
S. moocroftiana Wall. ex Benth. (roots) [217] 
S. officinalis L. (whole plant) [204] 
S. officinalis subsp. lavandulifolia (Vahl) Gams 
(roots) [205] 
S. pratensis L. (roots) [218] 
S. tchihatcheffii (Fisch. & C.A.Mey.) Boiss. (NS) [193] 
S. tomentosa Mill. (roots) [211,219] 
S. verbenaca L. (roots) [193] 





S. nutans L. (roots) [194,203] 















S. bucharica Popov (roots) [194] 
S. hydrangea DC. ex Benth. (roots) [194] 
S. korolkovii Regel & Schmalh. (roots) [194] 
7 16-Hydroxyroyleanone 
 
S. apiana Jeps. (roots) [221] 
8 19-Hydroxyroyleanone 
 
S. chionopeplica Epling (leaves) [222] 
9 2β-Hydroxyroyleanone 
 
S. absconditiflora Greuter & Burdet (roots) [223] 
10 6α-Hydroxyroyleanone 
 
S. fruticosa Mill. (roots) [206] 
11 7β-Hydroxyroyleanone 
 
S. lanigera Poir. (roots) [193] 






























S. divaricata Montbret & Aucher ex Benth. (aerial 
parts) [226] 
17 Trilobic acid 
 

















S. candidissima Vahl subsp. candidissima. (roots) 
[228] 
S. blepharochlaena Hedge & Hub.-Mor. (roots) 
[192] 







S. candelabrum Boiss. (aerial parts) [230] 
22 Salviskinone A 
 









S. sessei Benth. (aerial part) [232] 
24 Deacetylsessein 
 
S. regla Cav. (aerial parts) [210] 
25 Sessein 
 
S. regla Cav. (aerial parts) [210,233] 











S. canariensis L. (flowers) [235] 
27 Atuntzensin A 
 
S. officinalis L. (leaves) [236] 
28 Hypargenin F 
 
S. hypargeia Fisch. & C.A.Mey. (roots) [237] 








S. ballotiflora Benth. (aerial parts) [190] 
S. nemorosa L. (roots) [202] 








S. anastomosans Ramamoorthy (roots) [188] 
S. cana Wall. ex Benth. (whole plant) [195] 
S. lanigera Poir. (roots) [216] 
S. leriifolia Benth. (roots) [240] 
S. nemorosa L. (roots) [202] 
S. pubescens Benth. (aerial parts) [239] 
31 7-Oxoroyleanone 
 








S. barrelieri Etl. (roots) [191] 
S. lanigera Poir. (roots) [193] 
S. moocroftiana Wall. ex Benth. (roots) [201] 
S. pratensis L. (roots) [218] 
S. sclarea L. (roots) [241] 
33 7α-Ethoxyroyleanone 
 























S. anastomosans Ramamoorthy (aerial parts) [242] 
S. ballotiflora Benth. (aerial parts) [190] 
S. candicans M.Martens & Galeotti (aerial parts) 
[243] 
S. corrugata Vahl (aerial parts) C [224] 
S. pubescens Benth. (aerial parts) [239] 




















S. candicans M.Martens & Galeotti (aerial parts) 
[243] 
S. pubescens Benth. (aerial parts) [244] 






S. bracteata Banks & Sol. (roots) [213]  





S. miltiorrhiza Bunge (roots) [246] 
S. regla Cav. (aerial parts) [233] 
42 Columbaridione 
 
S. columbariae Benth. (aerial parts) [247] 
S. officinalis L. (leaves) [236] 




S. absconditiflora Greuter & Burdet (roots) [223] 
S. amplexicaulis Lam. (roots) [192] 
S. anastomosans Ramamoorthy (roots) [188] 
S. austriaca Jacq. (roots) [211] 
S. barrelieri Etl. (roots) [191] 
S. blepharochlaena Hedge & Hub.-Mor. (roots) 
[249] 
S. bracteata Banks & Sol. (roots) [213] 
S. cana Wall. ex Benth. (roots) [194] 
S. candidissima subsp. occidentalis Hedge (roots) 
[193,238] 
S. carduacea Benth. (roots) [250] 
S. chionantha Boiss. (aerial parts) [251] 
S. deserta Schangin (roots) [214] 
S. eriophora Boiss. & Kotschy (roots) [223] 
S. eriophora Boiss. & Kotschy (roots) [206] 
S. fruticosa Mill. (roots) [211];[237] 
S. hypargeia Fisch. & C.A.Mey. (roots) [214],[237] 
S. korolkovii Regel & Schmalh. (whole plant) [250] 
S. kronenburgii Rech. f. (aerial parts) [252] 
S. lavanduloides Kunth (roots) [195] 
S. mellifera Greene (roots) [200] 
S. moocroftiana Wall. ex Benth. (roots) [228] 
S. multicaulis Vahl (roots) [201,253] 
S. munzii Epling (leaves; roots) [229,254] 
S. napifolia Jacq. (roots) [241,253] 
S. nemorosa L. (aerial parts; roots) [229,255] 
S. nutans L. (whole plant) [203] 
S. officinalis L. (aerial plant) [204] 
S. pachystachya Trautv. (aerial plant) [206] 
S. palaestina Benth. (roots) [256] 
S. pisidica Boiss. & Heldr.ex Benth. (roots)  [257] 
S. potentillifolia Boiss. & Heldr. ex Benth. (roots) 
[223] 
S. pratensis L. (roots) [258] 
S. sahendica Boiss. & Buhse (roots) [188] 
S. semiatrata Zucc. (roots) [208] 
S. tomentosa Mill. (roots) [206] 
S. verbenaca L. (roots) [216],  
S. verticillata L. (roots) [259] 
S. virgata Jacq. (roots) (ULUBELEN 1992 CHEMISTRY 
AND PHARMACOLOGY OF TURKISH SALVIA SPECIES) 
S. viridis L. (NS; roots) [212,260] 


















S. multicaulis Vahl (roots) [245] 
S. recognita Fisch. & C.A.Mey. (roots) [261] 





















S. blepharochlaena Hedge & Hub.-Mor. (roots) 
[249] 
S. bracteata Banks & Sol (roots) [213] 
S. candidissima subsp. occidentalis Hedge (roots) 
[262] 
S. napifolia Jacq. (roots) [229] 







S. deserta Schangin (NS) [197,263] 








S. officinalis subsp. lavandulifolia (Vahl) Gams 
(roots) [205] 
51 Horminone tautomer 
 






S. viridis L. 'Blue Denim' (whole plant) [265] 
53 Horminone-18-oic acid 
 
S. divaricata Montbret & Aucher ex Benth. (aerial 
parts) [226] 
54 Isotanshinone II B 
 




S. mellifera Greene (roots) [200] 
S. miltiorrhiza Bunge (roots) [267]  
56 Isotanshinone II 
(Isotanshinone IIA) 
 
S. glutinosa L. (roots) [211] 
S. miltiorrhiza Bunge (roots) [267,268] 
S. yunnanensis C.H.Wright (roots) [269]  
57 Miltionone I 
 
S. miltiorrhiza Bunge (roots) [270] 
58 Miltionone II 
 
S. columbariae Benth. (roots) [271] 











S. rythidea Benth. (roots) [273] 
S. lanigera Poir. (roots) [193] 




S. miltiorrhiza Bunge [275] 




S. castanea Diels (whole plant) [276] 
63 Salvialerione 
 
S. lanigera Poir. (roots) [277] 
S. leriifolia Benth. (whole plant) [278] 
64 Danshenxinkun A 
 
S. miltiorrhiza Bunge (roots) [274] 
S. przewalskii Maxim. (roots) [279] 
65 Danshenxinkun B 
 
S. glutinosa L. (roots) [211] 
S. miltiorrhiza Bunge (roots) [274] 
S. prionitis Hance (roots) [193] 
S. przewalskii Maxim. (roots) [279] 
S. yunnanensis C.H.Wright (roots) [280] 
66 Oleoyldanshenxinkun A 
 
S. miltiorrhiza Bunge (roots) [275] 
119 
 
67 Danshenxinkun C 
 
S. miltiorrhiza Bunge (roots) [268] 
68 Danshenxinkun D 
 
S. miltiorrhiza Bunge (roots) [266] 
S. prionitis Hance (roots) [193] 









S. dichroantha Stapf (roots) [283] 
71 Taxodione 
 
S. austriaca Jacq. (hairy roots) [189,284] 
S. chorassanica Bunge (roots) [285] 
S. deserta Schangin (roots) [251] 
S. hypargeia Fisch. & C.A.Mey. (roots) [213] 
S. lachnocalyx Hedge (roots) [286] 
S. lanigera Poir. (roots) [199] 
S. mellifera Greene (roots) [200] 
S. montbretii Benth. (whole plant) [238] 
S. moocroftiana Wall. ex Benth. (roots) [287] 
S. munzii Epling (leaves; roots) [253] 
S. nipponica Miq. (roots) [274] 
S. oaxacana Fernald (aerial parts) [248] 
S. pachystachya Trautv. (aerial parts) [206] 
S. phlomoides Asso (roots) [207] 
S. prionitis Hance (roots) [288] 
S. rythidea Benth. (roots) [273] 
S. verbenaca L. (roots) [216] 

















O O  
S. austriaca Jacq. (hairy roots) [189] 
75 7-Hydroxytaxodione 
 




S. austriaca Jacq. (hairy roots) [292] 
S. munzii Epling (leaves; roots) [253] 







S. semiatrata Zucc. (roots) [188] 
S. thymoides Benth. (roots) [188] 














S. thymoides Benth. (roots)   












S. leriifolia Benth. (roots) [240] 
82 Isotanshinone I 
 
S. glutinosa L. (roots) [211] 
S. miltiorrhiza Bunge (roots) [267] 
S. trijuga Diels (roots) [294] 
83 Dihydroisotanshinone I 
 
S. glutinosa L. (roots) [211]  
S. miltiorrhiza Bunge (roots) [268] 
S. prionitis Hance (roots) [193] 
84 Aegyptinone A 
 
S. aegyptiaca L. (roots) [199] 
S. tebesana Bunge (roots) [295] 
85 Aegyptinone B 
 
S. aegyptiaca L. (roots) [199] 
S. tebesana Bunge (roots) [295] 
86 Aegyptinone C 
 
S. aegyptiaca L. (roots) [296] 
87 Aegyptinone D 
 
S. aegyptiaca L. (roots) [297] 
88 Tebesinone B O
O
OH  
S. tebesana Bunge (roots) [295] 
89 Anastomosine 
 
S. anastomosans Ramamoorthy (aerial parts) [242] 
S. ballotiflora Benth. (aerial parts) [298] 







S. anastomosans Ramamoorthy (roots) [188,298] 
S. ballotiflora Benth. (aerial parts) [298] 
91 Fruticulin A 
 
S. fruticulosa Benth. (aerial parts) [299] 
92 Demethylfruticulin A 
 
S. arizonica A.Gray (aerial parts) [300] 
S. corrugata Vahl (aerial parts) [67] 
S. fruticulosa Benth. (aerial parts) [299] 
93 7,20-Dihydrofruticuline A 
 
S. corrugata Vahl (aerial parts) [224] 
S. lachnostachys Benth. (leaves) [301] 
94 Fruticulin B 
 
S. fruticulosa Benth. (aerial parts) [299] 
95 Fruticulin C 
 
S. corrugata Vahl (aerial parts) [225] 
96 Isofruticuline A 
 
S. lachnostachys Benth. (leaves) [301] 
97 Icetexone 
 
S. anastomosans Ramamoorthy (aerial parts) [242] 
S. ballotiflora Benth. (aerial parts) [302,303] 
S. candicans M.Martens & Galeotti (aerial parts) 
[243] 














S. pubescens Benth. (aerial parts) [248] 
101 5-Epi-icetexone 
 
S. cuspidata subsp. gilliesii (Benth.) J.R.I.Wood 
(aerial parts) [304] 
102 Xantoquinone 
 
S. xanthocheila Boiss. ex Benth. (aerial parts) [305] 
103 Tanshinone II 
Tanshinone II A 
 
S. aerea H.Lév. (roots) [306] 
S. bowleyana Dunn (NS) [307] 
S. brevilabra Franch. (NS) 
S. bulleyana Diels (aerial parts, roots) [308] 
S. campanulata Wall. ex Benth. (NS) [197,307] 
S. castanea Diels (aerial parts, roots; whole plant) 
[197,307] 
S. cavaleriei var. simplicifolia E.Peter-Stibal (whole 
plant) [197,276,306,307] 
S. coccinea Buc'hoz ex Etl. (NS) [271] 
S. columbariae Benth. (roots) [308] 
S. cynica Dunn (NS) [197,307]  
S. dabieshanensis J.Q.He (NS) [308] 
S. digitaloides Diels (roots) [309] 
S. evansiana Hand.-Mazz. (aerial parts, roots) 
[197,307] 
S. flava Forrest ex Diels (aerial parts, roots) 
[197,307] 
S. fruticosa Mill. (roots) [193] 
S. glutinosa L.(roots) [310] 
S. hians Royle ex Benth. (roots) [311] 
S. kiaometiensis H.Lév. (roots) [312] 
S. maximowicziana Hemsl. (NS) [197,307] 
S. meiliensis S.W.Su (NS) [197,307] 
S. miltiorrhiza Bunge (roots) [313] 
S. nanchuanensis Y.Z.Sun (NS) [197,314] 
S. paramiltiorrhiza H.W.Li & X.L.Huang (aerial parts, 
roots) [308] 
S. plectranthoides Griff. (NS) [197] 
S. pratii Hemsl. (roots) [315] 
S. przewalskii Maxim. (roots) [279] 
S. roborowskii Maxim. (roots) [197] 
S. schizochila E.Peter-Stibal (NS) [197] 
S. sinica Migo (aerial parts, roots) [308] 
S. stibalii Alziar (aerial parts, roots) [197] 
124 
 
S. subpalmatinervis E.Peter-Stibal (NS) [246] 
S. tricuspis Franch. (NS) [308] 
S. trijuga Diels (roots) [308] 
S. umbratica Hance (aerial parts, roots) [197,316] 
S. vasta H.W.Li (roots) [197] 
S. yunnanensis C.H.Wright (roots; whole plant) 
[317],[280] 
104 17-Hydroxytanshinone II 
 
S. castanea Diels (roots) [306] 
S. miltiorrhiza Bunge (roots) [318] 
S. munzii Epling (roots) [253] 
S. przewalskii Maxim. (roots) [193] 
105 Tanshindiol A 
 
S. miltiorrhiza Bunge (roots) [319] 
106 Tanshindiol B 
 
S. miltiorrhiza Bunge (roots) [319] 
S. przewalskii Maxim. (roots) [193] 
107 Tanshindiol C 
 
S. kiaometiensis H.Lév. (roots) [312] 
S. miltiorrhiza Bunge (roots) [268,319] 
S. przewalskii Maxim. (roots) [193] 
108 Nortanshinone 
 
S. miltiorrhiza Bunge (roots) [319] 
S. przewalskii Maxim. (roots) [279] 




S. brevilabra Franch.(NS) [308] 
S. castanea Diels (roots) [276] 
S. coccinea Buc'hoz ex Etl. (NS) [308] 
S. cynica Dunn (NS) [308] 
S. fruticosa Mill. (roots) [193] 
S. miltiorrhiza Bunge (roots) 
[246,267,268,311,313,320] 
S. nanchuanensis Y.Z.Sun (NS) [308] 
S. przewalskii Maxim. (roots) [246,279] 
S. schizochila E.Peter-Stibal (NS) [308] 
S. subpalmatinervis E.Peter-Stibal (NS) [308] 
S. tricuspis Franch. (NS) [308]  
S. trijuga Diels (roots) [246] 
S. yunnanensis C.H.Wright (roots) [280] 
125 
 
110 Tanshinone II B 
 
S. castanea Diels (whole plant) [321] 
S. miltiorrhiza Bunge (roots) [267] 
S. przewalskii Maxim. (roots) [279] 







S. trijuga Diels (roots) [246] 






S. miltiorrhiza Bunge (roots) [313,319,320] 
S. przewalskii Maxim. (roots) [193] 
S. trijuga Diels (roots) [219] 






S. przewalskii Maxim. (roots) [246] 
114 3α,17-







S. hians Royle ex Benth. (roots) [311] 
S. przewalskii Maxim. (roots) [193] 
115 3α-Hydroxytanshinone II 
A 
 
S. miltiorrhiza Bunge (roots) [319] 
S. trijuga Diels (roots) [193] 
116 1,2 Dehydrotanshinone II 
A 
 
S. cuspidata Ruiz & Pav. (aerial parts) [322] 
S. cuspidata subsp. gilliesii (Benth.) J.R.I.Wood 
(aerial parts) [304] 
S. honania L.H.Bailey (NS) [307] 
S. kiangsiensis C.Y.Wu (NS) [307] 
S. miltiorrhiza Bunge (roots) [277] 
S. sahendica Boiss. & Buhse (roots) [258] 





S. przewalskii Maxim. (roots) [193] 
126 
 
118 Przewaquinone D 
 
S. przewalskii Maxim. (roots) [323] 











S. miltiorrhiza Bunge (roots) [313] 
S. przewalskii Maxim. (roots) [193] 
121 Cryptotanshinone 
 
S. aerea H.Lév. (roots) [306] 
S. apiana Jeps. (roots) [221] 
S. axillaris Moc. & Sessé ex Benth. (aerial parts; 
roots) [193,298] 
S. bulleyana Diels (aerial parts; roots) [197,307] 
S. campanulata Wall. ex Benth. (NS) [197,307] 
S. castanea Diels (aerial part; roots; whole plant) 
[197,276,306,307] 
S. cavaleriei var. simplicifolia E.Peter-Stibal (herbs) 
[197,307] 
S. columbariae Benth. (roots) [271] 
S. dabieshanensis J.Q.He (NS) [197,307] 
S. digitaloides Diels (roots) [309] 
S. drobovii Botsch. (roots) [193] 
S. evansiana Hand.-Mazz. (aerial part; roots) 
[197,307] 
S. flava Forrest ex Diels (aerial part; roots) [197,307] 
S. glutinosa L. (roots) [211] 
S. karabachensis Pobed. (NS) [193] 
S. kiaometiensis H.Lév. (roots) [312] 
S. maximowicziana Hemsl. (NS) [197,307] 
S. meiliensis S.W.Su (NS) [197,307] 
S. mellifera Greene (roots) [253] 
S. miltiorrhiza Bunge (roots) [253,267,274] 
S. munzii Epling (leaves;roots) [253] 
S. paramiltiorrhiza H.W.Li & X.L.Huang (aerial part; 
roots) [197] 
S. plectranthoides Griff. (aerial part; roots) [197] 
S. pratii Hemsl. (roots) [315] 
S. przewalskii Maxim. [279] 
S. roborowskii Maxim. (roots) [197] 
S. sinica Migo (aerial part; roots) [197] 
S. stibalii Alziar (NS) [197] 
S. trautvetteri Regel (roots) [193] 
S. trijuga Diels (roots) [193] 
S. umbratica Hance (aerial part; roots) [197] 
S. vasta H.W.Li (NS) [197,307] 






















S. miltiorrhiza Bunge (roots) [326] 
125 Trijuganone A 
 
S. trijuga Diels (roots) [282] 
126 Trijuganone B 
 
S. castanea Diels (whole plant) [276] 
S. miltiorrhiza Bunge (roots) [246] 
127 Trijuganone C 
 
S. trijuga Diels (roots) [193] 
128 Tanshinone I 
 
S. aerea H.Lév. (roots) [306] 
S. bowleyana Dunn (NS) [307] 
S. brevilabra Franch. (NS) [308] 
S. bulleyana Diels[197,307] 
S. campanulata Wall. ex Benth. (NS) [197,307] 
S. castanea Diels (roots) [197,276,306,307] 
S. cavaleriei var. simplicifolia E.Peter-Stibal (NS) 
[197,307] 
S. coccinea Buc'hoz ex Etl. (NS) [308] 
S. cynica Dunn (NS) [308] 
S. dabieshanensis J.Q.He (NS) [197,307] 
S. digitaloides Diels (roots) [309] 
S. drobovii Botsch. (roots) [193] 




S. flava Forrest ex Diels (aerial parts, roots) 
[197,307] 
S. fruticosa Mill. (roots) [193] 
S. glutinosa L. (roots) [211] 
S. kiaometiensis H.Lév. (roots) [312] 
S. maximowicziana Hemsl. (aerial parts, roots) 
[197,307] 
S. meiliensis S.W.Su (NS) [197,307] 
S. miltiorrhiza Bunge (roots) [274] 
S. nanchuanensis Y.Z.Sun (NS) [308] 
S. paramiltiorrhiza H.W.Li & X.L.Huang (aerial parts, 
roots) [197,307] 
S. plectranthoides Griff. (NS) [197] 
S. pratii Hemsl. (NS) [197] 
S. przewalskii Maxim. (roots) [193] 
S. roborowskii Maxim. (roots) [197] 
S. schizochila E.Peter-Stibal (NS) [308] 
S. sinica Migo (aerial parts, roots) [197] 
S. stibalii Alziar (aerial parts, roots) [197] 
S. subpalmatinervis E.Peter-Stibal (NS) [308] 
S. tricuspis Franch. (NS) [308] 
S. trijuga Diels (roots) [193] 
S. umbratica Hance (aerial parts, roots) [197] 
S. vasta H. W.Li (roots) [197,307] 
S. wardii E.Peter-Stibal (NS) [308] 
S. yunnanensis C.H.Wright (roots) [280,317] 
129 Dihydrotanshinone I 
 
S. castanea Diels (whole plant) [276] 
S. digitaloides Diels (roots) [309] 
S. aerea H.Lév. (roots) [306] 
S. campanulata Wall. ex Benth. (NS) [197,307] 
S. castanea Diels (aerial parts, roots) [197,307] 
S. cavaleriei var. simplicifolia E.Peter-Stibal (herbs) 
[197,307] 
S. castanea Diels (roots) [306] 
S. dabieshanensis J.Q.He (NS) [197,307] 
S. evansiana Hand.-Mazz. (aerial parts, roots) 
[197,307] 
S. flava Forrest ex Diels (aerial parts, roots) 
[197,307] 
S. glutinosa L. (roots) [211] 
S. kiaometiensis H.Lév. (roots) [312] 
S. maximowicziana Hemsl. [197,307] 
S. meiliensis S.W.Su (NS) [197,307] 
S. nipponica Miq. (roots) [274] 
S. paramiltiorrhiza H.W.Li & X.L.Huang (aerial parts, 
roots) [197,318] 
S. stibalii Alziar (aerial parts, roots) [197] 
S. plectranthoides Griff. (NS) [197] 
S. przewalskii Maxim. (roots) [279] 
S. roborowskii Maxim. (roots) [197] 
S. sinica Migo (aerial parts, roots) [197] 
S. trijuga Diels (roots) [246] 
S. umbratica Hance (aerial parts, roots) [197] 
S. vasta H.W.Li (NS) [197,307] 
S. yunnanensis C.H.Wright (roots) [269] 
S. omeiana E.Peter-Stibal (NS) [197]  





S. miltiorrhiza Bunge (roots) [268] 
131 Przewaquinone B 
 
S. castanea Diels (roots) [306] 
S. miltiorrhiza Bunge (roots) [318] 
S. przewalskii Maxim. (roots) [246] 
132 Salvipisone 
 
S. aethiopis L. (roots) [187] 
S. argentea L. (roots) [205] 
S. candidissima Vahl subsp. candidissima. (roots) 
[228] 
S. candidissima subsp. occidentalis Hedge (roots) 
[238] 
S. ceratophylla L. (roots) [327] 
S. cyanescens Boiss. & Balansa (aerial parts) [328] 
S. eriophora Boiss. & Kotschy (roots) [214] 
S. kronenburgii Rech. f. (NS) [198] 
S. nemorosa L. (aerial parts) [241] 
S. sclarea L. (hairy roots; roots) [228,329] 
S. verticillata L. (roots) [330] 
133 12-Deoxysalvipisone 
 
S. rythidea Benth. (roots) [331] 
134 Acetylsalvipisone 
 
S. sclarea L. (roots) [228] 
135 1-Oxosalvipisone 
 
S. candidissima Vahl (aerial parts) [332] 





S. candidissima Vahl subsp. occidentalis Hedge 
(aerial parts) [332] 





S. argentea L. (roots) [306] 
S. candidissima Vahl subsp. candidissima. (roots) 
[228] 
S. sclarea L. (roots) [241] 




S. eriophora Boiss. & Kotschy (roots) [214] 
S. prionitis Hance (NS) [204,209] 
139 Limbinal 
 
S. limbata C.A.Mey. (aerial parts) [259] 
S. mellifera Greene (aerial parts) [228] 
140 Prineoparaquinone 
 
S. prionitis Hance (roots) [288] 
141 Prionoid D 
 
S. prionitis Hance (roots) [334] 
142 Prionoid E 
 
S. prionitis Hance (roots) [334] 
143 Prionoid F 
 






S. cyanescens Boiss. & Balansa (aerial parts) [328] 
145 4-Dihydrosalvipisone 
 
S. eriophora Boiss. & Kotschy (roots) [214] 
S. kronenburgii Rech. f. (roots) [198] 
S. limbata C.A.Mey. (roots) [290] 
S. prionitis Hance (NS) [193] 





S. lachnocalyx Hedge (roots) [286] 
S. sahendica Boiss. & Buhse (roots) [258] 





S. aethiopis L. (ns) [325] 
S. argentea L. (roots) [205] 
S. candidissima subsp. occidentalis Hedge (roots) 
[262] 
S. ceratophylla L. (roots) [327] 
S. cyanescens Boiss. & Balansa (aerial parts) [328] 
S. eriophora Boiss. & Kotschy (roots) [214] 
S. hypargeia Fisch. & C.A.Mey. (roots) [335] 
S. palaestina Benth. (aerial parts) [336] 
S. sclarea L. (hairy roots; roots) [228,329] 
S. viridis L. (roots) [337] 
148 1-oxoaethiopinone 
 
S. argentea L. (roots) [205] 
S. sclarea L. (hary roots) [338] 
149 Salvisyrianone 
 











S. hypargeia Fisch. & C.A.Mey. (roots) [335] 
S. prionitis Hance (roots) [340] 
152 Sclareapinone 
 
S. prionitis Hance (roots) [341] 

















S. candelabrum Boiss. (aerial parts) [230] 
155 Tanshinone V 
 
S. miltiorrhiza Bunge (roots) [342] 
156 Tanshinone VI 
 
S. miltiorrhiza Bunge (roots) [193] 
157 Grandifolia D 
 





S. argentea L. (roots) [205] 
S. drobovii Botsch. (roots) [193] 
S. kiaometiensis H.Lév. (roots) [312] 
S. miltiorrhiza Bunge (roots) [344] 
S. officinalis L. (roots) [236] 
S. prionitis Hance (roots) [209] 
S. rythidea Benth. (roots) [331] 
159 1(R)-Hydroxymiltirone 
 
S. argentea L. (roots) [205] 
160 1,2-Didehydromiltirone 
 
S. castanea Diels (whole plant) [276] 
S. miltiorrhiza Bunge (roots) [268,326] 
S. przewalskii Maxim. (roots) [246] 
S. trijuga Diels (roots) [294] 
S. yunnanensis C.H.Wright (whole plant) [317] 
161 Saligerone 
 
S. lanigera Poir. (roots) [193] 
162 4-Methylenemiltirone 
 
S. miltiorrhiza Bunge (roots) [268,326] 
163 Salviphlomone 
 
S. phlomoides Asso (roots) [207] 
164 7-Deoxysalviphlomone 
 















S. canariensis L. (flowers) [235] 
167 6,7-Dideoxisalviphlomone 
 
S. candidissima Vahl subsp. candidissima. (roots) 
[228] 
S. hypargeia Fisch. & C.A.Mey. (roots) [335] 
S. miltiorrhiza Bunge (roots) [268] 
S. napifolia Jacq. (roots) [229] 
168 Viridoquinone 
 
S. viridis L. 'Blue Denim' (whole plant) [265] 
169 Przewalskin E 
 
S. przewalskii Maxim. (whole plant) [345] 
170 Przewalskin G 
 




hexaene-11, 12-dione)]   
 
S. glutinosa L. (roots) [211] 






S. blepharochlaena Hedge & Hub.-Mor. (roots) 
[249] 





S. blepharochlaena Hedge & Hub.-Mor. (roots) 
[249] 


















Salvia tingitana Etl. 
 
 
Figure S1: 1H NMR (600 MHz, CDCl3) spectrum of compound 1 
 
 




Figure S3. HMBC (600 MHz, CDCl3) spectrum of compound 1 
 
 





Figure S5. 1D TOCSY (600 MHz, CDCl3) spectrum of compound 1 
 
 












Figure S7. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 1, where 4R 













Figure S8. HRESIMS spectrum of compound 1 
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Figure S9. 1H NMR (600 MHz, CDCl3) spectrum of compound 2 
 
 





Figure S11. HSQC (600 MHz, CDCl3) spectrum of compound 2 
 
 





Figure S13. COSY (600 MHz, CDCl3) spectrum of compound 2 
 
 












Figure S15. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 2, where 4R 
stands for 4R5R8R9R10S 
 
 
Figure S16. Comparison of experimental and computed IR (CDCl3) spectra for compound 2, where 4R stands for 
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Figure S17. Comparison of experimental and computed VCD in CDCl3 spectra for compound 2 (A). Similarities (SimVA and 
SimVCD) between experimental and computed VA and VCD spectra of 2 were plotted as functions of wavenumber scale 
factor (B). 4R stands for 4R5R8R9R10S. The wavenumber scale factor corresponding to the maximal SimVA value in B 













Figure S18. HRESIMS spectrum of compound 2 
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Figure S19. 1H NMR (600 MHz, CDCl3) spectrum of compound 3 
 
 





Figure S21. HMBC (600 MHz, CDCl3) spectrum of compound 3 
 
 





Figure S23. NOESY (500 MHz, CDCl3) spectrum of compound 3 
 
 
Figure S24. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 3, where 4R 
stands for 4R5R8R9R10S 
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Figure S25. Comparison of experimental and computed IR (CDCl3) spectra for compound 3, where 4R stands for 
4R5R8R9R10S. The wavenumber scale factor 0.9845 was used to scale the computed spectra 
 
 
Figure S26. Comparison of experimental and computed VCD in CDCl3 spectra for compound 3 (A). Similarities (SimVA and 
SimVCD) between experimental and computed VA and VCD spectra of 3 were plotted as functions of wavenumber scale 
factor (B). 4R stands for 4R5R8R9R10S. The wavenumber scale factor corresponding to the maximal SimVA value in B 
(0.9845) was used to scale the computed spectra in A 
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Figure S27. HRESIMS spectrum of compound 3 
 
 





Figure S29. 13C NMR (125 MHz, CDCl3) spectrum of compound 4 
 
 





Figure S31. HMBC (600 MHz, CDCl3) spectrum of compound 4 
 
 





Figure S33. NOESY (500 MHz, CDCl3) spectrum of compound 4 
 
 
Figure S34. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 4, where 4R 
stands for 4R5R8R9R10S 
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Figure S35. HRESIMS spectrum of compound 4 
 
 





Figure S37. 13C NMR (125 MHz, CDCl3) spectrum of compound 5 
 
 





Figure S39. HMBC (600 MHz, CDCl3) spectrum of compound 5 
 
 





Figure S41. NOESY (500 MHz, CDCl3) spectrum of compound 5 
 
 
Figure S42. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 5, where 4R 
stands for 4R5R6S8R9R10S23S 
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Figure S43. HRESIMS spectrum of compound 5 
 
 





Figure S45. HSQC (600 MHz, CDCl3) spectrum of compound 6 
 
 





Figure S47. COSY (600 MHz, CDCl3) spectrum of compound 6 
 
 





Figure S49. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 6, where 4R 
stands for 4R5R6S8R9R10S23S 
 
 
Figure S50. Comparison of experimental and computed IR (CDCl3) spectra for compound 6, where 4R stands for 
4R5R6S8R9R10S23S. The wavenumber scale factor 0.9820 was used to scale the computed spectra 
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Figure S51. HRESIMS spectrum of compound 6 
 
 





Figure S53. HSQC (600 MHz, CDCl3) spectrum of compound 7 
 
 





Figure S55. ROESY (600 MHz, CDCl3) spectrum of compound 7 
 
 
Figure S56. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 7, where 4R 
stands for 4R5R6S8R9R10S23S 
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Figure S57. Comparison of experimental and computed IR (CDCl3) spectra for compound 7, where 4R stands for 
4R5R6S8R9R10S23S. The wavenumber scale factor 0.9820 was used to scale the computed spectra 
 
 
Figure S58. Comparison of experimental and computed VCD in CDCl3 spectra for compound 7 (A). Similarities (SimVA and 
SimVCD) between experimental and computed VA and VCD spectra of 7 were plotted as functions of wavenumber scale 
factor (B). 4R stands for 4R5R6S8R9R10S23S. The wavenumber scale factor corresponding to the maximal SimVA value in B 
(0.9820) was used to scale the computed spectra in A 
  







 Sim VCD calcd for 4R16R
 Sim VCD calcd for 4R16S
 Sim VA calcd for 4R16R










 exp. for compound 7
 calcd for 4R16R























 exp. for compound 7
 calcd for 4R16R





















Figure S59. HRESIMS spectrum of compound 7 
 
 




Figure S61. 13C NMR (125 MHz, CDCl3) spectrum of compound 8 
 
 





Figure S63. HMBC (600 MHz, CDCl3) spectrum of compound 8 
 
 





Figure S65. NOESY (500 MHz, CDCl3) spectrum of compound 8 
 
 
Figure S66. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 8, where 4R 
stands for 4R5R8R9R10S 
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Figure S67. HRESIMS spectrum of compound 8 
 
 





Figure S69. HSQC (600 MHz, CDCl3) spectrum of compound 9 
 
 





Figure S71. COSY (600 MHz, CDCl3) spectrum of compound 9 
 
 





Figure S73. NOESY (500 MHz, CDCl3) spectrum of compound 9 
 
 
Figure S74. Comparison of experimental and computed UV (A) and ECD (B) (CH3OH) spectra for compound 9, where 5S 
stands for 5S8R9R10S 
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Figure S76. Effect of sclareol (15) on viable cell number of selected susceptible Staphylococcus strains. Time-kill curves were 





Figure S77. Effect of total extract, n-hexane insoluble and soluble fractions and relative sub-fractions (Ia-VIa, Ib-VIb) on ATP 
synthesis in rod Outer Segments (OS). ATP synthesis by OS (5µg) in the presence of total extract, n-hexane insoluble and 
soluble fractions and relative sub-fractions (Ia-VIa, Ib-VIb) (80 µg/mL). Activity is expressed as μmol ATP produced/min/mg 
of total protein. All data were tested with one-way ANOVA (using MATLAB 2019a statistical toolkit). Mean and standard 
deviation of each measure are presented according to the standards of MATLAB boxplot. The application of Bonferroni 





Figure S78. Effect of total extract, n-hexane insoluble and soluble fractions and relative sub-fractions (Ia-VIa, Ib-VIb) on ATP 
hydrolysis activity in rod Outer Segments (OS). ATP hydrolysis by OS (5 µg) in the presence of total extract, n-hexane 
insoluble and soluble fractions and relative sub-fractions (Ia-VIa, Ib-VIb) (80 µg/mL). Positive control: 30 μM resveratrol. 
Activity is expressed as μmol ATP hydrolyzed/min/mg of total protein. All data were tested with one-way ANOVA (using 
MATLAB 2019a statistical toolkit), Mean and standard deviation of each measure is presented according to the standards 
of MATLAB boxplot. The application of Bonferroni method defined 3 groups (p < 0.05) indicated by colored rectangles. 
 
 
Figure S79. Analysis of the MD simulation of the reference complex (PDB code 2JJ2). In the first plot, the total energy of the 
system vs. time is reported; the second plot shows the RMSD of the ligand disposition from its crystallographic coordinates 
















Ib IIb IIIb IVb Vb VIb 
E. faecalis MB 1 
(VRE) 
128 128 >128 >128 >128 >128 >128 >128 >128 >128 128 64 128 >128 >128 
E. faecium MB 152 
(VRE) 
128 >128 >128 >128 >128 >128 >128 >128 128 >128 128 128 64 >128 >128 
S. aureus MB 18 
(MRSA) 
128 128 64 >128 >128 128 128 64 128 >128 >128 128 64 64 >128 
S. epidermidis MB 
165 (MRSE) 
>128 >128 32 64 64 128 64 32 64 >128 >128 128 128 128 >128 
S. agalactiae MB 149 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
S. pneumoniae MB 
35 
>128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
Proteus mirabilis MB 
14 
>128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
E.coli MB123 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
Moraxella catarrhalis 
MB 15 
>128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
Klebsiella 
pneumoniae MB 11 
>128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
C. albicans MB796 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
C. glabrata MB796 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
 
MIC values, expressed in μg/mL of total extract, n-hexane insoluble and soluble fractions and relative sub-fractions (Ia-VIa, Ib-VIb). MRSA: Methicillin resistant S. 








 EEL VDW ENPOLAR EPB ΔPBSA 
Pose 1 -5.12 -42.61 -4.16 42.75 -9.13 
Pose 2 -9.27 -44.18 -4.04 45.37 -12.12 
Pose 3 -11.42 -46.52 -3.81 40.36 -21.39 
 
ΔPBSA is the sum of the electrostatic (EEL) and van der Waals (VDW), as well as polar (EPB) and non-polar 


































































Fig.15. Work about Salvia corrugata published in 2019 by Life Sciences 
 
